{"article": "PMC10001958.txt", "subject": "insulin resistance", "relationship": "RELATED_PROGNOSIS", "object": "Risk of developing AD", "chunk": 1}
{"article": "PMC10001958.txt", "subject": "metabolic syndrome", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Development of dementia, especially AD", "chunk": 1}
{"article": "PMC10001958.txt", "subject": "type 2 diabetes mellitus (T2DM)", "relationship": "RELATED_PROGNOSIS", "object": "Risk of developing AD", "chunk": 1}
{"article": "PMC10001958.txt", "subject": "hypertension", "relationship": "RISK_FACTOR", "object": "AD", "chunk": 1}
{"article": "PMC10001958.txt", "subject": "hyperlipidemia", "relationship": "RISK_FACTOR", "object": "AD", "chunk": 1}
{"article": "PMC10001958.txt", "subject": "obesity", "relationship": "RISK_FACTOR", "object": "AD", "chunk": 1}
{"article": "PMC10001958.txt", "subject": "cholesterol", "relationship": "RELATED_TO", "object": "development of AD", "chunk": 2}
{"article": "PMC10001958.txt", "subject": "cholesterol", "relationship": "ASSOCIATED_WITH", "object": "compromised BBB integrity", "chunk": 2}
{"article": "PMC10001958.txt", "subject": "statins", "relationship": "ASSOCIATED_WITH", "object": "reduced incidence of AD or improvement in disease progression", "chunk": 2}
{"article": "PMC10001958.txt", "subject": "free fatty acids", "relationship": "ASSOCIATED_WITH", "object": "pucinous outcomes", "chunk": 2}
{"article": "PMC10001958.txt", "subject": "high fat diet", "relationship": "PROMOTES", "object": "AD pathogenesis", "chunk": 2}
{"article": "PMC10001958.txt", "subject": "polyunsaturated fatty acids", "relationship": "ASSOCIATED_WITH", "object": "protective effect against AD", "chunk": 2}
{"article": "PMC10001958.txt", "subject": "saturated fatty acids", "relationship": "PROMOTES", "object": "brain inflammatory response through TLR4 activation", "chunk": 2}
{"article": "PMC10001958.txt", "subject": "loss of function of TLR4", "relationship": "PROTECTS_AGAINST", "object": "high-fat-diet-induced deleterious effects", "chunk": 2}
{"article": "PMC10001958.txt", "subject": "free fatty acids", "relationship": "STIMULATES", "object": "assembly of both amyloid and tau filaments in vitro", "chunk": 2}
{"article": "PMC10001958.txt", "subject": "obesity", "relationship": "INCREASES", "object": "risk of suffering dementia", "chunk": 2}
{"article": "PMC10001958.txt", "subject": "sagittal abdominal diameter", "relationship": "CORRELATED_WITH", "object": "nearly a three-fold risk of developing dementia", "chunk": 2}
{"article": "PMC10001958.txt", "subject": "midlife obesity", "relationship": "INCREASES", "object": "risk of suffering dementia later in life", "chunk": 2}
{"article": "PMC10001958.txt", "subject": "midlife obesity", "relationship": "DECREASES", "object": "risk of suffering dementia when obesity occurs in old age", "chunk": 2}
{"article": "PMC10001958.txt", "subject": "diabetes mellitus (DM)", "relationship": "ASSOCIATED_WITH", "object": "higher risk of developing AD", "chunk": 2}
{"article": "PMC10001958.txt", "subject": "T2DM", "relationship": "RELATED_TO", "object": "insulin deficiency, insulin resistance, insulin receptor impairment, hyperglycaemia-induced toxicity, advanced glycation end products (AGEs)-induced adverse effects, inflammation and cerebrovascular damage", "chunk": 2}
{"article": "PMC10001958.txt", "subject": "insulin", "relationship": "INDICATES_PRESENCE_OF", "object": "Presence in the brain", "chunk": 3}
{"article": "PMC10001958.txt", "subject": "insulin", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Treatment selection for Diabetes Mellitus (DM)", "chunk": 3}
{"article": "PMC10001958.txt", "subject": "insulin", "relationship": "RELATED_TO", "object": "Glucose homeostasis and metabolism", "chunk": 3}
{"article": "PMC10001958.txt", "subject": "insulin", "relationship": "RELATED_TO", "object": "Central nervous system functions", "chunk": 3}
{"article": "PMC10001958.txt", "subject": "insulin", "relationship": "RELATED_TO", "object": "Synaptic plasticity, synapse density and neurotransmission", "chunk": 3}
{"article": "PMC10001958.txt", "subject": "insulin mRNA", "relationship": "INDICATES_PRESENCE_OF", "object": "Insulin production", "chunk": 3}
{"article": "PMC10001958.txt", "subject": "IR", "relationship": "RELATED_TREATMENT", "object": "Managing cognitive processes and metabolism", "chunk": 3}
{"article": "PMC10001958.txt", "subject": "IR", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Treating disease related to insulin signaling", "chunk": 3}
{"article": "PMC10001958.txt", "subject": "POMC", "relationship": "MONITORED_DURING_TREATMENT", "object": "Monitoring effect of insulin treatment", "chunk": 3}
{"article": "PMC10001958.txt", "subject": "Agrp", "relationship": "RELATED_PROGNOSIS", "object": "Prognosis of insulin signaling modulation", "chunk": 3}
{"article": "PMC10001958.txt", "subject": "insulin levels in the brain", "relationship": "MONITORED_DURING_TREATMENT", "object": "Monitoring treatment response concerning glucose metabolism", "chunk": 3}
{"article": "PMC10001958.txt", "subject": "A\u03b2 protein", "relationship": "COMMPETES_FOR_BINDING", "object": "Insulin-degrading enzyme (IDE)", "chunk": 4}
{"article": "PMC10001958.txt", "subject": "insulin", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "Improved memory", "chunk": 4}
{"article": "PMC10001958.txt", "subject": "insulin resistance", "relationship": "DIAGNOSITC_OF", "object": "Alzheimer's Disease", "chunk": 4}
{"article": "PMC10001958.txt", "subject": "insulin", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer's Disease", "chunk": 4}
{"article": "PMC10001958.txt", "subject": "hyperglycaemia", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Cognitive deficiencies", "chunk": 4}
{"article": "PMC10001958.txt", "subject": "insulin resistance", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Treatment for Alzheimer's Disease", "chunk": 4}
{"article": "PMC10001958.txt", "subject": "insulin", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Treatment for insulin resistance", "chunk": 4}
{"article": "PMC10001958.txt", "subject": "A\u03b2 protein", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 4}
{"article": "PMC10001958.txt", "subject": "Tau protein", "relationship": "RELATED_PROGNOSIS", "object": "Formation of Neurofibrillary tangles", "chunk": 4}
{"article": "PMC10001958.txt", "subject": "insulin", "relationship": "PREDICTS_SURVIVAL", "object": "Protection from cell death due to oxygen and glucose deprivation", "chunk": 4}
{"article": "PMC10001958.txt", "subject": "insulin signalling", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "Improved lifespan, delayed age-related processes", "chunk": 5}
{"article": "PMC10001958.txt", "subject": "insulin signalling", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Neurodegenerative disorderssss", "chunk": 5}
{"article": "PMC10001958.txt", "subject": "IGF-1 deficiency", "relationship": "RELATED_TREATMENT", "object": "Reversed premature mortality associated with AD", "chunk": 5}
{"article": "PMC10001958.txt", "subject": "IRS-2 deletion", "relationship": "RELATED_TREATMENT", "object": "Reduces A\u03b2 deposition and rescues behavioural deficits", "chunk": 5}
{"article": "PMC10001958.txt", "subject": "AQ4", "relationship": "DIAGNOSITC_OF", "object": "Levels downregulated in AD, leading to decreased clearance of A\u03b2", "chunk": 5}
{"article": "PMC10001958.txt", "subject": "AQ4", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Decreased clearance of A\u03b2 and possible protein accumulation", "chunk": 5}
{"article": "PMC10001958.txt", "subject": "AQ4", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Could be a target for therapeutic intervention in AD", "chunk": 5}
{"article": "PMC10001958.txt", "subject": "Glutamate", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": " Neuronal death caused by excessive postsynaptic receptor activity at glutamatergic synapses has been proposed to explain the pathogenesis of AD", "chunk": 6}
{"article": "PMC10001958.txt", "subject": "Glutamate", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "The overactivation of extra synaptic glutamatergic NMDA receptors, which is a consequence of glutamate release from astrocytes after exposure to A\u03b2, connects glutamate dyshomeostasis and the loss of synapses observed in AD", "chunk": 6}
{"article": "PMC10001958.txt", "subject": "ATP", "relationship": "INDICATES_PRESENCE_OF", "object": "Not only the release of glutamate from astrocytes, but also the release of ATP, D-serine and GABA are increased in AD", "chunk": 6}
{"article": "PMC10001958.txt", "subject": "D-serine", "relationship": "INDICATES_PRESENCE_OF", "object": "Not only the release of glutamate from astrocytes, but also the release of ATP, D-serine and GABA are increased in AD", "chunk": 6}
{"article": "PMC10001958.txt", "subject": "GABA", "relationship": "INDICATES_PRESENCE_OF", "object": "Not only the release of glutamate from astrocytes, but also the release of ATP, D-serine and GABA are increased in AD", "chunk": 6}
{"article": "PMC10001958.txt", "subject": "Insulin", "relationship": "RELATED_TREATMENT", "object": "targeting astrocytic insulin signalling may be more relevant as a way to treat AD because this may not only halt disease progression but also bypass the paradoxical actions of neuronal insulin", "chunk": 6}
{"article": "PMC10001958.txt", "subject": "insulin signalling", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "premature mortality associated with AD", "chunk": 7}
{"article": "PMC10001958.txt", "subject": "insulin signalling", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "delayed A\u03b2 accumulation", "chunk": 7}
{"article": "PMC10001958.txt", "subject": "insulin signalling", "relationship": "RELATED_TO_AGING", "object": "age-related processes", "chunk": 7}
{"article": "PMC10002844.txt", "subject": "bumetanide exposure", "relationship": "RELATED_TO_RISK", "object": "Reduced Alzheimer\u2019s Disease risk", "chunk": 1}
{"article": "PMC10002844.txt", "subject": "bumetanide exposure", "relationship": "INDICATES_PRESENCE_OF", "object": "Lower AD prevalence", "chunk": 1}
{"article": "PMC10002844.txt", "subject": "furosemide exposure", "relationship": "NOT_ASSOCIATED_WITH", "object": "Alzheimer\u2019s Disease risk", "chunk": 1}
{"article": "PMC10002844.txt", "subject": "socioeconomic status", "relationship": "CONTROLLING_VARIABLE", "object": "AD association with bumetanide", "chunk": 1}
{"article": "PMC10002844.txt", "subject": "congestive heart failure", "relationship": "CONTROLLING_VARIABLE", "object": "AD association with bumetanide", "chunk": 1}
{"article": "PMC10002844.txt", "subject": "bumetanide", "relationship": "INDICATES_TREATMENT_ELIGIBILITY", "object": "Past exposure to bumetanide", "chunk": 2}
{"article": "PMC10002844.txt", "subject": "bumetanide", "relationship": "RELATED_TREATMENT", "object": "Potential treatment for AD", "chunk": 2}
{"article": "PMC10002844.txt", "subject": "bumetanide", "relationship": "RELATED_PROGNOSIS", "object": "Reduced AD risk", "chunk": 2}
{"article": "PMC10002844.txt", "subject": "bumetanide", "relationship": "RELATED_PROGNOSIS", "object": "Increased AD risk", "chunk": 2}
{"article": "PMC10002844.txt", "subject": "bumetanide", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Similar side effect profile with furosemide suggests potential as an active placebo", "chunk": 2}
{"article": "PMC10013957.txt", "subject": "A\u03b2\u221242", "relationship": "RELATED_PROGNOSIS", "object": "Neurodegenerative diseases", "chunk": 1}
{"article": "PMC10013957.txt", "subject": "A\u03b2\u221242", "relationship": "DIAGNOSITC_OF", "object": "Alzheimer's Disease", "chunk": 1}
{"article": "PMC10013957.txt", "subject": "t-tau", "relationship": "DIAGNOSITC_OF", "object": "Alzheimer's Disease", "chunk": 1}
{"article": "PMC10013957.txt", "subject": "p-tau181", "relationship": "DIAGNOSITC_OF", "object": "Alzheimer's Disease", "chunk": 1}
{"article": "PMC10013957.txt", "subject": "A\u03b242", "relationship": "INDICATES_PRESENCE_OF", "object": "Beta-amyloid plaques", "chunk": 2}
{"article": "PMC10013957.txt", "subject": "A\u03b240", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "A\u03b242 is the more prone to aggregation form of Amyloid beta.", "chunk": 2}
{"article": "PMC10013957.txt", "subject": "A\u03b242", "relationship": "RELATED_TO", "object": "Neurofibrillary plaques", "chunk": 2}
{"article": "PMC10013957.txt", "subject": "tau protein", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Developing a treatment to target the abnormally phosphorylated tau protein", "chunk": 2}
{"article": "PMC10013957.txt", "subject": "A\u03b242", "relationship": "INDICATES_PRESENCE_OF", "object": "AD pathology", "chunk": 3}
{"article": "PMC10013957.txt", "subject": "t-tau", "relationship": "INDICATES_PRESENCE_OF", "object": "AD pathology", "chunk": 3}
{"article": "PMC10013957.txt", "subject": "p-tau", "relationship": "INDICATES_PRESENCE_OF", "object": "AD pathology", "chunk": 3}
{"article": "PMC10013957.txt", "subject": "A\u03b242", "relationship": "INDICATES_PRESENCE_OF", "object": "Amyloid plaque deposition in the brain", "chunk": 4}
{"article": "PMC10013957.txt", "subject": "p-tau", "relationship": "INDICATES_PRESENCE_OF", "object": "Increased tangle density in the brain", "chunk": 4}
{"article": "PMC10013957.txt", "subject": "A\u03b242/A\u03b240 ratio", "relationship": "DIAGNOSTIC_OF", "object": "Brain amyloidosis", "chunk": 4}
{"article": "PMC10013957.txt", "subject": "t-Tau/A\u03b242 ratio", "relationship": "DIAGNOSTIC_OF", "object": "Brain amyloidosis", "chunk": 4}
{"article": "PMC10013957.txt", "subject": "p-tau/A\u03b242 ratio", "relationship": "DIAGNOSTIC_OF", "object": "Brain amyloidosis", "chunk": 4}
{"article": "PMC10013957.txt", "subject": "A\u03b242", "relationship": "RELATED_TO", "object": "Neuritic plaque burden in the brain, determined by amyloid PET", "chunk": 4}
{"article": "PMC10013957.txt", "subject": "t-Tau", "relationship": "RELATED_TO", "object": "Increased intensity and spread of neuronal injury and neurodegeneration", "chunk": 4}
{"article": "PMC10013957.txt", "subject": "A\u03b242", "relationship": "PREDICT_INDICATES_SURVIVAL", "object": "When used in conjunction with amyloid PET, A\u03b242 has a higher sensitivity and specificity for detecting brain amyloidosis, leading to potentially closer monitoring of disease progression and potentially more informed treatment decisions.", "chunk": 4}
{"article": "PMC10013957.txt", "subject": "A\u03b242", "relationship": "INDICATES_PRESENCE_OF", "object": "AD", "chunk": 5}
{"article": "PMC10013957.txt", "subject": "A\u03b242", "relationship": "DIAGNOSITC_OF", "object": "AD neuropathology", "chunk": 5}
{"article": "PMC10013957.txt", "subject": "A\u03b242/A\u03b240", "relationship": "DIAGNOSITC_OF", "object": "AD neuropathology", "chunk": 5}
{"article": "PMC10013957.txt", "subject": "t-Tau", "relationship": "INDICATES_PRESENCE_OF", "object": "AD", "chunk": 5}
{"article": "PMC10013957.txt", "subject": "t-Tau", "relationship": "DIAGNOSITC_OF", "object": "AD neuropathology", "chunk": 5}
{"article": "PMC10013957.txt", "subject": "t-Tau/A\u03b242", "relationship": "DIAGNOSITC_OF", "object": "AD neuropathology", "chunk": 5}
{"article": "PMC10013957.txt", "subject": "p-tau", "relationship": "INDICATES_PRESENCE_OF", "object": "AD neuropathology", "chunk": 5}
{"article": "PMC10013957.txt", "subject": "p-tau/A\u03b242", "relationship": "DIAGNOSITC_OF", "object": "AD neuropathology", "chunk": 5}
{"article": "PMC10013957.txt", "subject": "A\u03b242", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 6}
{"article": "PMC10013957.txt", "subject": "t-Tau", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 6}
{"article": "PMC10013957.txt", "subject": "p-tau181", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 6}
{"article": "PMC10013957.txt", "subject": "A\u03b242", "relationship": "RELATED_TO_BIOMARKER_MEASUREMENT", "object": "Cerebral spinal fluid amyloid biomarker", "chunk": 7}
{"article": "PMC10013957.txt", "subject": "A\u03b242", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 7}
{"article": "PMC10013957.txt", "subject": "tau", "relationship": "RELATED_TO_BIOMARKER_MEASUREMENT", "object": "Cerebral spinal fluid amyloid biomarker", "chunk": 7}
{"article": "PMC10013957.txt", "subject": "p-tau", "relationship": "RELATED_TO_BIOMARKER_MEASUREMENT", "object": "Cerebral spinal fluid amyloid biomarker", "chunk": 7}
{"article": "PMC10013957.txt", "subject": "SCD", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive decline and dementia", "chunk": 8}
{"article": "PMC10013957.txt", "subject": "SCD", "relationship": "ASSOCIATED_WITH", "object": "Greater levels of neocortical A\u03b2-amyloid burden", "chunk": 8}
{"article": "PMC10013957.txt", "subject": "SCD", "relationship": "ASSOCIATED_WITH", "object": "Lower volumes of the hippocampus", "chunk": 8}
{"article": "PMC10013957.txt", "subject": "SCD", "relationship": "ASSOCIATED_WITH", "object": "Other AD signature areas", "chunk": 8}
{"article": "PMC10013957.txt", "subject": "SCD-plus", "relationship": "ASSOCIATED_WITH", "object": "Increased likelihood to be an expression of the preclinical stage of AD", "chunk": 8}
{"article": "PMC10013957.txt", "subject": "SCD-plus", "relationship": "ASSOCIATED_WITH", "object": "Future cognitive decline", "chunk": 8}
{"article": "PMC10013957.txt", "subject": "APOE \u03b54 genotype", "relationship": "ASSOCIATED_WITH", "object": "SCD", "chunk": 8}
{"article": "PMC10013957.txt", "subject": "Positive AD biomarkers", "relationship": "RELATED_TO", "object": "Life decisions", "chunk": 8}
{"article": "PMC10013957.txt", "subject": "Negative AD biomarkers", "relationship": "RELATED_TO", "object": "Further testing for alternative etiologies", "chunk": 8}
{"article": "PMC10013957.txt", "subject": "SCD with low index of suspicion for AD", "relationship": "ASSOCIATED_WITH", "object": "Lower likelihood to progress to cognitive decline, MCI, or AD over time", "chunk": 8}
{"article": "PMC10013957.txt", "subject": "Mild cognitive impairment", "relationship": "ASSOCIATED_WITH", "object": "An increased risk of progression to dementia", "chunk": 8}
{"article": "PMC10013957.txt", "subject": "Amnestic mild cognitive impairment", "relationship": "PREDICTS_SURVIVAL", "object": "AD", "chunk": 8}
{"article": "PMC10013957.txt", "subject": "Logopenic PPA", "relationship": "INDICATES_PRESENCE_OF", "object": "AD pathology", "chunk": 8}
{"article": "PMC10013957.txt", "subject": "PCA", "relationship": "INDICATES_PRESENCE_OF", "object": "AD pathology", "chunk": 8}
{"article": "PMC10013957.txt", "subject": "AD cerebral spinal fluid biomarker profile", "relationship": "PREDICTORS", "object": "Progression to dementia", "chunk": 8}
{"article": "PMC10013957.txt", "subject": "cerebral spinal fluid biomarkers", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Therapy or interventions", "chunk": 8}
{"article": "PMC10013957.txt", "subject": "cerebral spinal fluid biomarkers", "relationship": "INDICATES_PRESENCE_OF", "object": "AD", "chunk": 9}
{"article": "PMC10013957.txt", "subject": "cerebral spinal fluid biomarkers", "relationship": "RELATED_TO_PROGNOSIS", "object": "Younger onset dementia", "chunk": 9}
{"article": "PMC10013957.txt", "subject": "cerebral spinal fluid biomarkers", "relationship": "USED_TO_DIAGNOSE", "object": "AD dementia, FTD", "chunk": 9}
{"article": "PMC10013957.txt", "subject": "cerebral spinal fluid biomarkers", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Clinical diagnosis", "chunk": 9}
{"article": "PMC10013957.txt", "subject": "APOE\u03b54 allele", "relationship": "DIAGNOSITC_OF", "object": "Late onset AD", "chunk": 9}
{"article": "PMC10013957.txt", "subject": "cerebral spinal fluid amyloid", "relationship": "DIAGNOSTIC_OF", "object": "Cerebral amyloidosis", "chunk": 11}
{"article": "PMC10013957.txt", "subject": "cerebral spinal fluid amyloid", "relationship": "INDICATES_PRESENCE_OF", "object": "Cerebral amyloidosis", "chunk": 11}
{"article": "PMC10013957.txt", "subject": "total tau", "relationship": "RELATED_TO", "object": "AD pathology", "chunk": 11}
{"article": "PMC10013957.txt", "subject": "phosphorylated tau", "relationship": "RELATED_TO", "object": "AD pathology", "chunk": 11}
{"article": "PMC10013957.txt", "subject": "A\u03b242", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Testing", "chunk": 11}
{"article": "PMC10013957.txt", "subject": "t-Tau", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Testing", "chunk": 11}
{"article": "PMC10013957.txt", "subject": "p-tau181", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Testing", "chunk": 11}
{"article": "PMC10013957.txt", "subject": "cerebral cerebral cerebral cerebral spinal fluid AD biomarkers", "relationship": "RELATED_TO_DIAGNOSIS", "object": "Diagnosis: Alzheimer's Disease", "chunk": 12}
{"article": "PMC10013957.txt", "subject": "cerebral cerebral cerebral cerebral spinal fluid AD biomarkers", "relationship": "RELATED_TREATMENT", "object": "Clinical decision-making", "chunk": 12}
{"article": "PMC10013957.txt", "subject": "cerebral cerebral cerebral cerebral spinal fluid AD biomarkers", "relationship": "RELATED_TREATMENT", "object": "Guidance for LP and cerebral cerebral cerebral cerebral spinal fluid testing", "chunk": 12}
{"article": "PMC10013957.txt", "subject": "APOE4", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Clinical decision-making", "chunk": 12}
{"article": "PMC10075195.txt", "subject": "amyloid\u2010beta (A\u03b2)", "relationship": "INDICATES_PRESENCE_OF", "object": "AD pathology", "chunk": 1}
{"article": "PMC10075195.txt", "subject": "hyperphosphorylated tau", "relationship": "INDICATES_PRESENCE_OF", "object": "AD pathology", "chunk": 1}
{"article": "PMC10075195.txt", "subject": "A\u03b242/A\u03b240", "relationship": "USED_TO_DIAGNOSE", "object": "AD pathology", "chunk": 1}
{"article": "PMC10075195.txt", "subject": "phosphorylated tau [p\u2010tau]181", "relationship": "USED_TO_DIAGNOSE", "object": "AD pathology", "chunk": 1}
{"article": "PMC10075195.txt", "subject": "total tau [t\u2010tau]", "relationship": "BLOCKED_BY", "object": "Treatment", "chunk": 1}
{"article": "PMC10075195.txt", "subject": "18F\u2010florbetapir", "relationship": "USED_TO_DIAGNOSE", "object": "AD pathology", "chunk": 1}
{"article": "PMC10075195.txt", "subject": "A\u03b242/A\u03b240", "relationship": "RELATED_TO", "object": "FBP SUVR", "chunk": 2}
{"article": "PMC10075195.txt", "subject": "p\u2010tau", "relationship": "RELATED_TO", "object": "FBP SUVR", "chunk": 2}
{"article": "PMC10075195.txt", "subject": "A\u03b242/A\u03b240", "relationship": "PREDICTED_BY", "object": "A\u03b2-PET status", "chunk": 2}
{"article": "PMC10075195.txt", "subject": "A\u03b242/A\u03b240", "relationship": "ASSOCIATED_WITH", "object": "A\u03b2 positivity", "chunk": 2}
{"article": "PMC10075195.txt", "subject": "FBP SUVR", "relationship": "RELATED_PROGNOSIS", "object": "Worse performance on RI and DR was associated with higher FBP SUVR", "chunk": 3}
{"article": "PMC10075195.txt", "subject": "A\u03b242/A\u03b240", "relationship": "RELATED_PROGNOSIS", "object": "Worse performance on both RI and DR was associated with lower cerebral cerebral cerebral cerebral spinal fluid A\u03b242/A\u03b240", "chunk": 3}
{"article": "PMC10075195.txt", "subject": "p\u2010tau", "relationship": "RELATED_PROGNOSIS", "object": "Worse performance on both RI and DR was associated with higher p\u2010tau pathology", "chunk": 3}
{"article": "PMC10075195.txt", "subject": "FBP SUVR", "relationship": "RELATED_TO", "object": "Retroactive interference", "chunk": 5}
{"article": "PMC10075195.txt", "subject": "FBP SUVR", "relationship": "RELATED_TO", "object": "CA1 volume", "chunk": 5}
{"article": "PMC10075195.txt", "subject": "p\u2010tau", "relationship": "RELATED_TO", "object": "CA1 volume", "chunk": 5}
{"article": "PMC10075195.txt", "subject": "CA1 volume", "relationship": "MEDIATES", "object": "Relationship between FBP SUVR and Retroactive interference", "chunk": 5}
{"article": "PMC10075195.txt", "subject": "CA1 volume", "relationship": "MEDIATES", "object": "Relationship between p\u2010tau and Retroactive interference", "chunk": 5}
{"article": "PMC10075195.txt", "subject": "A\u03b242/A\u03b240", "relationship": "ASSOCIATED_WITH_BIOMARKER_DYNAMICS_UNDER_TREATMENT", "object": "cerebral  cerebral  cerebral  spinal fluid", "chunk": 6}
{"article": "PMC10075195.txt", "subject": "p\u2010tau", "relationship": "ASSOCIATED_WITH_BIOMARKER_DYNAMICS_UNDER_TREATMENT", "object": "cerebral  cerebral  cerebral  spinal fluid", "chunk": 6}
{"article": "PMC10075195.txt", "subject": "A\u03b2\u2010PET", "relationship": "INDICATES_PRESENCE_OF", "object": "AD pathology", "chunk": 6}
{"article": "PMC10075195.txt", "subject": "cerebral  cerebral  cerebral  spinal fluid A\u03b242/A\u03b240", "relationship": "INDICATES_PRESENCE_OF", "object": "AD pathology", "chunk": 6}
{"article": "PMC10075195.txt", "subject": "cerebral  cerebral  cerebral  spinal fluid p\u2010tau", "relationship": "INDICATES_PRESENCE_OF", "object": "AD pathology", "chunk": 6}
{"article": "PMC10075195.txt", "subject": "CA1 volume", "relationship": "RELATED_TO", "object": "memory performance", "chunk": 6}
{"article": "PMC10075195.txt", "subject": "DG volume", "relationship": "RELATED_TO", "object": "memory performance", "chunk": 6}
{"article": "PMC10075195.txt", "subject": "A\u03b2 pathology", "relationship": "RELATED_TO", "object": "memory performance", "chunk": 6}
{"article": "PMC10075195.txt", "subject": "CA1 volume", "relationship": "RELATED_PROGNOSIS", "object": "predicting memory deficits", "chunk": 6}
{"article": "PMC10092214.txt", "subject": "Alzheimer's disease", "relationship": "INDICATES_PRESENCE_OF", "object": "Major NCD in patients", "chunk": 1}
{"article": "PMC10092214.txt", "subject": "Alzheimer's disease", "relationship": "RELATED_TREATMENT", "object": "Music\u2010based interventions to improve emotional, social, and cognitive functioning", "chunk": 1}
{"article": "PMC10092214.txt", "subject": "sensorimotor synchronization (SMS)", "relationship": "RELATED_WITH_POOR_OUTCOME", "object": "Impaired sensorimotor synchronization abilities in patients with Major NCD", "chunk": 1}
{"article": "PMC10092214.txt", "subject": "MMSE scores", "relationship": "INDICATES_PRESENCE_OF", "object": "Major NCD", "chunk": 3}
{"article": "PMC10092214.txt", "subject": "MMSE", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive Decline", "chunk": 4}
{"article": "PMC10092214.txt", "subject": "MMSE", "relationship": "RELATED_TO", "object": "EFE+", "chunk": 4}
{"article": "PMC10092214.txt", "subject": "MMSE", "relationship": "RELATED_TO", "object": "SMS consistency", "chunk": 4}
{"article": "PMC10092214.txt", "subject": "SMS consistency", "relationship": "RELATED_TO", "object": "Cognitive Decline", "chunk": 4}
{"article": "PMC10092214.txt", "subject": "MMSE", "relationship": "RELATED_PROGNOSIS", "object": "Neurodegenerative disorderss progression and effectiveness of music therapy", "chunk": 6}
{"article": "PMC10092214.txt", "subject": "SMS consistency", "relationship": "RELATED_TREATMENT", "object": "live musical performance", "chunk": 6}
{"article": "PMC10092214.txt", "subject": "SMS consistency", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "adapting musical interventions depending on the stage of the disease", "chunk": 6}
{"article": "PMC10092214.txt", "subject": "EFE+", "relationship": "RELATED_TREATMENT", "object": "live musical performance", "chunk": 6}
{"article": "PMC10115176.txt", "subject": "p-tau217WashU", "relationship": "INDICATES_PRESENCE_OF", "object": "Abnormal brain amyloid-\u03b2 status", "chunk": 1}
{"article": "PMC10115176.txt", "subject": "p-tau217WashU", "relationship": "PREDICTS", "object": "Progression to Alzheimer's dementia", "chunk": 1}
{"article": "PMC10115176.txt", "subject": "p-tau217Lilly", "relationship": "INDICATES_PRESENCE_OF", "object": "Abnormal brain amyloid-\u03b2 status", "chunk": 1}
{"article": "PMC10115176.txt", "subject": "p-tau217Lilly", "relationship": "PREDICTS", "object": "Progression to Alzheimer's dementia", "chunk": 1}
{"article": "PMC10115176.txt", "subject": "p-tau181ADx", "relationship": "PREDICT", "object": "Progression to Alzheimer's dementia", "chunk": 1}
{"article": "PMC10115176.txt", "subject": "p-tau181WashU", "relationship": "PREDICT", "object": "Progression to Alzheimer's dementia", "chunk": 1}
{"article": "PMC10115176.txt", "subject": "p-tau217WashU", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer's dementia", "chunk": 1}
{"article": "PMC10115176.txt", "subject": "p-tau217Lilly", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer's dementia", "chunk": 1}
{"article": "PMC10115176.txt", "subject": "p-tau181ADx", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer's dementia", "chunk": 1}
{"article": "PMC10115176.txt", "subject": "p-tau181WashU", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer's dementia", "chunk": 1}
{"article": "PMC10115176.txt", "subject": "p-tau231UGOT", "relationship": "MONITORED_DURING_TREATMENT", "object": "Alzheimer's dementia", "chunk": 1}
{"article": "PMC10115176.txt", "subject": "p-tau181Lilly", "relationship": "MONITORED_DURING_TREATMENT", "object": "Alzheimer's dementia", "chunk": 1}
{"article": "PMC10115176.txt", "subject": "p-tau181UGOT", "relationship": "MONITORED_DURING_TREATMENT", "object": "Alzheimer's dementia", "chunk": 1}
{"article": "PMC10115176.txt", "subject": "p-tau181Fuji", "relationship": "MONITORED_DURING_TREATMENT", "object": "Alzheimer's dementia", "chunk": 1}
{"article": "PMC10115176.txt", "subject": "p-tau181Splex", "relationship": "MONITORED_DURING_TREATMENT", "object": "Alzheimer's dementia", "chunk": 1}
{"article": "PMC10115176.txt", "subject": "amyloid-\u03b2 (A\u03b2) plaques", "relationship": "DIAGNOSITC_OF", "object": "Alzheimer\u2019s disease", "chunk": 2}
{"article": "PMC10115176.txt", "subject": "Neurofibrillary tangles containing hyperphosphorylated tau (p-tau)", "relationship": "DIAGNOSITC_OF", "object": "Alzheimer\u2019s disease", "chunk": 2}
{"article": "PMC10115176.txt", "subject": "A\u03b2- and tau-PET", "relationship": "DIAGNOSTIC_OF", "object": "Alzheimer\u2019s disease", "chunk": 2}
{"article": "PMC10115176.txt", "subject": "cerebral spinal fluid A\u03b242/40 and p-tau", "relationship": "DIAGNOSTITC_OF", "object": "Alzheimer\u2019s disease", "chunk": 2}
{"article": "PMC10115176.txt", "subject": "p-tau181", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease-related A\u03b2 and tau pathologies", "chunk": 2}
{"article": "PMC10115176.txt", "subject": "p-tau217", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease-related A\u03b2 and tau pathologies", "chunk": 2}
{"article": "PMC10115176.txt", "subject": "p-tau231", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease-related A\u03b2 and tau pathologies", "chunk": 2}
{"article": "PMC10115176.txt", "subject": "p-tau217", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer\u2019s disease", "chunk": 2}
{"article": "PMC10115176.txt", "subject": "p-tau217", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "normal cerebral spinal fluid A\u03b2 status", "chunk": 2}
{"article": "PMC10115176.txt", "subject": "p-tau181", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer\u2019s disease", "chunk": 2}
{"article": "PMC10115176.txt", "subject": "p-tau231", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer\u2019s disease", "chunk": 2}
{"article": "PMC10115176.txt", "subject": "plasma p-tau217", "relationship": "PREDICTS", "object": "conversion to Alzheimer\u2019s disease dementia", "chunk": 2}
{"article": "PMC10115176.txt", "subject": "p-tau217WashU", "relationship": "RELATED_WITH_BETTER_OUTCOME", "object": "Lower p-tau217WashU levels associated with a milder cognitive decline", "chunk": 3}
{"article": "PMC10115176.txt", "subject": "p-tau217Lilly", "relationship": "RELATED_WITH_BETTER_OUTCOME", "object": "Lower p-tau217Lilly levels associated with a milder cognitive decline", "chunk": 3}
{"article": "PMC10115176.txt", "subject": "p-tau217Janss", "relationship": "RELATED_WITH_BETTER_OUTCOME", "object": "Lower p-tau217Janss levels associated with a milder cognitive decline", "chunk": 3}
{"article": "PMC10115176.txt", "subject": "p-tau181ADx", "relationship": "RELATED_WITH_BETTER_OUTCOME", "object": "Lower p-tau181ADx levels associated with a milder cognitive decline", "chunk": 3}
{"article": "PMC10115176.txt", "subject": "p-tau181WashU", "relationship": "RELATED_WITH_BETTER_OUTCOME", "object": "Lower p-tau181WashU levels associated with a milder cognitive decline", "chunk": 3}
{"article": "PMC10115176.txt", "subject": "p-tau231UGOT", "relationship": "RELATED_WITH_BETTER_OUTCOME", "object": "Lower p-tau231UGOT levels associated with a milder cognitive decline", "chunk": 3}
{"article": "PMC10115176.txt", "subject": "p-tau181Lilly", "relationship": "RELATED_WITH_BETTER_OUTCOME", "object": "Lower p-tau181Lilly levels associated with a milder cognitive decline", "chunk": 3}
{"article": "PMC10115176.txt", "subject": "p-tau181UGOT", "relationship": "RELATED_WITH_BETTER_OUTCOME", "object": "Lower p-tau181UGOT levels associated with a milder cognitive decline", "chunk": 3}
{"article": "PMC10115176.txt", "subject": "p-tau181Fuji", "relationship": "RELATED_WITH_BETTER_OUTCOME", "object": "Lower p-tau181Fuji levels associated with a milder cognitive decline", "chunk": 3}
{"article": "PMC10115176.txt", "subject": "p-tau181Splex", "relationship": "RELATED_WITH_BETTER_OUTCOME", "object": "Lower p-tau181Splex levels associated with a milder cognitive decline", "chunk": 3}
{"article": "PMC10115176.txt", "subject": "p-tau217WashU", "relationship": "INDICATES_PRESENCE_OF", "object": "Abormal baseline A\u03b2 status", "chunk": 4}
{"article": "PMC10115176.txt", "subject": "p-tau217WashU", "relationship": "RELATED_PROGNOSIS", "object": "Progression to ADD", "chunk": 4}
{"article": "PMC10115176.txt", "subject": "p-tau217Lilly", "relationship": "INDICATES_PRESENCE_OF", "object": "Abnormal baseline A\u03b2 status", "chunk": 4}
{"article": "PMC10115176.txt", "subject": "p-tau217Janss", "relationship": "INDICATES_PRESENCE_OF", "object": "Abnormal baseline A\u03b2 status", "chunk": 4}
{"article": "PMC10115176.txt", "subject": "p-tau181ADx", "relationship": "INDICATES_PRESENCE_OF", "object": "Abnormal baseline A\u03b2 status", "chunk": 4}
{"article": "PMC10115176.txt", "subject": "p-tau181WashU", "relationship": "INDICATES_PRESENCE_OF", "object": "Abnormal baseline A\u03b2 status", "chunk": 4}
{"article": "PMC10115176.txt", "subject": "p-tau231UGOT", "relationship": "INDICATES_PRESENCE_OF", "object": "Abnormal baseline A\u03b2 status", "chunk": 4}
{"article": "PMC10115176.txt", "subject": "p-tau181Lilly", "relationship": "INDICATES_PRESENCE_OF", "object": "Abnormal baseline A\u03b2 status", "chunk": 4}
{"article": "PMC10115176.txt", "subject": "p-tau181UGOT", "relationship": "INDICATES_PRESENCE_OF", "object": "Abnormal baseline A\u03b2 status", "chunk": 4}
{"article": "PMC10115176.txt", "subject": "p-tau181Fuji", "relationship": "INDICATES_PRESENCE_OF", "object": "Abnormal baseline A\u03b2 status", "chunk": 4}
{"article": "PMC10115176.txt", "subject": "p-tau181Splex", "relationship": "INDICATES_PRESENCE_OF", "object": "Abnormal baseline A\u03b2 status", "chunk": 4}
{"article": "PMC10115176.txt", "subject": "p-tau217WashU", "relationship": "INDICATES_PRESENCE_OF", "object": " Progression to AD", "chunk": 5}
{"article": "PMC10115176.txt", "subject": "p-tau217WashU", "relationship": "INDICATES_PRESENCE_OF", "object": " higher AUC compared to p-tau217Lilly", "chunk": 5}
{"article": "PMC10115176.txt", "subject": "p-tau217WashU", "relationship": "INDICATES_PRESENCE_OF", "object": " higher AUC compared to p-tau217Janss", "chunk": 5}
{"article": "PMC10115176.txt", "subject": "p-tau217WashU", "relationship": "INDICATES_PRESENCE_OF", "object": "higher AUC compared to p-tau181ADx", "chunk": 5}
{"article": "PMC10115176.txt", "subject": "p-tau217WashU", "relationship": "INDICATES_PRESENCE_OF", "object": " higher AUC compared to p-tau181WashU", "chunk": 5}
{"article": "PMC10115176.txt", "subject": "p-tau217Lilly", "relationship": "INDICATES_PRESENCE_OF", "object": " Progression to AD", "chunk": 5}
{"article": "PMC10115176.txt", "subject": "p-tau217Lilly", "relationship": "INDICATES_PRESENCE_OF", "object": " higher AUC compared to p-tau181Lilly", "chunk": 5}
{"article": "PMC10115176.txt", "subject": "p-tau217Lilly", "relationship": "INDICATES_PRESENCE_OF", "object": " higher AUC compared to p-tau181ADx", "chunk": 5}
{"article": "PMC10115176.txt", "subject": "p-tau217Lilly", "relationship": "INDICATES_PRESENCE_OF", "object": " higher AUC compared to p-tau181WashU", "chunk": 5}
{"article": "PMC10115176.txt", "subject": "p-tau217Janss", "relationship": "INDICATES_PRESENCE_OF", "object": " Progression to AD", "chunk": 5}
{"article": "PMC10115176.txt", "subject": "p-tau217Janss", "relationship": "INDICATES_PRESENCE_OF", "object": " higher AUC compared to p-tau181Lilly", "chunk": 5}
{"article": "PMC10115176.txt", "subject": "p-tau217Janss", "relationship": "INDICATES_PRESENCE_OF", "object": " higher AUC compared to p-tau181ADx", "chunk": 5}
{"article": "PMC10115176.txt", "subject": "p-tau217Janss", "relationship": "INDICATES_PRESENCE_OF", "object": " higher AUC compared to p-tau181WashU", "chunk": 5}
{"article": "PMC10115176.txt", "subject": "p-tau181ADx", "relationship": "INDICATES_PRESENCE_OF", "object": " Progression to AD", "chunk": 5}
{"article": "PMC10115176.txt", "subject": "p-tau181ADx", "relationship": "INDICATES_PRESENCE_OF", "object": " higher AUC compared to p-tau181Lilly", "chunk": 5}
{"article": "PMC10115176.txt", "subject": "p-tau181ADx", "relationship": "INDICATES_PRESENCE_OF", "object": " higher AUC compared to p-tau181WashU", "chunk": 5}
{"article": "PMC10115176.txt", "subject": "p-tau181WashU", "relationship": "INDICATES_PRESENCE_OF", "object": " Progression to AD", "chunk": 5}
{"article": "PMC10115176.txt", "subject": "p-tau217WashU", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Treatment decision making", "chunk": 5}
{"article": "PMC10115176.txt", "subject": "p-tau217Lilly", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Treatment decision making", "chunk": 5}
{"article": "PMC10115176.txt", "subject": "biomarkers", "relationship": "RELATED_TREATMENT", "object": "Disease management", "chunk": 5}
{"article": "PMC10115176.txt", "subject": "plasma p-tau217", "relationship": "RELATED_PROGNOSIS", "object": "Prediction of cognitive decline", "chunk": 5}
{"article": "PMC10115176.txt", "subject": "plasma p-tau217", "relationship": "RELATED_PROGNOSIS", "object": "Prediction of clinical outcomes", "chunk": 5}
{"article": "PMC10115176.txt", "subject": "Phosphorylation changes", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Diagnosing Alzheimer\u2019s disease", "chunk": 7}
{"article": "PMC10115176.txt", "subject": "Blood plasma assay", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Diagnosing Alzheimer\u2019s disease", "chunk": 7}
{"article": "PMC10127414.txt", "subject": "spatial navigation", "relationship": "INDICATES_PRESENCE_OF", "object": "SCD", "chunk": 1}
{"article": "PMC10127414.txt", "subject": "spatial navigation impairment", "relationship": "ASSOCIATED_WITH", "object": "AD dementia patients", "chunk": 1}
{"article": "PMC10127414.txt", "subject": "spatial navigation impairment", "relationship": "RELATED_TO", "object": "Neurodegeneration involving the medial temporal, frontal, and parietal lobes", "chunk": 1}
{"article": "PMC10127414.txt", "subject": "Spatial navigation impairment", "relationship": "DIAGNOSITC_OF", "object": "Mild cognitive impairment", "chunk": 2}
{"article": "PMC10127414.txt", "subject": "Spatial navigation performance", "relationship": "RELATED_PROGNOSIS", "object": "Future clinical progression in SCD subjects", "chunk": 2}
{"article": "PMC10127414.txt", "subject": "Spatial navigation performance", "relationship": "PREDICT_SURVIVAL", "object": "Progression to mild cognitive impairment in SCD subjects", "chunk": 2}
{"article": "PMC10127414.txt", "subject": "basal forebrain", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Lower volumes in the basal forebrain were observed in the B-SCD and mild cognitive impairment groups.", "chunk": 4}
{"article": "PMC10127414.txt", "subject": "right hippocampus", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "The mild cognitive impairment group showed lower right hippocampal volume than the other three groups.", "chunk": 4}
{"article": "PMC10127414.txt", "subject": "Ch4p", "relationship": "INDICATES_PRESENCE_OF", "object": "Greater executive function", "chunk": 5}
{"article": "PMC10127414.txt", "subject": "Subiculum", "relationship": "INDICATES_PRESENCE_OF", "object": "Greater memory function", "chunk": 5}
{"article": "PMC10127414.txt", "subject": "Fissure", "relationship": "INDICATES_PRESENCE_OF", "object": "Greater memory function", "chunk": 5}
{"article": "PMC10127414.txt", "subject": "Presubiculum", "relationship": "INDICATES_PRESENCE_OF", "object": "Greater memory function", "chunk": 5}
{"article": "PMC10127414.txt", "subject": "Molecular layer", "relationship": "INDICATES_PRESENCE_OF", "object": "Greater memory function", "chunk": 5}
{"article": "PMC10127414.txt", "subject": "Dentate gyrus", "relationship": "INDICATES_PRESENCE_OF", "object": "Greater memory function", "chunk": 5}
{"article": "PMC10127414.txt", "subject": "CA4", "relationship": "INDICATES_PRESENCE_OF", "object": "Greater memory function", "chunk": 5}
{"article": "PMC10127414.txt", "subject": "HATA", "relationship": "INDICATES_PRESENCE_OF", "object": "Greater memory function", "chunk": 5}
{"article": "PMC10127414.txt", "subject": "Tail", "relationship": "RELATED_PROGNOSIS", "object": "Navigation function", "chunk": 5}
{"article": "PMC10127414.txt", "subject": "CA1", "relationship": "RELATED_PROGNOSIS", "object": "Navigation function", "chunk": 5}
{"article": "PMC10127414.txt", "subject": "Molecular layer", "relationship": "RELATED_PROGNOSIS", "object": "Navigation function", "chunk": 5}
{"article": "PMC10127414.txt", "subject": "B-SCD group", "relationship": "INDICATES_PRESENCE_OF", "object": "reduced volumes in Ch4p and Ch4a-i basal forebrain subfields compared to G-SCD group", "chunk": 6}
{"article": "PMC10127414.txt", "subject": "B-SCD group", "relationship": "RELATED_PROGNOSIS", "object": "higher conversion rate to mild cognitive impairment  compared to G-SCD group", "chunk": 6}
{"article": "PMC10127414.txt", "subject": "greater volumes", "relationship": "ASSOCIATED_WITH", "object": "greater executive function (r=0.250, p<0.001)", "chunk": 6}
{"article": "PMC10127414.txt", "subject": "greater volumes in Ch4p", "relationship": "ASSOCIATED_WITH", "object": "greater language (r=0.162, p=0.032)", "chunk": 6}
{"article": "PMC10127414.txt", "subject": "greater volumes in Ch4p", "relationship": "ASSOCIATED_WITH", "object": "greater navigation function (r=-0.168, p=0.026)", "chunk": 6}
{"article": "PMC10127414.txt", "subject": "Cholinergic neurons", "relationship": "RELATED_PROGNOSIS", "object": "AD Progression", "chunk": 7}
{"article": "PMC10127414.txt", "subject": "Cholinergic degeneration", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "AD progression", "chunk": 7}
{"article": "PMC10127414.txt", "subject": "ch4", "relationship": "RELATED_TREATMENT", "object": "Treatment with acetylcholinesterase inhibitors", "chunk": 7}
{"article": "PMC10127414.txt", "subject": "amyloid \u03b2", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "future work", "chunk": 8}
{"article": "PMC10127414.txt", "subject": "tau", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "future work", "chunk": 8}
{"article": "PMC10167601.txt", "subject": "amyloid PET", "relationship": "INDICATES_PRESENCE_OF", "object": "Amyloid deposition in the brain", "chunk": 3}
{"article": "PMC10167601.txt", "subject": "amyloid deposition in the brain", "relationship": "IS_HALLMARK_OF", "object": "Alzheimer disease", "chunk": 3}
{"article": "PMC10167601.txt", "subject": "amyloid PET tracers", "relationship": "ALLOWS", "object": "Direct assessment of amyloid deposition in vivo", "chunk": 3}
{"article": "PMC10167601.txt", "subject": "amyloid PET", "relationship": "PREDICTS_SURVIVAL", "object": "Alzheimer disease", "chunk": 3}
{"article": "PMC10167601.txt", "subject": "amyloid PET", "relationship": "INDICATES_PRESENCE_OF", "object": "changes in patients\u2019 diagnosis and management", "chunk": 4}
{"article": "PMC10167601.txt", "subject": "amyloid PET", "relationship": "ASSOCIATED_WITH", "object": "more frequent changes in diagnosis, diagnostic confidence, and treatment plan", "chunk": 4}
{"article": "PMC10167601.txt", "subject": "amyloid PET", "relationship": "RELATED_TREATMENT", "object": "real-world use and clinical effect of unrestricted amyloid PET imaging", "chunk": 4}
{"article": "PMC10167601.txt", "subject": "amyloid loading", "relationship": "IS_TARGET_OF_TREATMENT", "object": "AMYPAD-DPMS study", "chunk": 4}
{"article": "PMC10167601.txt", "subject": "Amyloid PET", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's disease", "chunk": 6}
{"article": "PMC10167601.txt", "subject": "Amyloid PET", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive stage - Prevalence increases with severity", "chunk": 6}
{"article": "PMC10167601.txt", "subject": "Amyloid PET", "relationship": "RELATED_PROGNOSIS", "object": "Etiological diagnosis - Prevalence increases with AD diagnosis", "chunk": 6}
{"article": "PMC10167601.txt", "subject": "amyloid PET", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Diagnostic uncertainty", "chunk": 7}
{"article": "PMC10167601.txt", "subject": "amyloid PET", "relationship": "RELATED_TREATMENT", "object": "Changing etiological diagnosis", "chunk": 7}
{"article": "PMC10167601.txt", "subject": "amyloid PET", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Change in cognition-specific medications", "chunk": 7}
{"article": "PMC10167601.txt", "subject": "amyloid PET", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "The use of amyloid PET helps in deciding which treatment to select for Alzheimer's disease.", "chunk": 8}
{"article": "PMC10167601.txt", "subject": "amyloid PET", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Amyloid PET findings, particularly positives, are instrumental in deciding the course of treatment for Alzheimer's disease patients.", "chunk": 8}
{"article": "PMC10167601.txt", "subject": "amyloid PET", "relationship": "RELATED_TREATMENT", "object": "Studies like AMYPAD-DPMS explore the clinical impact of amyloid PET on treatment strategies for Alzheimer's disease.", "chunk": 8}
{"article": "PMC10233712.txt", "subject": "A\u03b242", "relationship": "INDICATES_PRESENCE_OF", "object": "Amyloid accumulation in brain", "chunk": 1}
{"article": "PMC10233712.txt", "subject": "p-tau", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Propagation of Neurofibrillary tangles", "chunk": 1}
{"article": "PMC10233712.txt", "subject": "A\u03b242", "relationship": "RELATED_PROGNOSIS", "object": "Diagnosis of AD dementia", "chunk": 1}
{"article": "PMC10233712.txt", "subject": "A\u03b240", "relationship": "RELATED_PROGNOSIS", "object": "Diagnosis of AD dementia", "chunk": 1}
{"article": "PMC10233712.txt", "subject": "t-tau", "relationship": "RELATED_PROGNOSIS", "object": "Diagnosis of AD dementia", "chunk": 1}
{"article": "PMC10233712.txt", "subject": "Gray matter volume", "relationship": "INDICATES_PRESENCE_OF", "object": "Progression of AD", "chunk": 1}
{"article": "PMC10233712.txt", "subject": "WMHs", "relationship": "INDICATES_PRESENCE_OF", "object": "Cerebrovascular pathology", "chunk": 1}
{"article": "PMC10233712.txt", "subject": "WMHs", "relationship": "RELATED_PROGNOSIS", "object": "Pathologies including hypoxia, amyloid angiopathy, blood brain barrier damage, degeneration, hypoperfusion, and inflammation", "chunk": 1}
{"article": "PMC10233712.txt", "subject": "WMHV", "relationship": "RELATED_PROGNOSIS", "object": "poor cognitive outcomes", "chunk": 2}
{"article": "PMC10233712.txt", "subject": "WMHV", "relationship": "INDICATES_TREATMENT_ELIGIBILITY", "object": "treatment to prevent WMH progression", "chunk": 2}
{"article": "PMC10233712.txt", "subject": "A\u03b242", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Determining therapeutic interventions for Alzheimer's Disease", "chunk": 3}
{"article": "PMC10233712.txt", "subject": "A\u03b240", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Determining therapeutic interventions for Alzheimer's Disease", "chunk": 3}
{"article": "PMC10233712.txt", "subject": "total tau", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Determining therapeutic interventions for Alzheimer's Disease", "chunk": 3}
{"article": "PMC10233712.txt", "subject": "tau phosphorylated at threonine 181", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Determining therapeutic interventions for Alzheimer's Disease", "chunk": 3}
{"article": "PMC10233712.txt", "subject": "WMHV", "relationship": "RELATED_PROGNOSIS", "object": "Greater declines in cognition and worsening of cerebral spinal fluid AD biomarker profiles", "chunk": 4}
{"article": "PMC10233712.txt", "subject": "WMHV", "relationship": "INDICATES_PRESENCE_OF", "object": "Cerebral small vessel disease and white matter damage", "chunk": 4}
{"article": "PMC10233712.txt", "subject": "WMHV", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Ependymal loss, cerebral ischemia, and demyelination", "chunk": 4}
{"article": "PMC10233712.txt", "subject": "WMHV", "relationship": "RELATED_TREATMENT", "object": "INI treatment for 12 months slowed the progression of WMHs globally and in deep WM and frontal regions compared to placebo assignment", "chunk": 4}
{"article": "PMC10233712.txt", "subject": "WMHV", "relationship": "RELATED_PROGNOSIS", "object": "Higher baseline WMHV predicts worse cognitive outcomes measured by the ADAS-Cog and CDR", "chunk": 4}
{"article": "PMC10233712.txt", "subject": "WMHV", "relationship": "MONITORED_DURING_TREATMENT", "object": "Longitudinal increases in WMHV correlate with decreases in cognition measured by the ADAS-Cog13, CDR-SOB, ADCS-ADL, and a memory composite", "chunk": 4}
{"article": "PMC10233712.txt", "subject": "A\u03b242", "relationship": "RELATED_PROGNOSIS", "object": "Greater A\u03b2 load, indicated by lower cerebral spinal fluid A\u03b242 concentration and increased A\u0392 PET, correlates with greater WMH burden", "chunk": 4}
{"article": "PMC10233712.txt", "subject": "A\u03b242", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Increased cerebral spinal fluid A\u03b242 levels and decreased hyperphosphorylated tau concentrations have been proposed as markers demonstrating improvement in AD pathology", "chunk": 4}
{"article": "PMC10233712.txt", "subject": "A\u03b242", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "Insulin treatment was associated with improved (increased) A\u03b242/A\u03b2 40 and A42/tau ratios", "chunk": 4}
{"article": "PMC10233712.txt", "subject": "WMHV", "relationship": "BIOMARKER_DYNAMICS_UNDER_TREATMENT", "object": "WMHV changes inversely correlate with changes in A\u03b240, A\u03b242, A\u03b242/A\u03b240 ratio, and A\u03b242/t-tau ratio; however, these associations differ by region and cerebral spinal fluid metric", "chunk": 4}
{"article": "PMC10233712.txt", "subject": "A\u03b242/A\u03b240 ratio", "relationship": "RELATED_TREATMENT", "object": "INI treatment for 12 months reduced WMHV progression in key brain regions", "chunk": 4}
{"article": "PMC10233712.txt", "subject": "A\u03b242/t-tau ratio", "relationship": "RELATED_TREATMENT", "object": "INI treatment for 12 months reduced WMHV progression in key brain regions", "chunk": 4}
{"article": "PMC10233712.txt", "subject": "A\u03b242", "relationship": "RELATED_TO", "object": "Changes in frontal WMHV ", "chunk": 6}
{"article": "PMC10233712.txt", "subject": "A\u03b242/A\u03b240 ratio", "relationship": "RELATED_TO", "object": "Changes in frontal WMHV", "chunk": 6}
{"article": "PMC10233712.txt", "subject": "A\u03b242/T-tau ratio", "relationship": "RELATED_TO", "object": "Changes in frontal WMHV", "chunk": 6}
{"article": "PMC10236460.txt", "subject": "eCarb/eFat", "relationship": "RELATED_TO", "object": "global cognition", "chunk": 1}
{"article": "PMC10236460.txt", "subject": "eCarb/eFat", "relationship": "PREDICTED_SURVIVAL", "object": "Cognitive health", "chunk": 1}
{"article": "PMC10236460.txt", "subject": "APOE \u03b5-4", "relationship": "DIAGNOSITC_OF", "object": "Early-onset Alzheimer's Disease", "chunk": 4}
{"article": "PMC10236460.txt", "subject": "APOE \u03b5-4", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer's Disease", "chunk": 4}
{"article": "PMC10236460.txt", "subject": "APOE no \u03b5-4", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer's Disease", "chunk": 4}
{"article": "PMC10236460.txt", "subject": "CFr", "relationship": "RELATED_PROGNOSIS", "object": "Global cognition", "chunk": 5}
{"article": "PMC10236460.txt", "subject": "eCarb", "relationship": "RELATED_PROGNOSIS", "object": "Global cognition", "chunk": 5}
{"article": "PMC10236460.txt", "subject": "eProt", "relationship": "RELATED_PROGNOSIS", "object": "Global cognition", "chunk": 5}
{"article": "PMC10236460.txt", "subject": "CFr", "relationship": "RELATED_PROGNOSIS", "object": "Memory subdomain", "chunk": 5}
{"article": "PMC10236460.txt", "subject": "eCarb", "relationship": "RELATED_PROGNOSIS", "object": "Memory subdomain", "chunk": 5}
{"article": "PMC10236460.txt", "subject": "eFat", "relationship": "RELATED_PROGNOSIS", "object": "Memory subdomain", "chunk": 5}
{"article": "PMC10236460.txt", "subject": "eProt", "relationship": "RELATED_PROGNOSIS", "object": "Memory subdomain", "chunk": 5}
{"article": "PMC10236460.txt", "subject": "SAFr", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive performance", "chunk": 5}
{"article": "PMC10236460.txt", "subject": "CFr", "relationship": "RELATED_PROGNOSIS", "object": "Global cognition (negatively associated)", "chunk": 6}
{"article": "PMC10236460.txt", "subject": "CFr", "relationship": "RELATED_PROGNOSIS", "object": "Memory subdomain (negatively associated)", "chunk": 6}
{"article": "PMC10236460.txt", "subject": "eCarb", "relationship": "RELATED_PROGNOSIS", "object": "Global cognition (negatively associated)", "chunk": 6}
{"article": "PMC10236460.txt", "subject": "eFat", "relationship": "RELATED_PROGNOSIS", "object": "Global cognition (positive association, but significant only without adjustment for TEI)", "chunk": 6}
{"article": "PMC10236460.txt", "subject": "eCarb", "relationship": "RELATED_PROGNOSIS", "object": "Memory subdomain (negatively associated)", "chunk": 6}
{"article": "PMC10236460.txt", "subject": "eFat", "relationship": "RELATED_PROGNOSIS", "object": "Memory subdomain (positive association)", "chunk": 6}
{"article": "PMC10236460.txt", "subject": "SAFr", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Cognitive performance (lowest quintile)", "chunk": 6}
{"article": "PMC10236460.txt", "subject": "Protein", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive decline risk (lower risk associated with higher intake)", "chunk": 6}
{"article": "PMC10236460.txt", "subject": "CFr", "relationship": "RELATED_TO", "object": "Better global cognition", "chunk": 7}
{"article": "PMC10287562.txt", "subject": "tau protein", "relationship": "ASSOCIATED_WITH_COGNITIVE_DECLINE", "object": "AD", "chunk": 2}
{"article": "PMC10287562.txt", "subject": "tau protein", "relationship": "IS_TARGET_OF_TREATMENT", "object": "MAPTRx", "chunk": 2}
{"article": "PMC10287562.txt", "subject": "t-tau", "relationship": "MONITORED_DURING_TREATMENT", "object": "MAPTRx", "chunk": 2}
{"article": "PMC10287562.txt", "subject": "phosphorylated tau (p-tau)", "relationship": "MONITORED_DURING_TREATMENT", "object": "MAPTRx", "chunk": 2}
{"article": "PMC10287562.txt", "subject": "t-tau", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 3}
{"article": "PMC10287562.txt", "subject": "p-tau181", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 3}
{"article": "PMC10287562.txt", "subject": "t-tau/A\u03b242", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 3}
{"article": "PMC10287562.txt", "subject": "t-tau", "relationship": "RELATED_TREATMENT", "object": "dose-dependent decreases in the concentration of t-tau in cerebral spinal fluid", "chunk": 4}
{"article": "PMC10287562.txt", "subject": "t-tau", "relationship": "RELATED_TREATMENT", "object": "steady-state maximal reduction of the concentration of cerebral spinal fluid t-tau was not reached during the 13-week treatment period", "chunk": 4}
{"article": "PMC10287562.txt", "subject": "t-tau", "relationship": "RELATED_TREATMENT", "object": "t-tau concentrations continued to decline during the post-treatment period", "chunk": 4}
{"article": "PMC10287562.txt", "subject": "t-tau", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimers Disease", "chunk": 5}
{"article": "PMC10287562.txt", "subject": "p-tau181", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimers Disease", "chunk": 5}
{"article": "PMC10287562.txt", "subject": "t-tau/A\u03b242", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimers Disease", "chunk": 5}
{"article": "PMC10287562.txt", "subject": "NfL", "relationship": "MONITORED_DURING_TREATMENT", "object": "MAPTRx treatment", "chunk": 5}
{"article": "PMC10287562.txt", "subject": "NfH", "relationship": "MONITORED_DURING_TREATMENT", "object": "MAPTRx treatment", "chunk": 5}
{"article": "PMC10287562.txt", "subject": "NRGN", "relationship": "MONITORED_DURING_TREATMENT", "object": "MAPTRx treatment", "chunk": 5}
{"article": "PMC10287562.txt", "subject": "YKL40", "relationship": "MONITORED_DURING_TREATMENT", "object": "MAPTRx treatment", "chunk": 5}
{"article": "PMC10287562.txt", "subject": "Ventricular Volume (VV)", "relationship": "MONITORED_DURING_TREATMENT", "object": "MAPTRx treatment", "chunk": 5}
{"article": "PMC10287562.txt", "subject": "t-tau", "relationship": "MONITORED_DURING_TREATMENT", "object": "treatment with MAPTRx", "chunk": 6}
{"article": "PMC10287562.txt", "subject": "t-tau", "relationship": "LEVELS_REFLECT_RESPONSE", "object": "  reduction in new tau synthesis", "chunk": 6}
{"article": "PMC10287562.txt", "subject": "p-tau181", "relationship": "MONITORED_DURING_TREATMENT", "object": "treatment with MAPTRx", "chunk": 6}
{"article": "PMC10287562.txt", "subject": "p-tau181", "relationship": "LEVELS_REFLECT_RESPONSE", "object": " dose- and time-dependent reduction in the concentration", "chunk": 6}
{"article": "PMC10287562.txt", "subject": "tau", "relationship": "RELATED_TREATMENT", "object": "MAPTRx prevents tau protein production", "chunk": 6}
{"article": "PMC10287562.txt", "subject": "t-tau", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 7}
{"article": "PMC10287562.txt", "subject": "p-tau", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 7}
{"article": "PMC10287562.txt", "subject": "t-tau", "relationship": "RELATED_TREATMENT", "object": "MAPTRx", "chunk": 7}
{"article": "PMC10287562.txt", "subject": "t-tau", "relationship": "MONITORED_DURING_TREATMENT", "object": "MAPTRx", "chunk": 7}
{"article": "PMC10287562.txt", "subject": "A\u03b242", "relationship": "ASSOCIATED_WITH_AD", "object": "Alzheimer's Disease", "chunk": 8}
{"article": "PMC10287562.txt", "subject": "p-tau", "relationship": "ASSOCIATED_WITH_AD", "object": "Alzheimer's Disease", "chunk": 8}
{"article": "PMC10287562.txt", "subject": "t-tau", "relationship": "RELATED_TREATMENT", "object": "explorations of the effects of MAPTRx on PD biomarkers", "chunk": 8}
{"article": "PMC10287562.txt", "subject": "NfL", "relationship": "RELATED_TREATMENT", "object": "explorations of the effects of MAPTRx on PD biomarkers", "chunk": 8}
{"article": "PMC10287562.txt", "subject": "NfH", "relationship": "RELATED_TREATMENT", "object": "explorations of the effects of MAPTRx on PD biomarkers", "chunk": 8}
{"article": "PMC10287562.txt", "subject": "YKL40", "relationship": "RELATED_TREATMENT", "object": "explorations of the effects of MAPTRx on PD biomarkers", "chunk": 8}
{"article": "PMC10287562.txt", "subject": "NRGN", "relationship": "RELATED_TREATMENT", "object": "explorations of the effects of MAPTRx on PD biomarkers", "chunk": 8}
{"article": "PMC10294511.txt", "subject": "APP", "relationship": "RELATED_TO_Alzheimer's_DISEASE", "object": "Production of A\u03b2 peptides", "chunk": 1}
{"article": "PMC10294511.txt", "subject": "PSEN1", "relationship": "RELATED_TO_Alzheimer's_DISEASE", "object": "Production of A\u03b2 peptides", "chunk": 1}
{"article": "PMC10294511.txt", "subject": "PSEN2", "relationship": "RELATED_TO_Alzheimer's_DISEASE", "object": "Production of A\u03b2 peptides", "chunk": 1}
{"article": "PMC10294511.txt", "subject": "ZDHHC21T209S/T209S mice", "relationship": "INDICATES_PRESENCE_OF", "object": "Synaptic dysfunction", "chunk": 1}
{"article": "PMC10294511.txt", "subject": "ZDHHC21T209S/T209S mice", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive impairment", "chunk": 1}
{"article": "PMC10294511.txt", "subject": "A\u03b2", "relationship": "INDICATES_PRESENCE_OF", "object": "A\u03b2 plaque deposition is a hallmark of Alzheimer's Disease.", "chunk": 2}
{"article": "PMC10294511.txt", "subject": "A\u03b2", "relationship": "MONITORED_DURING_TREATMENT", "object": "A\u03b2 retention was measured using [11C-PIB] positron emission tomography (PET) during treatment evaluation.", "chunk": 2}
{"article": "PMC10294511.txt", "subject": "APP", "relationship": "RELATED_PROGNOSIS", "object": "Palmitoylation of APP affects synaptic dysfunction and can contribute to  Alzheimer's disease progression.", "chunk": 2}
{"article": "PMC10294511.txt", "subject": "Fyn", "relationship": "RELATED_PROGNOSIS", "object": "Palmitoylation of FYN can contribute to AD pathology and cognitive impairment", "chunk": 2}
{"article": "PMC10294511.txt", "subject": "A\u03b2", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Immunohistochemistry", "chunk": 3}
{"article": "PMC10294511.txt", "subject": "A\u03b242", "relationship": "MEASURED_BY", "object": "A\u03b2 ELISA kits", "chunk": 4}
{"article": "PMC10294511.txt", "subject": "A\u03b240", "relationship": "MEASURED_BY", "object": "A\u03b2 ELISA kits", "chunk": 4}
{"article": "PMC10294511.txt", "subject": "p-tau", "relationship": "RELATED_TO", "object": "immunohistochemistry analysis", "chunk": 4}
{"article": "PMC10294511.txt", "subject": "APOE4", "relationship": "RELATED_PROGNOSIS", "object": "AD", "chunk": 5}
{"article": "PMC10294511.txt", "subject": "APOE \u03b54 allele", "relationship": "INDICATES_PRESENCE_OF", "object": "AD ", "chunk": 5}
{"article": "PMC10294511.txt", "subject": "ZDHHC21", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Mutation p.T209S", "chunk": 6}
{"article": "PMC10294511.txt", "subject": "ZDHHC21", "relationship": "RELATED_TO_BIOMARKER_DYNAMICS_UNDER_TREATMENT", "object": "Palmitoylation of APP and FYN", "chunk": 6}
{"article": "PMC10294511.txt", "subject": "APP", "relationship": "RELATED_TO_BIOMARKER_DYNAMICS_UNDER_TREATMENT", "object": "Palmitoylation regulated by ZDHHC21 mutation", "chunk": 6}
{"article": "PMC10294511.txt", "subject": "FYN", "relationship": "RELATED_TO_BIOMARKER_DYNAMICS_UNDER_TREATMENT", "object": "Palmitoylation regulated by ZDHHC21 mutation", "chunk": 6}
{"article": "PMC10294511.txt", "subject": "A\u03b2", "relationship": "INDICATES_PRESENCE_OF", "object": "AD Pathology", "chunk": 6}
{"article": "PMC10294511.txt", "subject": "p-tau", "relationship": "INDICATES_PRESENCE_OF", "object": "AD Pathology", "chunk": 6}
{"article": "PMC10294511.txt", "subject": "A\u03b240", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Synaptotoxicity in AD", "chunk": 6}
{"article": "PMC10294511.txt", "subject": "A\u03b242", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Synaptotoxicity in AD", "chunk": 6}
{"article": "PMC10294511.txt", "subject": "A\u03b242/A\u03b240 ratio", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Increased risk of AD", "chunk": 6}
{"article": "PMC10294511.txt", "subject": "p-tau (Thr181, Thr217, Thr231, Ser396)", "relationship": "INDICATES_PRESENCE_OF", "object": "Tau Hyperphosphorylation in AD", "chunk": 6}
{"article": "PMC10294511.txt", "subject": "hippocampus", "relationship": "RELATED_TO", "object": "Synaptic function, memory impairment, neuronal plasticity", "chunk": 7}
{"article": "PMC10294511.txt", "subject": "A\u03b242 and A\u03b240", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 7}
{"article": "PMC10294511.txt", "subject": "tau phosphorylation", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 7}
{"article": "PMC10294511.txt", "subject": "ZDHHC21T209S/T209S mutation", "relationship": "ASSOCIATED_WITH", "object": "Neuronal loss and synaptic dysfunction", "chunk": 7}
{"article": "PMC10294511.txt", "subject": "FYN palmitoylation", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Treating excitotoxicity", "chunk": 7}
{"article": "PMC10294511.txt", "subject": "2-BP and cerulenin", "relationship": "RELATED_TREATMENT", "object": "Palmitoylation inhibitors", "chunk": 7}
{"article": "PMC10294511.txt", "subject": "p.T209S mutation", "relationship": "PREDICTS_SURVIVAL", "object": "Neuronal vulnerability to excitotoxicity", "chunk": 7}
{"article": "PMC10294511.txt", "subject": "NMDAR2B phosphorylation", "relationship": "INDICATES_PRESENCE_OF", "object": "Excitotoxicity", "chunk": 7}
{"article": "PMC10294511.txt", "subject": "NMDAR2B activity", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Neuronal loss", "chunk": 7}
{"article": "PMC10294511.txt", "subject": "APP", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "increased A\u03b2 generation", "chunk": 8}
{"article": "PMC10294511.txt", "subject": "ZDHHC21", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Understanding the role of ZDHHC21 in AD pathogenesis may lead to the development of targeted therapies", "chunk": 8}
{"article": "PMC10294511.txt", "subject": "ZDHHC21 p.T209S mutation", "relationship": "PREDICTS_SURVIVAL", "object": "Increased A\u03b2  accumulation, synaptic dysfunction, and cognitive impairment", "chunk": 8}
{"article": "PMC10294511.txt", "subject": "palmitoylation", "relationship": "RELATED_TREATMENT", "object": "Palmitoylation inhibitors may be a potential therapeutic strategy for addressing the aberrant palmitoylation associated with AD", "chunk": 8}
{"article": "PMC10294511.txt", "subject": "ZDHHC21 T209S mutation", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive decline", "chunk": 9}
{"article": "PMC10294511.txt", "subject": "ZDHHC21 T209S mutation", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Potential target for drug therapy", "chunk": 9}
{"article": "PMC10294511.txt", "subject": "ZDHHC21 T209S mutation", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Synaptic integrity and function impairments", "chunk": 9}
{"article": "PMC10294511.txt", "subject": "2-BP and cerulenin", "relationship": "MONITORED_DURING_TREATMENT", "object": "FYN signaling", "chunk": 9}
{"article": "PMC10294511.txt", "subject": "A\u03b2 production", "relationship": "INDICATES_PRESENCE_OF", "object": "AD pathology", "chunk": 9}
{"article": "PMC10294511.txt", "subject": "tau phosphorylation", "relationship": "INDICATES_PRESENCE_OF", "object": "AD pathology", "chunk": 9}
{"article": "PMC10294511.txt", "subject": "APP palmitoylation", "relationship": "RELATED_PROGNOSIS", "object": "Impaired synapses", "chunk": 9}
{"article": "PMC10294511.txt", "subject": "ZDHHC21T209S/T209S", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Therapeutic strategy for AD ", "chunk": 9}
{"article": "PMC10306194.txt", "subject": "insulin signaling", "relationship": "RELATED_TO", "object": "several metabolic and cognitive disorders", "chunk": 1}
{"article": "PMC10306194.txt", "subject": "Intranasal insulin (INI)", "relationship": "ALLOWS", "object": "investigation and modulation of insulin signaling in the brain", "chunk": 1}
{"article": "PMC10306194.txt", "subject": "Intranasal insulin (INI)", "relationship": "LIMITS", "object": "peripheral side effects", "chunk": 1}
{"article": "PMC10306194.txt", "subject": "insulin", "relationship": "RELATED_TO", "object": "brain insulin signaling pathways", "chunk": 2}
{"article": "PMC10306194.txt", "subject": "insulin", "relationship": "RELATED_TO", "object": "processes such as cognition, appetite, and glucose regulation", "chunk": 2}
{"article": "PMC10306194.txt", "subject": "insulin", "relationship": "RELATED_TO", "object": "processes of long-term potentiation and long-term depression", "chunk": 2}
{"article": "PMC10306194.txt", "subject": "insulin", "relationship": "RELATED_TO", "object": "triggering release of various neurotrophic factors to promote neuronal survival", "chunk": 2}
{"article": "PMC10306194.txt", "subject": "insulin", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "potential treatment intervention", "chunk": 2}
{"article": "PMC10306194.txt", "subject": "central insulin resistance", "relationship": "DIAGNOSITC_OF", "object": "age-related cognitive decline and Alzheimer\u2019s disease (AD)", "chunk": 2}
{"article": "PMC10306194.txt", "subject": "central insulin resistance", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "various clinical conditions including Parkinson\u2019s disease, schizophrenia, dementia, depression, and type 2 diabetes mellitus (T2DM)", "chunk": 2}
{"article": "PMC10306194.txt", "subject": "Intranasal Insulin (INI)", "relationship": "USED_TO_DIAGNOSE", "object": "cognition in patients with mild cognitive impairment (MCI) or dementia", "chunk": 2}
{"article": "PMC10306194.txt", "subject": "INI", "relationship": "RELATED_TREATMENT", "object": "Improve global cognition in patients with AD and mild cognitive impairment", "chunk": 4}
{"article": "PMC10306194.txt", "subject": "INI", "relationship": "RELATED_TREATMENT", "object": "Provide more therapeutic benefits than acute administration", "chunk": 4}
{"article": "PMC10306194.txt", "subject": "ADAS-Cog scores", "relationship": "RESPONDED_TO", "object": "Long-term INI treatment", "chunk": 4}
{"article": "PMC10306194.txt", "subject": "APOE-\u03b54", "relationship": "RELATED_PROGNOSIS", "object": "Insulin resistance, and may contribute to heterogeneity in cognitive response to INI treatment", "chunk": 5}
{"article": "PMC10306194.txt", "subject": "APOE-\u03b54", "relationship": "INDICATES_PRESENCE_OF", "object": "Insulin resistance", "chunk": 5}
{"article": "PMC10306194.txt", "subject": "APOE4", "relationship": "DIAGNOSITC_OF", "object": "Early-onset Alzheimer's Disease", "chunk": 5}
{"article": "PMC10310693.txt", "subject": "Obesity", "relationship": "RELATED_PROGNOSIS", "object": "increased risk of stroke and neurodegenerative disorders", "chunk": 1}
{"article": "PMC10310693.txt", "subject": "Metabolic syndrome (MetS)", "relationship": "ASSOCIATED_WITH", "object": "increased risk of stroke", "chunk": 1}
{"article": "PMC10310693.txt", "subject": "Metabolic syndrome (MetS)", "relationship": "ASSOCIATED_WITH", "object": "risk of developing neurodegenerative disorderssss", "chunk": 1}
{"article": "PMC10310693.txt", "subject": "high triglycerides", "relationship": "IS_COMPONENT_OF", "object": "Metabolic syndrome (MetS)", "chunk": 1}
{"article": "PMC10310693.txt", "subject": "low high-density lipoprotein (HDL) levels", "relationship": "IS_COMPONENT_OF", "object": "Metabolic syndrome (MetS)", "chunk": 1}
{"article": "PMC10310693.txt", "subject": "Hypertension", "relationship": "IS_COMPONENT_OF", "object": "Metabolic syndrome (MetS)", "chunk": 1}
{"article": "PMC10310693.txt", "subject": "Hyperglycemia", "relationship": "IS_COMPONENT_OF", "object": "Metabolic syndrome (MetS)", "chunk": 1}
{"article": "PMC10310693.txt", "subject": "waist circumference", "relationship": "INDICATES_PRESENCE_OF", "object": "Metabolic Syndrome (MetS)", "chunk": 2}
{"article": "PMC10310693.txt", "subject": "Triglyceride", "relationship": "INDICATES_PRESENCE_OF", "object": "Metabolic Syndrome (MetS)", "chunk": 2}
{"article": "PMC10310693.txt", "subject": "HDL", "relationship": "INDICATES_PRESENCE_OF", "object": "Metabolic Syndrome (MetS)", "chunk": 2}
{"article": "PMC10310693.txt", "subject": "Hypertension", "relationship": "INDICATES_PRESENCE_OF", "object": "Metabolic Syndrome (MetS)", "chunk": 2}
{"article": "PMC10310693.txt", "subject": "fasting glucose", "relationship": "INDICATES_PRESENCE_OF", "object": "Metabolic Syndrome (MetS)", "chunk": 2}
{"article": "PMC10310693.txt", "subject": "HbA1c", "relationship": "INDICATES_PRESENCE_OF", "object": "Average blood glucose levels over the last 2 to 3 months", "chunk": 3}
{"article": "PMC10310693.txt", "subject": "HbA1c", "relationship": "ASSOCIAATED_WITH_POOR_OUTCOME", "object": "Diabetes treatment", "chunk": 3}
{"article": "PMC10310693.txt", "subject": "HbA1c", "relationship": "RELATED_PROGNOSIS", "object": "Prevalence and severity of Metabolic Syndrome (MetS)", "chunk": 3}
{"article": "PMC10310693.txt", "subject": "Waist circumference", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Increased cortical surface area and decreased cortical thickness in  the central and superior frontal gyri", "chunk": 4}
{"article": "PMC10310693.txt", "subject": "Waist circumference", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Larger cortical surface area and thinner cortical thickness in the lateral frontal lobe, supramarginal gyrus, lateral temporal lobe, posterior cingulate cortex, and insula", "chunk": 4}
{"article": "PMC10310693.txt", "subject": "Waist circumference", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Decreased thickness in the medial temporal lobe", "chunk": 4}
{"article": "PMC10310693.txt", "subject": "Waist circumference", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Larger bilateral putamen, right caudate, and thalamus, as well as right amygdala", "chunk": 4}
{"article": "PMC10310693.txt", "subject": "Triglyceride", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Increased cortical surface area and decreased cortical thickness in the bilateral central gyrus, supramarginal gyrus, and middle temporal gyrus", "chunk": 4}
{"article": "PMC10310693.txt", "subject": "HDL", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Increased cortical surface area and decreased cortical thickness in the bilateral central gyrus, supramarginal gyrus, and middle temporal gyrus ", "chunk": 4}
{"article": "PMC10310693.txt", "subject": "Triglyceride", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Increased putamen and pallidus  volumes", "chunk": 4}
{"article": "PMC10310693.txt", "subject": "HDL", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Increased putamen and pallidus volumes", "chunk": 4}
{"article": "PMC10310693.txt", "subject": "Hypertension", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Reduced thickness in the parahippocampal gyrus, posterior cingulate cortex, and insula, as well as to an increased volume in the bilateral caudate and putamen", "chunk": 4}
{"article": "PMC10310693.txt", "subject": "HbA1c", "relationship": "RELATED_TO", "object": "cortical morphology", "chunk": 5}
{"article": "PMC10310693.txt", "subject": "HbA1c", "relationship": "ASSOCIATED_WITH", "object": "larger cortical surface area", "chunk": 5}
{"article": "PMC10310693.txt", "subject": "HbA1c", "relationship": "ASSOCIATED_WITH", "object": "thinner cortical thickness in the lateral orbitofrontal cortex, frontal gyrus, motor region, lateral temporal lobe, and superior and inferior parietal cortex", "chunk": 5}
{"article": "PMC10310693.txt", "subject": "HbA1c", "relationship": "ASSOCIATED_WITH", "object": "thinner cortex spread to the posterior cingulate cortex, medial temporal lobe, and precuneus", "chunk": 5}
{"article": "PMC10310693.txt", "subject": "HbA1c", "relationship": "ASSOCIATED_WITH", "object": "thalamus", "chunk": 5}
{"article": "PMC10310693.txt", "subject": "HbA1c", "relationship": "ASSOCIATED_WITH", "object": "pallidus volume reductions", "chunk": 5}
{"article": "PMC10310693.txt", "subject": "HbA1c", "relationship": "ASSOCIATED_WITH", "object": "hippocampus volume reductions", "chunk": 5}
{"article": "PMC10310693.txt", "subject": "HbA1c", "relationship": "RELATED_TREATMENT", "object": "brain health", "chunk": 5}
{"article": "PMC10310693.txt", "subject": "waist circumference", "relationship": "ASSOCIATED_WITH", "object": "widespread brain morphology", "chunk": 6}
{"article": "PMC10310693.txt", "subject": "HbA1c", "relationship": "ASSOCIATED_WITH", "object": "hippocampal volume reduction", "chunk": 6}
{"article": "PMC10310693.txt", "subject": "enteric cortex volume reduction", "relationship": "ASSOCIATED_WITH", "object": "early AD", "chunk": 6}
{"article": "PMC10310693.txt", "subject": "parahippocampal gyrus volume reduction", "relationship": "ASSOCIATED_WITH", "object": "early AD", "chunk": 6}
{"article": "PMC10310693.txt", "subject": "hippocampal volume reduction", "relationship": "ASSOCIATED_WITH", "object": "early AD", "chunk": 6}
{"article": "PMC10310693.txt", "subject": "waist circumference", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "volumetric reduction in the basal ganglia", "chunk": 7}
{"article": "PMC10310693.txt", "subject": "waist circumference", "relationship": "INDICATES_PRESENCE_OF", "object": "ad", "chunk": 7}
{"article": "PMC10310693.txt", "subject": "five MetS components", "relationship": "RELATED_TO_PROGNOSIS", "object": "greater brain-age gaps in stroke and multiple sclerosis than aging", "chunk": 7}
{"article": "PMC10310693.txt", "subject": "MetS-associated brain morphology", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Estimating  the risk of individuals", "chunk": 7}
{"article": "PMC10310693.txt", "subject": "HbA1c", "relationship": "INDICATES_PRESENCE_OF", "object": "ad", "chunk": 7}
{"article": "PMC10363100.txt", "subject": "amyloid protein", "relationship": "RELATED_TO", "object": "AD pathology", "chunk": 1}
{"article": "PMC10363100.txt", "subject": "tau protein", "relationship": "RELATED_TO", "object": "AD pathology", "chunk": 1}
{"article": "PMC10363100.txt", "subject": "neurodegeneration", "relationship": "RELATED_TO", "object": "AD pathology", "chunk": 1}
{"article": "PMC10363100.txt", "subject": "blood-based biomarkers", "relationship": "RELATED_TO", "object": "Detect AD pathology", "chunk": 2}
{"article": "PMC10363100.txt", "subject": "cerebrospinal fluid (CSF) tests", "relationship": "RELATED_TO", "object": "Detect AD pathology", "chunk": 2}
{"article": "PMC10363100.txt", "subject": "positron emission tomography (PET) scans", "relationship": "RELATED_TO", "object": "Detect AD pathology", "chunk": 2}
{"article": "PMC10363100.txt", "subject": "MRI", "relationship": "RELATED_TO_DIAGNOSIS", "object": "Automated diagnosis of AD", "chunk": 4}
{"article": "PMC10363100.txt", "subject": "PET", "relationship": "RELATED_TO_DIAGNOSIS", "object": "Automated diagnosis of AD", "chunk": 4}
{"article": "PMC10363100.txt", "subject": "CT scans", "relationship": "RELATED_TO_DIAGNOSIS", "object": "Automated diagnosis of AD", "chunk": 4}
{"article": "PMC10363100.txt", "subject": "MRI", "relationship": "RELATED_TO_DIAGNOSIS", "object": "Automated diagnosis of PD", "chunk": 4}
{"article": "PMC10363100.txt", "subject": "PET", "relationship": "RELATED_TO_DIAGNOSIS", "object": "Automated diagnosis of PD", "chunk": 4}
{"article": "PMC10363100.txt", "subject": "MRI and PET", "relationship": "RELATED_PROGNOSIS", "object": "Performance of automated diagnosis of AD", "chunk": 4}
{"article": "PMC10363100.txt", "subject": "Single modal analysis", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Performance of automated diagnosis of AD", "chunk": 4}
{"article": "PMC10363100.txt", "subject": "Multimodal studies using MRI and PET data", "relationship": "RELATED_PROGNOSIS", "object": "Accuracy of classifying HC from those with AD", "chunk": 4}
{"article": "PMC10363100.txt", "subject": "Multimodal studies using MRI and PET data", "relationship": "RELATED_PROGNOSIS", "object": "Accuracy of classifying MCI, AD and HC", "chunk": 4}
{"article": "PMC10363100.txt", "subject": "MRI and PET scan data", "relationship": "RELATED_PROGNOSIS", "object": "Accuracy of classifying PD and HC", "chunk": 4}
{"article": "PMC10363100.txt", "subject": "Genetics", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "genetic data improve classification performance", "chunk": 6}
{"article": "PMC10363100.txt", "subject": "Genetics", "relationship": "RELATED_PROGNOSIS", "object": "presence of genetic mutations can indicate an increased risk of developing AD or PD", "chunk": 6}
{"article": "PMC10363100.txt", "subject": "Genetics", "relationship": "DIAGNOSITC_OF", "object": "AD or PD", "chunk": 6}
{"article": "PMC10363100.txt", "subject": "Amyloid beta peptides", "relationship": "INDICATES_PRESENCE_OF", "object": "AD", "chunk": 7}
{"article": "PMC10363100.txt", "subject": "Tau", "relationship": "INDICATES_PRESENCE_OF", "object": "AD", "chunk": 7}
{"article": "PMC10363100.txt", "subject": "EEG microstates", "relationship": "RELATED_TO", "object": " AD severity", "chunk": 7}
{"article": "PMC10363100.txt", "subject": "EEG microstates", "relationship": "RELATED_TO", "object": "Mild cognitive impairment", "chunk": 7}
{"article": "PMC10439779.txt", "subject": "Alzheimer\u2019s disease", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "insomnia disorder (ID)", "chunk": 1}
{"article": "PMC10439779.txt", "subject": "insomnia disorder (ID)", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive impairment in different stages of the continuum of AD", "chunk": 1}
{"article": "PMC10439779.txt", "subject": "insomnia disorder (ID)", "relationship": "RELATED_TREATMENT", "object": "pharmacological and nonpharmacological pathways", "chunk": 1}
{"article": "PMC10439779.txt", "subject": "Alzheimer\u2019s disease", "relationship": "RELATED_TREATMENT", "object": "pharmacological and nonpharmacological pathways", "chunk": 1}
{"article": "PMC10439779.txt", "subject": "left angular gyrus (MNI: \u221245, \u221267, 38)", "relationship": "USED_TO_DIAGNOSE", "object": "improving episodic memory in AD spectrum patients", "chunk": 1}
{"article": "PMC10439779.txt", "subject": "Mini-Mental State Examination (MMSE)", "relationship": "RELATED_PROGNOSIS", "object": "Staging of dementia severity", "chunk": 2}
{"article": "PMC10439779.txt", "subject": "Montreal Cognitive Assessment (MoCA)", "relationship": "RELATED_PROGNOSIS", "object": "Staging of dementia severity", "chunk": 2}
{"article": "PMC10439779.txt", "subject": "Pittsburgh Sleep Quality Index (PSQI)", "relationship": "INDICATES_PRESENCE_OF", "object": "Insomnia disorder", "chunk": 2}
{"article": "PMC10439779.txt", "subject": "Insomnia Severity Index (ISI)", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "subjective sleep quality", "chunk": 3}
{"article": "PMC10439779.txt", "subject": "ISI", "relationship": "RELATED_TREATMENT", "object": "sleep quality", "chunk": 3}
{"article": "PMC10439779.txt", "subject": "Insomnia Severity Index (ISI)", "relationship": "MONITORED_DURING_TREATMENT", "object": "subjective sleep quality", "chunk": 3}
{"article": "PMC10439779.txt", "subject": "Self-Rating Scale of Sleep (SRSS)", "relationship": "MONITORED_DURING_TREATMENT", "object": "subjective sleep quality", "chunk": 3}
{"article": "PMC10439779.txt", "subject": "PSQI", "relationship": "MONITORED_DURING_TREATMENT", "object": "subjective sleep quality", "chunk": 3}
{"article": "PMC10439779.txt", "subject": "Epworth Sleepiness Scale (ESS)", "relationship": "MONITORED_DURING_TREATMENT", "object": "subjective sleep quality", "chunk": 3}
{"article": "PMC10439779.txt", "subject": "sleep duration", "relationship": "MONITORED_DURING_TREATMENT", "object": "subjective sleep quality", "chunk": 3}
{"article": "PMC10439779.txt", "subject": "sleep quality", "relationship": "MONITORED_DURING_TREATMENT", "object": "subjective sleep quality", "chunk": 3}
{"article": "PMC10439779.txt", "subject": "ISI", "relationship": "INDICATES_PRESENCE_OF", "object": "Poor sleep quality at baseline in the AD spectrum with ID group", "chunk": 4}
{"article": "PMC10439779.txt", "subject": "AIS", "relationship": "INDICATES_PRESENCE_OF", "object": "Poor sleep quality at baseline in the AD spectrum with ID group", "chunk": 4}
{"article": "PMC10439779.txt", "subject": "PSQI", "relationship": "INDICATES_PRESENCE_OF", "object": "Poor sleep quality at baseline in the AD spectrum with ID group", "chunk": 4}
{"article": "PMC10439779.txt", "subject": "SRSS", "relationship": "INDICATES_PRESENCE_OF", "object": "Poor sleep quality at baseline in the AD spectrum with ID group", "chunk": 4}
{"article": "PMC10439779.txt", "subject": "ESS", "relationship": "INDICATES_PRESENCE_OF", "object": "Poor sleep quality at baseline in the AD spectrum with ID group", "chunk": 4}
{"article": "PMC10439779.txt", "subject": "HAMD", "relationship": "INDICATES_PRESENCE_OF", "object": "Depression", "chunk": 5}
{"article": "PMC10439779.txt", "subject": "HAMA", "relationship": "INDICATES_PRESENCE_OF", "object": "Anxiety", "chunk": 5}
{"article": "PMC10439779.txt", "subject": "MMSE", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive function", "chunk": 5}
{"article": "PMC10439779.txt", "subject": "MoCA", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive function", "chunk": 5}
{"article": "PMC10439779.txt", "subject": "AVLT-SDR", "relationship": "RELATED_PROGNOSIS", "object": "Verbal memory", "chunk": 5}
{"article": "PMC10439779.txt", "subject": "AVLT-LDR", "relationship": "RELATED_PROGNOSIS", "object": "Verbal memory", "chunk": 5}
{"article": "PMC10439779.txt", "subject": "WMS-VR", "relationship": "RELATED_PROGNOSIS", "object": "Visual memory", "chunk": 5}
{"article": "PMC10439779.txt", "subject": "ISI", "relationship": "INDICATES_PRESENCE_OF", "object": "Insomnia severity", "chunk": 5}
{"article": "PMC10439779.txt", "subject": "AIS", "relationship": "INDICATES_PRESENCE_OF", "object": "Insomnia severity", "chunk": 5}
{"article": "PMC10439779.txt", "subject": "PSQI", "relationship": "INDICATES_PRESENCE_OF", "object": "Poor sleep quality", "chunk": 5}
{"article": "PMC10439779.txt", "subject": "SRSS", "relationship": "INDICATES_PRESENCE_OF", "object": "Sleep disorders", "chunk": 5}
{"article": "PMC10439779.txt", "subject": "ESS", "relationship": "INDICATES_PRESENCE_OF", "object": "Excessive daytime sleepiness", "chunk": 5}
{"article": "PMC10439779.txt", "subject": "Affective Auditory Processing Network", "relationship": "INDICATES_PRESENCE_OF", "object": "Insomnia Disorder in AD Spectrum Patients", "chunk": 7}
{"article": "PMC10439779.txt", "subject": "Sensory-Motor Collaborative Network", "relationship": "INDICATES_PRESENCE_OF", "object": "Auditory Sensory-Emotional Processing Circuit Abnormalities", "chunk": 7}
{"article": "PMC10439779.txt", "subject": "Brain Spontaneous Activity (Affective Auditory Processing and Sensory-Motor Collaborative Network)", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Sleep Quality in AD Spectrum with Insomnia Disorder Patients", "chunk": 7}
{"article": "PMC10439779.txt", "subject": "Spontaneous Activity of Baseline Differential Collaborative Network", "relationship": "RELATED_TO", "object": "Improvement in Cognitive Function (Specifically Memory) in AD Spectrum Patients with ID", "chunk": 7}
{"article": "PMC10439779.txt", "subject": "Insomnia disorder", "relationship": "INDICATES_PRESENCE_OF", "object": "Decline in functional activity of the affective auditory processing network and sensorimotor network", "chunk": 8}
{"article": "PMC10439779.txt", "subject": "Insomnia disorder", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Memory and cognitive decline", "chunk": 8}
{"article": "PMC10439779.txt", "subject": "Hippocampal reactivation during sleep", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "rTMS stimulation of the corresponding cerebral cortex to improve both cognition and sleep", "chunk": 8}
{"article": "PMC10439779.txt", "subject": "Cortical slow oscillations (SOs)", "relationship": "BIOMARKER_DYNAMICS_UNDER_TREATMENT", "object": "Enhanced by rTMS stimulation", "chunk": 8}
{"article": "PMC10439779.txt", "subject": "Sleep quality", "relationship": "RELATED_PROGNOSIS", "object": "Good sleep quality is a state in which network activity reaches stability", "chunk": 8}
{"article": "PMC10439779.txt", "subject": "Memory consolidation pathway", "relationship": "MONITORED_DURING_TREATMENT", "object": "Stabilizing the pathway through changes in sleep-related network activity", "chunk": 8}
{"article": "PMC10439779.txt", "subject": "rTMS", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Selection of targets based on meta-analyses of reported brain regions", "chunk": 8}
{"article": "PMC10450067.txt", "subject": "dementia care managers", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Individual care plan", "chunk": 1}
{"article": "PMC10475546.txt", "subject": "MoCA total score", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive functioning", "chunk": 4}
{"article": "PMC10475546.txt", "subject": "MoCA Memory Index Score", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive functioning", "chunk": 4}
{"article": "PMC10475546.txt", "subject": "NIH Toolbox Pattern Comparison Processing Speed test score", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive functioning", "chunk": 4}
{"article": "PMC10475546.txt", "subject": "Flanker score", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive functioning", "chunk": 4}
{"article": "PMC10475546.txt", "subject": "EQ-5D-5L summary score", "relationship": "RELATED_PROGNOSIS", "object": "Health-related quality of life", "chunk": 4}
{"article": "PMC10475546.txt", "subject": "EQ-VAS", "relationship": "RELATED_PROGNOSIS", "object": "Health-related quality of life", "chunk": 4}
{"article": "PMC10475546.txt", "subject": "6MWT total distance", "relationship": "RELATED_PROGNOSIS", "object": "Physical functioning", "chunk": 4}
{"article": "PMC10475546.txt", "subject": "MoCA", "relationship": "DETECTED_IMPROVEMENT", "object": "General cognition", "chunk": 6}
{"article": "PMC10475546.txt", "subject": "Multicomponent exercise training", "relationship": "ASSOCIATED_WITH_IMPROVED", "object": "Global cognition, attention, and executive function", "chunk": 6}
{"article": "PMC10475546.txt", "subject": "Aerobic training", "relationship": "ASSOCIATED_WITH_IMPROVED", "object": "Global cognition", "chunk": 6}
{"article": "PMC10475546.txt", "subject": "Multicomponent exercise training", "relationship": "ASSOCIATED_WITH_NO_IMPROVEMENT", "object": "Memory", "chunk": 6}
{"article": "PMC10475546.txt", "subject": "Aerobic training", "relationship": "ASSOCIATED_WITH_WEAK_IMPROVEMENT", "object": "Memory", "chunk": 6}
{"article": "PMC10512116.txt", "subject": "positive emotion regulation", "relationship": "RELATED_TREATMENT", "object": "Intervention to reduce caregiver burden", "chunk": 1}
{"article": "PMC10512116.txt", "subject": "self-guided eHealth intervention", "relationship": "RELATED_TREATMENT", "object": "Delivery format to maximize scalability of intervention", "chunk": 1}
{"article": "PMC10512116.txt", "subject": "Positive affect", "relationship": "PREDICT_SURVIVAL", "object": "NIH Positive Affect Questionnaire scores", "chunk": 6}
{"article": "PMC10512116.txt", "subject": "PROMIS\u2014depression", "relationship": "RELATED_PROGNOSIS", "object": "Caregiving experiences", "chunk": 6}
{"article": "PMC10512116.txt", "subject": "PROMIS\u2014anxiety", "relationship": "RELATED_PROGNOSIS", "object": "Social interaction", "chunk": 6}
{"article": "PMC10512116.txt", "subject": "PROMIS\u2014meaning and purpose", "relationship": "RELATED_PROGNOSIS", "object": "Caregiving well-being", "chunk": 6}
{"article": "PMC10515582.txt", "subject": "mild cognitive impairment", "relationship": "INDICATES_PRESENCE_OF", "object": "increased risk of developing Alzheimer\u2019s disease or related dementia (ADRD)", "chunk": 1}
{"article": "PMC10515582.txt", "subject": "mild cognitive impairment", "relationship": "RELATED_TO", "object": " subjective cognitive decline (SCD)", "chunk": 1}
{"article": "PMC10515582.txt", "subject": "Alzheimer\u2019s disease or related dementia (ADRD)", "relationship": "RELATED_TO", "object": "small symptomatic relief for some patients", "chunk": 1}
{"article": "PMC10515582.txt", "subject": "Alzheimer\u2019s disease or related dementia (ADRD)", "relationship": "INDICATES_PRESENCE_OF", "object": "loss of independence", "chunk": 1}
{"article": "PMC10515582.txt", "subject": "Alzheimer\u2019s disease or related dementia (ADRD)", "relationship": "RELATED_TO", "object": "improved cognitive functioning", "chunk": 1}
{"article": "PMC10515582.txt", "subject": "non-pharmacologic and behavioral interventions", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "people with mild cognitive impairment or Dementia", "chunk": 1}
{"article": "PMC10515582.txt", "subject": "Preventing Loss of Independence through Exercise (PLI\u00c9)", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "improve multiple outcomes and enhance quality of life", "chunk": 1}
{"article": "PMC10515582.txt", "subject": "Quick dementia Rating Scale", "relationship": "RELATED_TREATMENT", "object": "Cognitive impairment assessment for eligibility in online Moving Together program", "chunk": 3}
{"article": "PMC10515582.txt", "subject": "online program", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "design of online interventions for people with dementia", "chunk": 9}
{"article": "PMC10542675.txt", "subject": "DRP total score", "relationship": "RELATED_TREATMENT", "object": "Analysis of the effect of engagement with the PDMOOC, which includes personalized DRP reports, on DRP total score.", "chunk": 5}
{"article": "PMC10542675.txt", "subject": "DRP Total Score", "relationship": "RELATED_TO", "object": "Changes in risk behaviours", "chunk": 6}
{"article": "PMC10624070.txt", "subject": "depression", "relationship": "DIAGNOSITC_OF", "object": "Neuropsychiatric symptoms (NPS), also known as behavioral and psychological symptoms of dementia, are signs and symptoms of disturbed perception, thought content, mood or behavior", "chunk": 1}
{"article": "PMC10624070.txt", "subject": "anxiety", "relationship": "DIAGNOSITC_OF", "object": "Neuropsychiatric symptoms (NPS), also known as behavioral and psychological symptoms of dementia, are signs and symptoms of disturbed perception, thought content, mood or behavior", "chunk": 1}
{"article": "PMC10624070.txt", "subject": "depression", "relationship": "INDICATES_PRESENCE_OF", "object": "patient- and caregiver-reported poorer quality of life, greater impairment in activities of daily living, increased rates of sleep disturbance and aggression, increased wandering, worsened cognitive impairment, and higher rates of institutionalization", "chunk": 1}
{"article": "PMC10624070.txt", "subject": "anxiety", "relationship": "INDICATES_PRESENCE_OF", "object": "patient- and caregiver-reported poorer quality of life, greater impairment in activities of daily living, increased rates of sleep disturbance and aggression, increased wandering, worsened cognitive impairment, and higher rates of institutionalization", "chunk": 1}
{"article": "PMC10624070.txt", "subject": "depression", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "patient- and caregiver-reported poorer quality of life, greater impairment in activities of daily living, increased rates of sleep disturbance and aggression, increased wandering, worsened cognitive impairment, and higher rates of institutionalization", "chunk": 1}
{"article": "PMC10624070.txt", "subject": "anxiety", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "patient- and caregiver-reported poorer quality of life, greater impairment in activities of daily living, increased rates of sleep disturbance and aggression, increased wandering, worsened cognitive impairment, and higher rates of institutionalization", "chunk": 1}
{"article": "PMC10624070.txt", "subject": "depression", "relationship": "PREDICTES_SURVIVAL", "object": "higher rates of institutionalization", "chunk": 1}
{"article": "PMC10624070.txt", "subject": "anxiety", "relationship": "PREDICTES_SURVIVAL", "object": "higher rates of institutionalization", "chunk": 1}
{"article": "PMC10624070.txt", "subject": "pharmacological therapy", "relationship": "RELATED_TREATMENT", "object": "Untreated depression and anxiety in dementia have led the development of pharmacological therapies.", "chunk": 1}
{"article": "PMC10624070.txt", "subject": "selective serotonin reuptake inhibitors", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Pharmacological treatment of depression in dementia has largely centered on selective serotonin reuptake inhibitors and other antidepressants", "chunk": 1}
{"article": "PMC10624070.txt", "subject": "Geriatric Depression Scale (GDS)", "relationship": "USED_TO_DIAGNOSE", "object": "Depression symptom severity in older adults", "chunk": 2}
{"article": "PMC10624070.txt", "subject": "Geriatric Depression Scale (GDS)", "relationship": "INDICATES_PRESENCE_OF", "object": "Depression symptoms", "chunk": 2}
{"article": "PMC10624070.txt", "subject": "Geriatric Depression Scale (GDS)", "relationship": "RELATED_PROGNOSIS", "object": "The severity of depression symptoms", "chunk": 2}
{"article": "PMC10624070.txt", "subject": "Geriatric Anxiety Scale-Short Form (GAI-SF)", "relationship": "USED_TO_DIAGNOSE", "object": "Anxiety symptoms", "chunk": 2}
{"article": "PMC10624070.txt", "subject": "Geriatric Anxiety Scale-Short Form (GAI-SF)", "relationship": "INDICATES_PRESENCE_OF", "object": "Anxiety symptoms", "chunk": 2}
{"article": "PMC10624070.txt", "subject": "Geriatric Anxiety Scale-Short Form (GAI-SF)", "relationship": "RELATED_PROGNOSIS", "object": "The severity of anxiety symptoms", "chunk": 2}
{"article": "PMC10624070.txt", "subject": "GDS", "relationship": "INDICATES_PRESENCE_OF", "object": "Depression symptoms", "chunk": 3}
{"article": "PMC10624070.txt", "subject": "GDS", "relationship": "DIAGNOSITC_OF", "object": "Depression", "chunk": 3}
{"article": "PMC10624070.txt", "subject": "GAI", "relationship": "INDICATES_PRESENCE_OF", "object": "Depression symptoms", "chunk": 3}
{"article": "PMC10624070.txt", "subject": "Antidepressant medications", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "Severity of Depression", "chunk": 3}
{"article": "PMC10624070.txt", "subject": "Psychotropic medications", "relationship": "RELATED_PROGNOSIS", "object": "Severity of Depression", "chunk": 3}
{"article": "PMC10704137.txt", "subject": "18F-FDG-PET/CT", "relationship": "INDICATES_PRESENCE_OF", "object": "Hypometabolism in cerebral regions", "chunk": 1}
{"article": "PMC10704137.txt", "subject": "functional MRI", "relationship": "INDICATES_PRESENCE_OF", "object": "Hypometabolism in cerebral regions", "chunk": 1}
{"article": "PMC10704137.txt", "subject": "18F-FDG-PET/CT scan", "relationship": "RELATED_TO", "object": "Neuro-PASC", "chunk": 1}
{"article": "PMC10704137.txt", "subject": "functional MRI", "relationship": "RELATED_TO", "object": "Neuro-PASC", "chunk": 1}
{"article": "PMC10704137.txt", "subject": "SPECT imaging", "relationship": "RELATED_TO", "object": "Neuro-PASC", "chunk": 1}
{"article": "PMC10704137.txt", "subject": "SWI sequence", "relationship": "RELATED_TO", "object": "Neuro-PASC", "chunk": 1}
{"article": "PMC10704137.txt", "subject": "18F-amyloid PET/CT", "relationship": "RELATED_TO", "object": "Neuro-PASC", "chunk": 1}
{"article": "PMC10704137.txt", "subject": "arterial spin labeling (ASL)", "relationship": "RELATED_TO", "object": "Neuro-PASC", "chunk": 1}
{"article": "PMC10704137.txt", "subject": "18F-FDG", "relationship": "RELATED_TO_DIAGNOSIS", "object": "early metabolic changes after infection", "chunk": 2}
{"article": "PMC10704137.txt", "subject": "18F-FDG", "relationship": "RELATED_TO_DIAGNOSIS", "object": "persistent anosmia/ageusia, fatigue, and vascular uptake detection", "chunk": 2}
{"article": "PMC10704137.txt", "subject": "18F-FDG", "relationship": "INDICATES_PRESENCE_OF", "object": "hypometabolism in the right parahippocampus and thalamus", "chunk": 2}
{"article": "PMC10704137.txt", "subject": "18F-FDG", "relationship": "INDICATES_PRESENCE_OF", "object": "hypometabolism in the orbitofrontal cortex", "chunk": 2}
{"article": "PMC10704137.txt", "subject": "18F-FDG", "relationship": "INDICATES_PRESENCE_OF", "object": "relative hypometabolism in the bilateral parahippocampus and fusiform gyri and in the left insula", "chunk": 2}
{"article": "PMC10704137.txt", "subject": "18F-FDG", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Metabolically active processes", "chunk": 3}
{"article": "PMC10704137.txt", "subject": "18F-FDG", "relationship": "INDICATES_PRESENCE_OF", "object": "Hyper or hypometabolic states", "chunk": 3}
{"article": "PMC10704137.txt", "subject": "18F-FDG", "relationship": "DIAGNOSITC_OF", "object": "Oncology", "chunk": 3}
{"article": "PMC10704137.txt", "subject": "18F-FDG", "relationship": "RELATED_PROGNOSIS", "object": "Workup and follow-up", "chunk": 3}
{"article": "PMC10704137.txt", "subject": "18F-FDG-PET/CT", "relationship": "INDICATES_PRESENCE_OF", "object": "Neuro-PASC", "chunk": 4}
{"article": "PMC10704137.txt", "subject": "18F-FDG-PET/CT", "relationship": "USED_TO_DIAGNOSE", "object": "Neuro-PASC", "chunk": 4}
{"article": "PMC10704137.txt", "subject": "18F-FDG-PET/CT", "relationship": "MONITORED_DURING_TREATMENT", "object": "Post-COVID syndrome", "chunk": 4}
{"article": "PMC10704137.txt", "subject": "18F-FDG-PET/CT", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Neuro-PASC", "chunk": 4}
{"article": "PMC10704137.txt", "subject": "18F-FDG-PET/CT", "relationship": "RELATED_PROGNOSIS", "object": "Changes in brain", "chunk": 4}
{"article": "PMC10704137.txt", "subject": "18F-FDG-PET/CT", "relationship": "RELATED_PROGNOSIS", "object": "Functioning status", "chunk": 4}
{"article": "PMC10704137.txt", "subject": "Hypometabolism", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Cognitive decline", "chunk": 4}
{"article": "PMC10704137.txt", "subject": "Hypometabolism", "relationship": "INDICATES_PRESENCE_OF", "object": "Cerebral damage", "chunk": 4}
{"article": "PMC10704137.txt", "subject": "Hypometabolism", "relationship": "PREDICTS_SURVIVAL", "object": "Post-COVID syndrome", "chunk": 4}
{"article": "PMC10704137.txt", "subject": "18F-amyloid PET/CT", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Treatment for amyloid plaques", "chunk": 4}
{"article": "PMC10704137.txt", "subject": "18F-FDG-PET/CT", "relationship": "RELATED_TO", "object": "Hypoperfusion on SPECT imaging", "chunk": 4}
{"article": "PMC10704137.txt", "subject": "Hyposmia", "relationship": "ASSOCIATED_WITH", "object": "Cerebellar hypometabolism", "chunk": 4}
{"article": "PMC10704137.txt", "subject": "Insomnia", "relationship": "ASSOCIATED_WITH", "object": "Hypometabolism in frontal cortex, brainstem and cerebellum", "chunk": 4}
{"article": "PMC10704137.txt", "subject": "Cognitive decline (MoCA)", "relationship": "ASSOCIATED_WITH", "object": "Cerebral hypometabolism", "chunk": 4}
{"article": "PMC10704137.txt", "subject": "Amyloid plaques", "relationship": "RELATED_TO", "object": "Cognitive impairment", "chunk": 4}
{"article": "PMC10704137.txt", "subject": "amyloid beta peptides peptides", "relationship": "RELATED_TO", "object": "plasma levels", "chunk": 6}
{"article": "PMC10704137.txt", "subject": "amyloid beta peptides peptides", "relationship": "INDICATES_PRESENCE_OF", "object": "Neuro-PASC", "chunk": 6}
{"article": "PMC10704137.txt", "subject": "diffusion", "relationship": "RELATED_PROGNOSIS", "object": "tissue damage", "chunk": 6}
{"article": "PMC10704137.txt", "subject": "diffusivity", "relationship": "RELATED_PROGNOSIS", "object": "olfactory dysfunction", "chunk": 6}
{"article": "PMC10704137.txt", "subject": "diffusivity", "relationship": "USED_TO_DIAGNOSE", "object": "Neuro-PASC", "chunk": 6}
{"article": "PMC10704137.txt", "subject": "mean diffusivity", "relationship": "RELATED_TO", "object": "white matter regions", "chunk": 6}
{"article": "PMC10704137.txt", "subject": "radial diffusivity", "relationship": "RELATED_TO", "object": "white matter regions", "chunk": 6}
{"article": "PMC10704137.txt", "subject": "DTI", "relationship": "DIAGNOSITC_OF", "object": "Neuro-PASC", "chunk": 6}
{"article": "PMC10704137.txt", "subject": "Susceptibility-weighted imaging", "relationship": "DIAGNOSITC_OF", "object": "Neuro-PASC", "chunk": 6}
{"article": "PMC10704137.txt", "subject": "18F-FDG-PET/CT", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Neuro-PASC marker identification", "chunk": 7}
{"article": "PMC10704137.txt", "subject": "sMRI", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Neuro-PASC marker identification", "chunk": 7}
{"article": "PMC10704137.txt", "subject": "18F-FDG-PET/CT", "relationship": "MONITORED_DURING_TREATMENT", "object": "Response to treatment in Neuro-PASC", "chunk": 7}
{"article": "PMC10704137.txt", "subject": "Hypometabolism", "relationship": "RELATED_TO", "object": "Cerebral damage of post-COVID syndrome", "chunk": 7}
{"article": "PMC10710152.txt", "subject": "P-tau217", "relationship": "MONITORED_DURING_TREATMENT", "object": "Throughout the 24-week duration of the study", "chunk": 3}
{"article": "PMC10710152.txt", "subject": "P-tau231", "relationship": "MONITORED_DURING_TREATMENT", "object": "Throughout the 24-week duration of the study", "chunk": 3}
{"article": "PMC10710152.txt", "subject": "Neurofilament light", "relationship": "MONITORED_DURING_TREATMENT", "object": "Throughout the 24-week duration of the study", "chunk": 3}
{"article": "PMC10710152.txt", "subject": "AB 42/40 ratio", "relationship": "MONITORED_DURING_TREATMENT", "object": "Throughout the 24-week duration of the study", "chunk": 3}
{"article": "PMC10710152.txt", "subject": "structural changes in the MTL", "relationship": "RELATED_PROGNOSIS", "object": "selectively impaired on generalization", "chunk": 4}
{"article": "PMC10710152.txt", "subject": "Acquired Equivalence", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "depends on the entorhinal cortex (EC) and parahippocampal regions of the MTL", "chunk": 4}
{"article": "PMC10710152.txt", "subject": "Acquired Equivalence", "relationship": "INDICATES_PRESENCE_OF", "object": "problems in the entorhinal cortex (EC) and parahippocampal regions of the MTL", "chunk": 4}
{"article": "PMC10710152.txt", "subject": "generalization", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "effects of the CDF intervention on cognition", "chunk": 4}
{"article": "PMC10710152.txt", "subject": "A\u03b2 42/40", "relationship": "RELATED_PROGNOSIS", "object": "Changes in blood biomarkers will be correlated with behavioral generalization and MTL flexibility change scores", "chunk": 8}
{"article": "PMC10710152.txt", "subject": "p-tau217", "relationship": "RELATED_PROGNOSIS", "object": "Changes in blood biomarkers will be correlated with behavioral generalization and MTL flexibility change scores", "chunk": 8}
{"article": "PMC10710152.txt", "subject": "p-tau231", "relationship": "RELATED_PROGNOSIS", "object": "Changes in blood biomarkers will be correlated with behavioral generalization and MTL flexibility change scores", "chunk": 8}
{"article": "PMC10710152.txt", "subject": "neurofilament light", "relationship": "RELATED_PROGNOSIS", "object": "Changes in blood biomarkers will be correlated with behavioral generalization and MTL flexibility change scores", "chunk": 8}
{"article": "PMC10758173.txt", "subject": "slow wave sleep (SWS)", "relationship": "RELATED_TO", "object": "strong memory traces", "chunk": 1}
{"article": "PMC10758173.txt", "subject": "slow wave sleep (SWS)", "relationship": "RELATED_TO", "object": "clearance of amyloid-beta (A\u03b2)", "chunk": 1}
{"article": "PMC10758173.txt", "subject": "slow wave activity (SWA)", "relationship": "PREDICTS_SURVIVAL", "object": "cognitive decline", "chunk": 1}
{"article": "PMC10758173.txt", "subject": "decreased slow wave sleep", "relationship": "INDICATES_PRESENCE_OF", "object": "neurodegeneration", "chunk": 1}
{"article": "PMC10758173.txt", "subject": "slower wave activity", "relationship": "IS_TARGET_OF_TREATMENT", "object": "acoustic stimulation", "chunk": 1}
{"article": "PMC10758173.txt", "subject": "phase-locked acoustic stimulation (PLAS)", "relationship": "IMPLODES_EVIDENCE_FOR", "object": "long-lasting memory benefits", "chunk": 1}
{"article": "PMC10758173.txt", "subject": "phase-locked acoustic stimulation (PLAS)", "relationship": "IMPLODES_EVIDENCE_FOR", "object": "amyloid clearance", "chunk": 1}
{"article": "PMC10758173.txt", "subject": "phase-locked acoustic stimulation (PLAS)", "relationship": "RELATED_TREATMENT", "object": "prevention of cognitive decline", "chunk": 1}
{"article": "PMC10758173.txt", "subject": "amyloid-beta (A\u03b2)", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Alzheimer\u2019s disease", "chunk": 1}
{"article": "PMC10758173.txt", "subject": "A\u03b242/A\u03b240 ratios", "relationship": "INDICATES_PRESENCE_OF", "object": "Increased mild cognitive impairment / AD risk", "chunk": 2}
{"article": "PMC10758173.txt", "subject": "Change scores from pre- to post-intervention in A\u03b2", "relationship": "RELATED_TREATMENT", "object": "A\u03b2-response to treatment, with higher change scores indicating an advantageous response", "chunk": 2}
{"article": "PMC10758173.txt", "subject": "SO-power", "relationship": "RELATED_PROGNOSIS", "object": "memory performance", "chunk": 3}
{"article": "PMC10758173.txt", "subject": "Spindle-power", "relationship": "RELATED_PROGNOSIS", "object": "memory performance", "chunk": 3}
{"article": "PMC10758173.txt", "subject": "delta-power", "relationship": "RELATED_PROGNOSIS", "object": "memory performance", "chunk": 3}
{"article": "PMC10758173.txt", "subject": "SO/spindle coupling responsiveness", "relationship": "RELATED_PROGNOSIS", "object": "memory performance", "chunk": 3}
{"article": "PMC10758173.txt", "subject": "SO/spindle coupling strength", "relationship": "PREDICTS_SURVIVAL", "object": "relative memory increase", "chunk": 4}
{"article": "PMC10758173.txt", "subject": "SO/spindle coupling strength", "relationship": "PREDICTS_SURVIVAL", "object": "relative memory increase at 1-week follow-up", "chunk": 4}
{"article": "PMC10758173.txt", "subject": "SO power", "relationship": "PREDICTS_SURVIVAL", "object": "relative memory increase", "chunk": 4}
{"article": "PMC10758173.txt", "subject": "spindle power", "relationship": "PREDICTS_SURVIVAL", "object": "relative memory increase", "chunk": 4}
{"article": "PMC10758173.txt", "subject": "delta power", "relationship": "PREDICTS_SURVIVAL", "object": "relative memory increase", "chunk": 4}
{"article": "PMC10758173.txt", "subject": "A\u03b242/A\u03b240-change", "relationship": "PREDICTS_SURVIVAL", "object": "relative memory increases at the 1-week follow-up", "chunk": 4}
{"article": "PMC10758173.txt", "subject": "SO power changes", "relationship": "INDICATES_PRESENCE_OF", "object": "more favorable A\u03b2 development", "chunk": 4}
{"article": "PMC10758173.txt", "subject": "A\u03b242/A\u03b240 change scores", "relationship": "RELATED_PROGNOSIS", "object": "memory increase at the 1-week follow-up", "chunk": 4}
{"article": "PMC10758173.txt", "subject": "A\u03b242/A\u03b240", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "unfavourable baseline A\u03b242/A\u03b240 values", "chunk": 5}
{"article": "PMC10758173.txt", "subject": "A\u03b242/A\u03b240", "relationship": "RELATED_TREATMENT", "object": "Potential for improvement,", "chunk": 5}
{"article": "PMC10758173.txt", "subject": "A\u03b242/A\u03b240", "relationship": "PREDICTED_SURVIVAL", "object": "Individuals with higher amyloid burden, and consequently greater dementia risk", "chunk": 5}
{"article": "PMC10758173.txt", "subject": "A\u03b242/A\u03b240", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Individuals at risk for dementia", "chunk": 5}
{"article": "PMC10758173.txt", "subject": "SO/spindle coupling", "relationship": "RELATED_PROGNOSIS", "object": "Beneficial amyloid response", "chunk": 5}
{"article": "PMC10758173.txt", "subject": "SO/spindle coupling", "relationship": "RELATED_PROGNOSIS", "object": "memory benefits", "chunk": 5}
{"article": "PMC10758173.txt", "subject": "SO/spindle coupling", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "deterioration with age, predicting forgetting and brain atrophy", "chunk": 5}
{"article": "PMC10758173.txt", "subject": "SO/spindle coupling", "relationship": "RELATED_TREATMENT", "object": "re-coupling of spindles and SOs through PLAS", "chunk": 5}
{"article": "PMC10758173.txt", "subject": "SO/spindle coupling", "relationship": "INDICATES_TREATMENT_ELIGIBILITY", "object": "Individuals with  a suboptimal oscillatory coupling hierarchy", "chunk": 5}
{"article": "PMC10758173.txt", "subject": "A\u03b2", "relationship": "ASSOCIATED_WITH", "object": "Sleep", "chunk": 6}
{"article": "PMC10758173.txt", "subject": "Amyloid burden", "relationship": "ASSOCIATED_WITH", "object": "Decreased SWS", "chunk": 6}
{"article": "PMC10758173.txt", "subject": "Decreased SWS", "relationship": "ASSOCIATED_WITH", "object": "Worsened amyloid burden", "chunk": 6}
{"article": "PMC10787596.txt", "subject": "Amyloid beta peptides", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Diagnosing and treating Alzheimer's Disease", "chunk": 1}
{"article": "PMC10787596.txt", "subject": "Tau cytoskeletal filaments", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Diagnosing and treating Alzheimer's Disease", "chunk": 1}
{"article": "PMC10787596.txt", "subject": "amyloid beta peptides", "relationship": "INDICATES_PRESENCE_OF", "object": "dementia", "chunk": 2}
{"article": "PMC10787596.txt", "subject": "tau protein", "relationship": "INDICATES_PRESENCE_OF", "object": "dementia", "chunk": 2}
{"article": "PMC10787596.txt", "subject": "neurofilament light chain (NfL)", "relationship": "INDICATES_PRESENCE_OF", "object": "neurodegeneration in the brain", "chunk": 2}
{"article": "PMC10787596.txt", "subject": "Plasma phosphorylated tau (p-tau)", "relationship": "INDICATES_PRESENCE_OF", "object": "dementia", "chunk": 2}
{"article": "PMC10787596.txt", "subject": "amyloid beta peptides", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "AD", "chunk": 2}
{"article": "PMC10787596.txt", "subject": "tau", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "AD", "chunk": 2}
{"article": "PMC10787596.txt", "subject": "donepezil", "relationship": "RELATED_TREATMENT", "object": "AD", "chunk": 2}
{"article": "PMC10787596.txt", "subject": "rivastigmine", "relationship": "RELATED_TREATMENT", "object": "AD", "chunk": 2}
{"article": "PMC10787596.txt", "subject": "galantamine", "relationship": "RELATED_TREATMENT", "object": "AD", "chunk": 2}
{"article": "PMC10787596.txt", "subject": "memantine", "relationship": "RELATED_TREATMENT", "object": "AD", "chunk": 2}
{"article": "PMC10787596.txt", "subject": "Lecanemab", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Treatment of Mild Cognitive Impairment and Mild Dementia caused by AD", "chunk": 3}
{"article": "PMC10787596.txt", "subject": "Lecanemab", "relationship": "TARGETS", "object": " Amyloid-beta Plaques", "chunk": 3}
{"article": "PMC10787596.txt", "subject": "Aducanumab", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Treatment of AD", "chunk": 3}
{"article": "PMC10787596.txt", "subject": "Aducanumab", "relationship": "TARGETS", "object": "Amyloid-beta Plaques", "chunk": 3}
{"article": "PMC10787596.txt", "subject": "MMSE", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Cognitive decline assessment", "chunk": 4}
{"article": "PMC10787596.txt", "subject": "MedDiet", "relationship": "RELATED_PROGNOSIS", "object": "Slower rate of cognitive decline and Reduced risk of AD", "chunk": 4}
{"article": "PMC10787596.txt", "subject": "Mediterranean Diet", "relationship": "RELATED_PROGNOSIS", "object": "Reduced risk of dementia", "chunk": 4}
{"article": "PMC10787596.txt", "subject": "Omega-3 fatty acids", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "Improved cognitive function and a lower risk of dementia", "chunk": 4}
{"article": "PMC10787596.txt", "subject": "Ketogenic Diet", "relationship": "RELATED_TREATMENT", "object": "Potential neuroprotective approach against cognitive decline", "chunk": 4}
{"article": "PMC10787596.txt", "subject": "Beta-hydroxybutyrate", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Neuroprotective property", "chunk": 4}
{"article": "PMC10787596.txt", "subject": "Physical Activity", "relationship": "RELATED_PROGNOSIS", "object": "Preventive effect against approximately 3% of all dementia cases", "chunk": 4}
{"article": "PMC10787596.txt", "subject": "Physical activity", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Managing cardiovascular risk factors", "chunk": 4}
{"article": "PMC10787596.txt", "subject": "Adequate Sleep", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Memory consolidation and the removal of amyloid beta peptides and hyperphosphorylated tau", "chunk": 4}
{"article": "PMC10787596.txt", "subject": "Non-pharmacological sleep therapies", "relationship": "RELATED_PROGNOSIS", "object": "Improving sleep quality and cognitive function in individuals with dementia", "chunk": 4}
{"article": "PMC10916999.txt", "subject": "amyloid beta peptides", "relationship": "INDICATES_PRESENCE_OF", "object": "Presymptomatic AD", "chunk": 1}
{"article": "PMC10916999.txt", "subject": "tau deposition", "relationship": "INDICATES_PRESENCE_OF", "object": "Presymptomatic AD", "chunk": 1}
{"article": "PMC10916999.txt", "subject": "Hand motor function decline", "relationship": "INDICATES_PRESENCE_OF", "object": "Presymptomatic AD", "chunk": 1}
{"article": "PMC10916999.txt", "subject": "Gait slowing", "relationship": "INDICATES_PRESENCE_OF", "object": "AD", "chunk": 1}
{"article": "PMC10916999.txt", "subject": "Episodic memory symptoms", "relationship": "INDICATES_PRESENCE_OF", "object": "AD", "chunk": 1}
{"article": "PMC10916999.txt", "subject": "Slow and less rhythmic keyboard tapping", "relationship": "INDICATES_PRESENCE_OF", "object": "Mild Cognitive Impairment", "chunk": 1}
{"article": "PMC10916999.txt", "subject": "Slow and less rhythmic keyboard tapping", "relationship": "INDICATES_PRESENCE_OF", "object": "AD", "chunk": 1}
{"article": "PMC10916999.txt", "subject": "dominant hand tapping frequency", "relationship": "PREDICTS_SURVIVAL", "object": "Episodic memory", "chunk": 5}
{"article": "PMC10916999.txt", "subject": "non-dominant hand tapping variability", "relationship": "PREDICTS_SURVIVAL", "object": "Episodic memory", "chunk": 5}
{"article": "PMC10916999.txt", "subject": "single-key tapping features", "relationship": "RELATED_TO_TREATMENT", "object": "Episodic memory", "chunk": 5}
{"article": "PMC10916999.txt", "subject": "alternate-key tapping features", "relationship": "RELATED_TO_TREATMENT", "object": "Episodic memory", "chunk": 5}
{"article": "PMC10917684.txt", "subject": "aquaporin-4", "relationship": "USED_TO_DIAGNOSE", "object": "Exchange between cerebral spinal fluid and interstitial fluid", "chunk": 1}
{"article": "PMC10917684.txt", "subject": "amyloid", "relationship": "RELATED_PROGNOSIS", "object": "Accumulation associated with Alzheimer's disease", "chunk": 1}
{"article": "PMC10917684.txt", "subject": "arterial pulsation", "relationship": "INDICATES_PRESENCE_OF", "object": "Improved glymphatic clearance", "chunk": 1}
{"article": "PMC10917684.txt", "subject": "glymphatic clearance", "relationship": "RELATED_TREATMENT", "object": "Therapeutic interventions proposed to treat Alzheimer's disease pathology", "chunk": 1}
{"article": "PMC10917684.txt", "subject": "multisensory 40\u2009Hz stimulation", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Promotes glymphatic clearance and amyloid removal", "chunk": 1}
{"article": "PMC10917684.txt", "subject": "vasoactive intestinal peptide interneurons", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Facilitate glymphatic clearance by regulating arterial pulsatility", "chunk": 1}
{"article": "PMC10917684.txt", "subject": "AQP4", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Multisensory 40 Hz stimulation", "chunk": 2}
{"article": "PMC10917684.txt", "subject": "AQP4", "relationship": "RELATED_TREATMENT", "object": "Reduction of AQP4 function using the small molecule TGN020", "chunk": 2}
{"article": "PMC10917684.txt", "subject": "AQP4", "relationship": "RELATED_TREATMENT", "object": "Genetic reduction of Aqp4 in astrocytes", "chunk": 2}
{"article": "PMC10917684.txt", "subject": "Amyloid", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimers", "chunk": 2}
{"article": "PMC10917684.txt", "subject": "Amyloid", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Exacerbated amyloid burden ", "chunk": 2}
{"article": "PMC10917684.txt", "subject": "Amyloid", "relationship": "PREDICTED_SURVIVAL", "object": "Multisensory 40 Hz stimulation might", "chunk": 2}
{"article": "PMC10917684.txt", "subject": "meningeal lymphatic vessels", "relationship": "INDICATES_PRESENCE_OF", "object": "Glymphatic exchange", "chunk": 3}
{"article": "PMC10917684.txt", "subject": "multisensory 40\u2009Hz stimulation", "relationship": "RELATED_TREATMENT", "object": "Increased meningeal lymphatic vessel diameter", "chunk": 3}
{"article": "PMC10917684.txt", "subject": "multisensory 40\u2009Hz stimulation", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Altered expression of genes in endothelial cells, astrocytes, and interneurons", "chunk": 3}
{"article": "PMC10917684.txt", "subject": "AQP4", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "Increased AQP4 polarization along astrocytic endfeet", "chunk": 4}
{"article": "PMC10917684.txt", "subject": "AQP4", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Treatment for glymphatic clearance of amyloid", "chunk": 4}
{"article": "PMC10917684.txt", "subject": "Kcnk1", "relationship": "INDICATES_PRESENCE_OF", "object": "Astrocyte activation", "chunk": 4}
{"article": "PMC10917684.txt", "subject": "VIP", "relationship": "RELATED_TO", "object": "Attenuation of Alzheimer's disease pathology", "chunk": 4}
{"article": "PMC10917684.txt", "subject": "AAV5-GFAP-EGFP-shAqp4", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Reduce AQP4 in astrocytes", "chunk": 7}
{"article": "PMC10917684.txt", "subject": "AAV-EGFP-shLacZ", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Reduce AQP4 levels", "chunk": 7}
{"article": "PMC10917684.txt", "subject": "shAqp4", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Reduce AQP4 levels", "chunk": 7}
{"article": "PMC10917684.txt", "subject": "shLacZ", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Broadly reduce AQP4 levels", "chunk": 7}
{"article": "PMC10917684.txt", "subject": "TGN020", "relationship": "RELATED_TREATMENT", "object": "Modulate AQP4 function", "chunk": 7}
{"article": "PMC10917684.txt", "subject": "AQP4", "relationship": "ASSOCIATED_WITH", "object": "Astrocytic Endfeet", "chunk": 10}
{"article": "PMC10917684.txt", "subject": "Texas Red-Dextran-70kD", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Extravasated tracer clearance", "chunk": 13}
{"article": "PMC10917684.txt", "subject": "FITC-Dextran-3kD", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Cerebral spinal fluid tracer dynamics", "chunk": 13}
{"article": "PMC10917684.txt", "subject": "AQP4", "relationship": "IS_TARGET_OF_TREATMENT", "object": "gamma stimulation", "chunk": 15}
{"article": "PMC10917684.txt", "subject": "AQP4", "relationship": "RELATED_TREATMENT", "object": "sensory stimulation", "chunk": 15}
{"article": "PMC10917684.txt", "subject": "Clic5a", "relationship": "RELATED_TREATMENT", "object": "40\u2009Hz stimulation", "chunk": 15}
{"article": "PMC10917684.txt", "subject": "VIP", "relationship": "RELATED_TREATMENT", "object": "gamma stimulation", "chunk": 15}
{"article": "PMC11273591.txt", "subject": "Not feeling hungry", "relationship": "INDICATES_PRESENCE_OF", "object": "Dementia", "chunk": 4}
{"article": "PMC11274940.txt", "subject": "A\u03b2", "relationship": "INDICATES_PRESENCE_OF", "object": "AD", "chunk": 1}
{"article": "PMC11274940.txt", "subject": "A\u03b2 plaques", "relationship": "DIAGNOSITC_OF", "object": "AD", "chunk": 1}
{"article": "PMC11274940.txt", "subject": "amyloid-\u03b2", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "AD treatment", "chunk": 1}
{"article": "PMC11274940.txt", "subject": "ap,lioprotein C 2 (APOC2)", "relationship": "RELATED_PROGNOSIS", "object": "AD", "chunk": 1}
{"article": "PMC11274940.txt", "subject": "bridging integrator 1 (BIN1)", "relationship": "RELATED_PROGNOSIS", "object": "AD", "chunk": 1}
{"article": "PMC11274940.txt", "subject": "microtubule-associated protein tau (MAPT)", "relationship": "RELATED_PROGNOSIS", "object": "AD", "chunk": 1}
{"article": "PMC11274940.txt", "subject": "BIN1", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "AD treatment", "chunk": 1}
{"article": "PMC11274940.txt", "subject": "neuroinflammation", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "AD", "chunk": 1}
{"article": "PMC11274940.txt", "subject": "proinflammatory cytokines", "relationship": "RELATED_TO_AD", "object": "AD pathogenesis", "chunk": 1}
{"article": "PMC11274940.txt", "subject": "tau", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "AD", "chunk": 1}
{"article": "PMC11274940.txt", "subject": "ApoE", "relationship": "INDICATES_PRESENCE_OF", "object": "Disease-associated microglia (DAM) ", "chunk": 2}
{"article": "PMC11274940.txt", "subject": "ApoE", "relationship": "USED_TO_DIAGNOSE", "object": "Early-onset Alzheimer's Disease", "chunk": 2}
{"article": "PMC11274940.txt", "subject": "TMEM119", "relationship": "INDICATES_PRESENCE_OF", "object": "Disease-associated microglia (DAM) ", "chunk": 2}
{"article": "PMC11274940.txt", "subject": "P2RY12", "relationship": "INDICATES_PRESENCE_OF", "object": "Disease-associated microglia (DAM) ", "chunk": 2}
{"article": "PMC11274940.txt", "subject": "CX3CR1", "relationship": "INDICATES_PRESENCE_OF", "object": "Disease-associated microglia (DAM) ", "chunk": 2}
{"article": "PMC11274940.txt", "subject": "CST7", "relationship": "INDICATES_PRESENCE_OF", "object": "Disease-associated microglia (DAM) ", "chunk": 2}
{"article": "PMC11274940.txt", "subject": "Axl", "relationship": "INDICATES_PRESENCE_OF", "object": "Disease-associated microglia (DAM) ", "chunk": 2}
{"article": "PMC11274940.txt", "subject": "Clec7a", "relationship": "INDICATES_PRESENCE_OF", "object": "Microglial neurodegenerative phenotype (MGnD)", "chunk": 2}
{"article": "PMC11274940.txt", "subject": "Lgals3", "relationship": "INDICATES_PRESENCE_OF", "object": "Microglial neurodegenerative phenotype (MGnD)", "chunk": 2}
{"article": "PMC11274940.txt", "subject": "Gpnmb", "relationship": "INDICATES_PRESENCE_OF", "object": "Microglial neurodegenerative phenotype (MGnD)", "chunk": 2}
{"article": "PMC11274940.txt", "subject": "Itgax", "relationship": "INDICATES_PRESENCE_OF", "object": "Microglial neurodegenerative phenotype (MGnD)", "chunk": 2}
{"article": "PMC11274940.txt", "subject": "Fabp5", "relationship": "INDICATES_PRESENCE_OF", "object": "Microglial neurodegenerative phenotype (MGnD)", "chunk": 2}
{"article": "PMC11274940.txt", "subject": "Ccl2", "relationship": "INDICATES_PRESENCE_OF", "object": "Microglial neurodegenerative phenotype (MGnD)", "chunk": 2}
{"article": "PMC11274940.txt", "subject": "ApoE", "relationship": "INDICATES_PRESENCE_OF", "object": "White matter-associate microglia (WAM) ", "chunk": 2}
{"article": "PMC11274940.txt", "subject": "CD63", "relationship": "INDICATES_PRESENCE_OF", "object": "White matter-associate microglia (WAM) ", "chunk": 2}
{"article": "PMC11274940.txt", "subject": "TMEM119", "relationship": "INDICATES_PRESENCE_OF", "object": "White matter-associate microglia (WAM) ", "chunk": 2}
{"article": "PMC11274940.txt", "subject": "CX3CR1", "relationship": "INDICATES_PRESENCE_OF", "object": "White matter-associate microglia (WAM) ", "chunk": 2}
{"article": "PMC11274940.txt", "subject": "P2RY12", "relationship": "INDICATES_PRESENCE_OF", "object": "White matter-associate microglia (WAM) ", "chunk": 2}
{"article": "PMC11274940.txt", "subject": "CD11c", "relationship": "RELATED_TO", "object": "Amicroglia ", "chunk": 2}
{"article": "PMC11274940.txt", "subject": "TREM2", "relationship": "RELATED_ TO", "object": "Amicroglia ", "chunk": 2}
{"article": "PMC11274940.txt", "subject": "Age", "relationship": "RELATED_TO", "object": "Microglial Phenotype", "chunk": 2}
{"article": "PMC11274940.txt", "subject": "APOE4", "relationship": "RELATED_TO", "object": "Microglia ", "chunk": 2}
{"article": "PMC11274940.txt", "subject": "CSF1R", "relationship": "RELATED_TREATMENT", "object": "Microglial Activity", "chunk": 2}
{"article": "PMC11274940.txt", "subject": "PLX3397", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Alzheimer's disease ", "chunk": 2}
{"article": "PMC11274940.txt", "subject": "PLX5622", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Alzheimer's disease ", "chunk": 2}
{"article": "PMC11274940.txt", "subject": "GW2580", "relationship": "RELATED_TREATMENT", "object": "Alzheimer's disease", "chunk": 2}
{"article": "PMC11274940.txt", "subject": "TNF-\u03b1", "relationship": "IS_RELATED_TO", "object": "Microglial Activation in Alzheimer's", "chunk": 2}
{"article": "PMC11274940.txt", "subject": "IL-1\u03b2", "relationship": "IS_RELATED_TO", "object": "A1 Astrocyte Activation in Alzheimer's", "chunk": 2}
{"article": "PMC11274940.txt", "subject": "TREM2", "relationship": "INDICATES_PRESENCE_OF", "object": "Amyloid pathology", "chunk": 4}
{"article": "PMC11274940.txt", "subject": "CD33", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Amyloid deposition", "chunk": 4}
{"article": "PMC11274940.txt", "subject": "CD33", "relationship": "RELATED_TREATMENT", "object": "AL003 (a CD33-blocking antibody)", "chunk": 4}
{"article": "PMC11274940.txt", "subject": "CR1", "relationship": "RELATED_PROGNOSIS", "object": "AD risk", "chunk": 4}
{"article": "PMC11274940.txt", "subject": "C1q", "relationship": "RELATED_TREATMENT", "object": "Blocks C3b/CR complement activation", "chunk": 4}
{"article": "PMC11274940.txt", "subject": "C3", "relationship": "RELATED_TREATMENT", "object": "Blocks C3b/CR complement activation", "chunk": 4}
{"article": "PMC11274940.txt", "subject": "GRN (Granulin)", "relationship": "RELATED_PROGNOSIS", "object": "Onset of late-stage AD", "chunk": 4}
{"article": "PMC11274940.txt", "subject": "PGRN", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Lentivirus-mediated PGRN overexpression", "chunk": 4}
{"article": "PMC11274940.txt", "subject": "miR-155 (MicroRNA-155)", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "AD treatment", "chunk": 4}
{"article": "PMC11274940.txt", "subject": "IFN-\u03b3", "relationship": "TARGETS_TREATMENT", "object": "AD treatment", "chunk": 4}
{"article": "PMC11274940.txt", "subject": "Piezo1", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Pharmacological activation of Piezo1", "chunk": 4}
{"article": "PMC11274940.txt", "subject": "RIPK1", "relationship": "RELATED_TREATMENT", "object": "Pharmacological or genetic inhibition of RIPK1", "chunk": 4}
{"article": "PMC11274940.txt", "subject": "SYK", "relationship": "RELATED_TREATMENT", "object": "Antibody against CLEC7A", "chunk": 4}
{"article": "PMC11274940.txt", "subject": "Axl", "relationship": "RELATED_TREATMENT", "object": "TAM ligand Gas6 and phosphatidylserine", "chunk": 4}
{"article": "PMC11274940.txt", "subject": "Mer", "relationship": "RELATED_TREATMENT", "object": "TAM ligand Gas6 and phosphatidylserine", "chunk": 4}
{"article": "PMC11274940.txt", "subject": "CD33", "relationship": "RELATED_TO_TREATMENT", "object": "Inhibitors: P22; Lintuzumab; AL003", "chunk": 5}
{"article": "PMC11274940.txt", "subject": "CD33", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Blocked CD33 expression", "chunk": 5}
{"article": "PMC11274940.txt", "subject": "Complement C3", "relationship": "RELATED_TO_TREATMENT", "object": "C3 knockout", "chunk": 5}
{"article": "PMC11274940.txt", "subject": "GRN", "relationship": "RELATED_TO_TREATMENT", "object": "Selectively reducing microglial expression of PGRN; Lentivirus-mediated PGRN overexpression", "chunk": 5}
{"article": "PMC11274940.txt", "subject": "MicroRNA-155 (miR155)", "relationship": "RELATED_TO_TREATMENT", "object": "Deletion of miR-155; blocked IFN-\u03b3 signaling", "chunk": 5}
{"article": "PMC11274940.txt", "subject": "Piezo1", "relationship": "RELATED_TO_TREATMENT", "object": "Piezo1 deletion; pharmacological activation of Piezo1", "chunk": 5}
{"article": "PMC11274940.txt", "subject": "RIPK1", "relationship": "RELATED_TO_TREATMENT", "object": "RIPK1 deletion or Inhibitor", "chunk": 5}
{"article": "PMC11274940.txt", "subject": "SYK", "relationship": "RELATED_TO_TREATMENT", "object": "SYK deletion; An antibody against CLEC7A; Directly activates SYK", "chunk": 5}
{"article": "PMC11274940.txt", "subject": "TAM receptor", "relationship": "RELATED_TO_TREATMENT", "object": "TAM deficient", "chunk": 5}
{"article": "PMC11274940.txt", "subject": "TREM2", "relationship": "RELATED_TO_TREATMENT", "object": "TREM2 overexpression; soluble TREM2; agonist: AL002; 4D9. Transplantation of Trem2+/+ CDMC", "chunk": 5}
{"article": "PMC11274940.txt", "subject": "TNF-\u03b1", "relationship": "DIAGNOSITC_OF", "object": "Elevated TNF-\u03b1 levels are strongly correlated with the incidence of AD", "chunk": 5}
{"article": "PMC11274940.txt", "subject": "Etanercept", "relationship": "RELATED_TO_TREATMENT", "object": "Individuals with rheumatoid arthritis (RA) and other systemic inflammatory diseases who utilize TNF-\u03b1 blockers exhibit a reduced risk of developing dementia", "chunk": 5}
{"article": "PMC11274940.txt", "subject": "XENP345", "relationship": "RELATED_TO_TREATMENT", "object": "Suppresses AD-like pathology and attenuates chronic systemic inflammation in 3xTg-AD mice", "chunk": 5}
{"article": "PMC11274940.txt", "subject": "Thalidomide", "relationship": "RELATED_TO_TREATMENT", "object": "Reduces neuroinflammation, decreases amyloid precursor protein (APP) processing, A\u03b2 plaque formation, and promotes cognitive function", "chunk": 5}
{"article": "PMC11274940.txt", "subject": "3,6\u2032-dithiothalidomide", "relationship": "RELATED_TO_TREATMENT", "object": "Reduces neuroinflammation, decreases amyloid precursor protein (APP) processing, A\u03b2 plaque formation, and promotes cognitive function", "chunk": 5}
{"article": "PMC11274940.txt", "subject": "Pegipanermin", "relationship": "RELATED_TO_TREATMENT", "object": "Investigated in phase II clinical trials", "chunk": 5}
{"article": "PMC11274940.txt", "subject": "P2X7R", "relationship": "RELATED_TO_TREATMENT", "object": "Downregulation or pharmacological inhibition of P2X7R", "chunk": 5}
{"article": "PMC11274940.txt", "subject": "NLRP3", "relationship": "RELATED_TO_TREATMENT", "object": "NLRP3 inflammasome inhibitors, such as JC-124 and fenamate", "chunk": 5}
{"article": "PMC11274940.txt", "subject": "ASC", "relationship": "RELATED_TO_TREATMENT", "object": "An antibody neutralizing extracellular ASC", "chunk": 5}
{"article": "PMC11274940.txt", "subject": "IL-1\u03b2", "relationship": "RELATED_TO_DISEASE", "object": "Alzheimer\u2019s Disease", "chunk": 8}
{"article": "PMC11274940.txt", "subject": "IL-6", "relationship": "RELATED_TO_DISEASE", "object": "Alzheimer\u2019s Disease", "chunk": 8}
{"article": "PMC11274940.txt", "subject": "IL-10", "relationship": "RELATED_TO_DISEASE", "object": "Alzheimer\u2019s Disease", "chunk": 8}
{"article": "PMC11274940.txt", "subject": "IL-18", "relationship": "RELATED_TO_DISEASE", "object": "Alzheimer\u2019s Disease", "chunk": 8}
{"article": "PMC11274940.txt", "subject": "IL-4", "relationship": "RELATED_TO_DISEASE", "object": "Alzheimer\u2019s Disease", "chunk": 8}
{"article": "PMC11274940.txt", "subject": "TNF-\u03b1", "relationship": "RELATED_TO_DISEASE", "object": "Alzheimer\u2019s Disease", "chunk": 8}
{"article": "PMC11274940.txt", "subject": "TGF-\u03b2", "relationship": "RELATED_TO_DISEASE", "object": "Alzheimer\u2019s Disease", "chunk": 8}
{"article": "PMC11274940.txt", "subject": "NO", "relationship": "RELATED_TO_DISEASE", "object": "Alzheimer\u2019s Disease", "chunk": 8}
{"article": "PMC11274940.txt", "subject": "INF-\u03b3", "relationship": "RELATED_TO_DISEASE", "object": "Alzheimer\u2019s Disease", "chunk": 8}
{"article": "PMC11274940.txt", "subject": "NGF", "relationship": "RELATED_TO_DISEASE", "object": "Alzheimer\u2019s Disease", "chunk": 8}
{"article": "PMC11274940.txt", "subject": "BDNF", "relationship": "RELATED_TO_DISEASE", "object": "Alzheimer\u2019s Disease", "chunk": 8}
{"article": "PMC11274940.txt", "subject": "TMEM119", "relationship": "RELATED_TO_DISEASE", "object": "Alzheimer\u2019s Disease", "chunk": 8}
{"article": "PMC11274940.txt", "subject": "P2RY12", "relationship": "RELATED_TO_DISEASE", "object": "Alzheimer\u2019s Disease", "chunk": 8}
{"article": "PMC11274940.txt", "subject": "CX3CR1", "relationship": "RELATED_TO_DISEASE", "object": "Alzheimer\u2019s Disease", "chunk": 8}
{"article": "PMC11274940.txt", "subject": "TREM2", "relationship": "RELATED_TO_DISEASE", "object": "Alzheimer\u2019s Disease", "chunk": 8}
{"article": "PMC11274940.txt", "subject": "CST7", "relationship": "RELATED_TO_DISEASE", "object": "Alzheimer\u2019s Disease", "chunk": 8}
{"article": "PMC11274940.txt", "subject": "RAP1B", "relationship": "RELATED_TO_DISEASE", "object": "Alzheimer\u2019s Disease", "chunk": 8}
{"article": "PMC11274940.txt", "subject": "RAK1", "relationship": "RELATED_TO_DISEASE", "object": "Alzheimer\u2019s Disease", "chunk": 8}
{"article": "PMC11274940.txt", "subject": "CD63", "relationship": "RELATED_TO_DISEASE", "object": "Alzheimer\u2019s Disease", "chunk": 8}
{"article": "PMC11274940.txt", "subject": "Clec7a", "relationship": "RELATED_TO_DISEASE", "object": "Alzheimer\u2019s Disease", "chunk": 8}
{"article": "PMC11274940.txt", "subject": "SNX17", "relationship": "RELATED_TO_DISEASE", "object": "Alzheimer\u2019s Disease", "chunk": 8}
{"article": "PMC11274940.txt", "subject": "Lgals3", "relationship": "RELATED_TO_DISEASE", "object": "Alzheimer\u2019s Disease", "chunk": 8}
{"article": "PMC11274940.txt", "subject": "Gpnmb", "relationship": "RELATED_TO_DISEASE", "object": "Alzheimer\u2019s Disease", "chunk": 8}
{"article": "PMC11274940.txt", "subject": "Fabp5", "relationship": "RELATED_TO_DISEASE", "object": "Alzheimer\u2019s Disease", "chunk": 8}
{"article": "PMC11274940.txt", "subject": "ccl2", "relationship": "RELATED_TO_DISEASE", "object": "Alzheimer\u2019s Disease", "chunk": 8}
{"article": "PMC11274940.txt", "subject": "TLR2/4", "relationship": "RELATED_TO_DISEASE", "object": "Alzheimer\u2019s Disease", "chunk": 8}
{"article": "PMC11274940.txt", "subject": "CD47", "relationship": "RELATED_TO_DISEASE", "object": "Alzheimer\u2019s Disease", "chunk": 8}
{"article": "PMC11274940.txt", "subject": "CSF1R", "relationship": "RELATED_TO_DISEASE", "object": "Alzheimer\u2019s Disease", "chunk": 8}
{"article": "PMC11493878.txt", "subject": "A\u03b242/A\u03b240", "relationship": "RELATED_PROGNOSIS", "object": "Lower ratios indicate a higher risk of developing AD", "chunk": 2}
{"article": "PMC11493878.txt", "subject": "A\u03b242/A\u03b240 ratio", "relationship": "PREDICTED_BY", "object": "Induced second slow-wave peak", "chunk": 5}
{"article": "PMC11493878.txt", "subject": "A\u03b242/A\u03b240 ratio", "relationship": "RELATED_PROGNOSIS", "object": "Beneficial change", "chunk": 5}
{"article": "PMC11493878.txt", "subject": "Amplitude of SW peak", "relationship": "PREDICTED_MEMORY_PERFORMANCE", "object": "Memory Performance", "chunk": 6}
{"article": "PMC11493878.txt", "subject": "Electrophysiological response", "relationship": "PREDICTED_MEMORY_PERFORMANCE", "object": "Memory performance post-intervention", "chunk": 6}
{"article": "PMC11493878.txt", "subject": "Electrophysiological response", "relationship": "RELATED_TO_TREATMENT_EFFECT", "object": "Memory performance", "chunk": 6}
{"article": "PMC11493878.txt", "subject": "Summed power in ERSP clusters", "relationship": "REVEALED_EFFECT_ON_TREATMENT", "object": "Improved A\u03b2 dynamics and memory performance", "chunk": 6}
{"article": "PMC11493878.txt", "subject": "A\u03b2", "relationship": "RELATED_TREATMENT", "object": "potentially facilitated using portable auditory stimulation devices to enhance slow-wave sleep (SWS)", "chunk": 8}
{"article": "PMC11493878.txt", "subject": "A\u03b2", "relationship": "BIOMARKER_DYNAMICS_UNDER_TREATMENT", "object": "PLAS influences memory consolidation and the clearance of A\u03b2", "chunk": 8}
{"article": "PMC11493878.txt", "subject": "A\u03b2", "relationship": "INDICATES_PRESENCE_OF", "object": "physiologic (including A\u03b2) and behavioral level", "chunk": 8}
{"article": "PMC11552198.txt", "subject": "Mini International Neuropsychiatric Interview", "relationship": "RELATED_TO_TREATMENT", "object": "Example for an intervention module as part of the focus psychiatric care within the action field medical diagnosis and treatment", "chunk": 1}
{"article": "PMC2952121.txt", "subject": "Om", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Yoga Therapy", "chunk": 1}
{"article": "PMC3088375.txt", "subject": "SIS", "relationship": "USED_TO_DIAGNOSE", "object": "Cognitive impairment", "chunk": 2}
{"article": "PMC3088375.txt", "subject": "CLOX1", "relationship": "USED_TO_DIAGNOSE", "object": "Cognitive impairment", "chunk": 2}
{"article": "PMC3088375.txt", "subject": "scores \u2264 10 on the CLOX1", "relationship": "INDICATES_PRESENCE_OF", "object": "Deficits in executive functioning", "chunk": 2}
{"article": "PMC3088375.txt", "subject": "SIS score \u22644", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive impairment deficits", "chunk": 2}
{"article": "PMC3088375.txt", "subject": "greater than two errors on the SIS", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive impairment", "chunk": 2}
{"article": "PMC3097009.txt", "subject": "amyloid beta peptides (A\u03b2)", "relationship": "IS_TARGET_OF_TREATMENT", "object": "disease-modifying drugs", "chunk": 1}
{"article": "PMC3097009.txt", "subject": "hyperphosphorylated tau protein", "relationship": "IS_TARGET_OF_TREATMENT", "object": "disease-modifying drugs", "chunk": 1}
{"article": "PMC3097009.txt", "subject": "acetylcholinesterase (AChE) inhibitors", "relationship": "RELATED_TREATMENT", "object": "Alzheimer's Disease (AD)", "chunk": 1}
{"article": "PMC3097009.txt", "subject": "donepezil", "relationship": "RELATED_TREATMENT", "object": "Alzheimer's Disease (AD)", "chunk": 1}
{"article": "PMC3097009.txt", "subject": "rivastigmine", "relationship": "RELATED_TREATMENT", "object": "Alzheimer's Disease (AD)", "chunk": 1}
{"article": "PMC3097009.txt", "subject": "galantamine", "relationship": "RELATED_TREATMENT", "object": "Alzheimer's Disease (AD)", "chunk": 1}
{"article": "PMC3097009.txt", "subject": "memantine", "relationship": "RELATED_TREATMENT", "object": "Alzheimer's Disease (AD)", "chunk": 1}
{"article": "PMC3097009.txt", "subject": "A\u03b2 peptide", "relationship": "INDICATES_PRESENCE_OF", "object": "Neuronal apoptosis", "chunk": 3}
{"article": "PMC3097009.txt", "subject": "hyperhomocysteinaemia", "relationship": "RELATED_TO", "object": "Risk factor for AD", "chunk": 3}
{"article": "PMC3097009.txt", "subject": "Yokukansan", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Treatment of psychiatric disorders", "chunk": 3}
{"article": "PMC3097009.txt", "subject": "Yokukansan", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "BPSD in AD patients", "chunk": 3}
{"article": "PMC3110111.txt", "subject": "insulin-like growth factor-1 (IGF-1)", "relationship": "RELATED_TO_TREATMENT", "object": "Potential to stimulate plasticity of the brain", "chunk": 1}
{"article": "PMC3110111.txt", "subject": "animal studies", "relationship": "INDICATES_PRESENCE_OF", "object": "a range of positive neurobiological outcomes", "chunk": 1}
{"article": "PMC3110111.txt", "subject": "memory-enhancing cognitive and exercise training", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "decreased inflammatory cytokines", "chunk": 1}
{"article": "PMC3110111.txt", "subject": "memory-enhancing cognitive and exercise training", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "decreased cortisol response to stressors", "chunk": 1}
{"article": "PMC3110111.txt", "subject": "memory-enhancing cognitive and exercise training", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "increased insulin-like growth factor-1 (IGF-1) into the brain", "chunk": 1}
{"article": "PMC3110111.txt", "subject": "memory-enhancing cognitive and exercise training", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "increased cerebral blood flow and angiogenesis", "chunk": 1}
{"article": "PMC3110111.txt", "subject": "memory-enhancing cognitive and exercise training", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "increased hippocampal volume", "chunk": 1}
{"article": "PMC3110111.txt", "subject": "cognitive and exercise training", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "increased brain derived neurotrophic factor (BDNF)", "chunk": 1}
{"article": "PMC3110111.txt", "subject": "cognitive and exercise training", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "increased neurogenesis", "chunk": 1}
{"article": "PMC3110111.txt", "subject": "cognitive and exercise training", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "increased synaptic density", "chunk": 1}
{"article": "PMC3110111.txt", "subject": "BDNF", "relationship": "INDICATES_PRESENCE_OF", "object": "Changes in BDNF [21], and increases in IGF-1 [22]", "chunk": 2}
{"article": "PMC3110111.txt", "subject": "IGF-1", "relationship": "INDICATES_PRESENCE_OF", "object": "Changes in BDNF [21], and increases in IGF-1 [22]", "chunk": 2}
{"article": "PMC3110111.txt", "subject": "BDNF", "relationship": "RELATED_PROGNOSIS", "object": "Animal and human exercise trials indicate that exercise may improve brain function", "chunk": 2}
{"article": "PMC3110111.txt", "subject": "IGF-1", "relationship": "RELATED_PROGNOSIS", "object": "Animal and human exercise trials indicate that exercise may improve brain function", "chunk": 2}
{"article": "PMC3110111.txt", "subject": "BDNF", "relationship": "IS_TARGET_OF_TREATMENT", "object": "SMART trial [23] has shown that resistance training results in many beneficial adaptations in older adults that may be relevant to the cognitive improvement mechanisms.", "chunk": 2}
{"article": "PMC3110111.txt", "subject": "IGF-1", "relationship": "IS_TARGET_OF_TREATMENT", "object": "SMART trial [23] has shown that resistance training results in many beneficial adaptations in older adults that may be relevant to the cognitive improvement mechanisms.", "chunk": 2}
{"article": "PMC3110111.txt", "subject": "BDNF", "relationship": "MONITORED_DURING_TREATMENT", "object": "Secondary Hypotheses 1 : All active training interventions will improve brain morphology and biochemistry compared to the sham control condition, as defined by", "chunk": 2}
{"article": "PMC3110111.txt", "subject": "IGF-1", "relationship": "MONITORED_DURING_TREATMENT", "object": "Secondary Hypotheses 1 : All active training interventions will improve brain morphology and biochemistry compared to the sham control condition, as defined by", "chunk": 2}
{"article": "PMC3110111.txt", "subject": "BDNF", "relationship": "BIOMARKER_DYNAMICS_UNDER_TREATMENT", "object": "Secondary Hypotheses 1 : All active training interventions will improve brain morphology and biochemistry compared to the sham control condition, as defined by increased hippocampal volume (mm3) by MRI scanning;", "chunk": 2}
{"article": "PMC3110111.txt", "subject": "IGF-1", "relationship": "BIOMARKER_DYNAMICS_UNDER_TREATMENT", "object": "Secondary Hypotheses 1 : All active training interventions will improve brain morphology and biochemistry compared to the sham control condition, as defined by increased hippocampal volume (mm3) by MRI scanning;", "chunk": 2}
{"article": "PMC3110111.txt", "subject": "MMSE", "relationship": "RELATED_TO", "object": "screening for eligibility in the SMART trial.", "chunk": 3}
{"article": "PMC3110111.txt", "subject": "CDR", "relationship": "RELATED_TO", "object": "screening for eligibility in the SMART trial.", "chunk": 3}
{"article": "PMC3110111.txt", "subject": "TICS-M", "relationship": "RELATED_TO", "object": "screening for eligibility in the SMART trial.", "chunk": 3}
{"article": "PMC3110111.txt", "subject": "ADAS-Cog", "relationship": "DIAGNOSITC_OF", "object": "Alzheimer's disease cognitive dysfunction", "chunk": 5}
{"article": "PMC3110111.txt", "subject": "ADAS-Cog", "relationship": "RELATED_PROGNOSIS", "object": "Pharmacological studies of dementia and mild cognitive impairment", "chunk": 5}
{"article": "PMC3110111.txt", "subject": "B-ADL", "relationship": "DIAGNOSITC_OF", "object": "Deficits in the activities of daily life in individuals with mild cognitive impairment", "chunk": 5}
{"article": "PMC3110111.txt", "subject": "B-ADL", "relationship": "RELATED_TREATMENT", "object": "Response to pharmacological agents", "chunk": 5}
{"article": "PMC3110111.txt", "subject": "MMSE", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive impairment", "chunk": 5}
{"article": "PMC3110111.txt", "subject": "MMSE", "relationship": "RELATED_PROGNOSIS", "object": "Changes in cognitive function over time", "chunk": 5}
{"article": "PMC3110111.txt", "subject": "GP-Cog", "relationship": "INDICATES_PRESENCE_OF", "object": "Greater difficulty functioning in 6 areas of daily life compared to 5-10 years earlier", "chunk": 5}
{"article": "PMC3110111.txt", "subject": "Clinical dementia Rating (CDR)", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Global assessment of dementia severity", "chunk": 5}
{"article": "PMC3110111.txt", "subject": "LEQ", "relationship": "RELATED_PROGNOSIS", "object": "Amount and quality of mental activity person has engaged in over their life time", "chunk": 5}
{"article": "PMC3110111.txt", "subject": "Matrices", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "Executive functions, requiring visual perception, organization, and synthesis of visual spatial information ", "chunk": 5}
{"article": "PMC3110111.txt", "subject": "BMI", "relationship": "INDICATES_PRESENCE_OF", "object": "Obesity", "chunk": 6}
{"article": "PMC3110111.txt", "subject": "Body mass index (BMI", "relationship": "RELATED_PROGNOSIS", "object": "Health", "chunk": 6}
{"article": "PMC3110111.txt", "subject": "Skeletal muscle mass (SMM)", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Muscle strengthening exercises", "chunk": 6}
{"article": "PMC3110111.txt", "subject": "Fat-free mass (FFM)", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Nutritional interventions", "chunk": 6}
{"article": "PMC3110111.txt", "subject": "Pulse Wave Velocity (PWV)", "relationship": "RELATED_TREATMENT", "object": "Lifestyle modifications to improve cardiovascular health", "chunk": 6}
{"article": "PMC3110111.txt", "subject": "Ankle Brachial Index (ABI)", "relationship": "DIAGNOSITC_OF", "object": "Peripheral artery disease", "chunk": 6}
{"article": "PMC3110111.txt", "subject": "Orthostatic Hypotension (OH)", "relationship": "RELATED_PROGNOSIS", "object": "Future falls and cardiovascular events", "chunk": 6}
{"article": "PMC3110111.txt", "subject": "Cortisol", "relationship": "RELATED_PROGNOSIS", "object": "Stress levels", "chunk": 6}
{"article": "PMC3110111.txt", "subject": "APOE 4", "relationship": "DIAGNOSTIC_OF", "object": "Early-onset Alzheimer's Disease", "chunk": 7}
{"article": "PMC3110111.txt", "subject": "high sensitivity C\u2212reactive protein (hs\u2212CRP)", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer's Disease", "chunk": 7}
{"article": "PMC3110111.txt", "subject": "InterLeukin (IL)\u22121b", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Alzheimer's Disease", "chunk": 7}
{"article": "PMC3110111.txt", "subject": "IL\u22126", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Alzheimer's Disease", "chunk": 7}
{"article": "PMC3110111.txt", "subject": "IL\u22128", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Alzheimer's Disease", "chunk": 7}
{"article": "PMC3110111.txt", "subject": "IL\u221210", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Alzheimer's Disease", "chunk": 7}
{"article": "PMC3110111.txt", "subject": "IL\u221212p70", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Alzheimer's Disease", "chunk": 7}
{"article": "PMC3110111.txt", "subject": "IL\u221218", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Alzheimer's Disease", "chunk": 7}
{"article": "PMC3110111.txt", "subject": "Tumor Necrosis Factor\u2212 proteins (TNF-proteins)", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Alzheimer's Disease", "chunk": 7}
{"article": "PMC3110111.txt", "subject": "Brain Derived Neurotrophic Factor (BDNF)", "relationship": "RELATED_TO_TREATMENT", "object": "Alzheimer's Disease", "chunk": 7}
{"article": "PMC3110111.txt", "subject": "Insulin Growth Factor-1 (IGF-1)", "relationship": "RELATED_TO_TREATMENT", "object": "Alzheimer's Disease", "chunk": 7}
{"article": "PMC3110111.txt", "subject": "N-acetylaspartate (NAA)", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Alzheimer's Disease", "chunk": 7}
{"article": "PMC3110111.txt", "subject": "Cholines", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Alzheimer's Disease", "chunk": 7}
{"article": "PMC3110111.txt", "subject": "Myo-inositol", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Alzheimer's Disease", "chunk": 7}
{"article": "PMC3110111.txt", "subject": "Creatine+Phosphocreatine", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Alzheimer's Disease", "chunk": 7}
{"article": "PMC3110199.txt", "subject": "cortisol", "relationship": "INDICATES_PRESENCE_OF", "object": "oxidatively generated DNA and RNA damage", "chunk": 1}
{"article": "PMC3110199.txt", "subject": "cortisol", "relationship": "RELATED_TREATMENT", "object": "to increase oxidative stress", "chunk": 1}
{"article": "PMC3110199.txt", "subject": "cortisol", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "The level of cortisol might guide the treatment selection for stress-related conditions", "chunk": 1}
{"article": "PMC3110199.txt", "subject": "8-oxodG", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Treatment decisions for stress-related conditions could be based on the level of 8-oxodG.", "chunk": 1}
{"article": "PMC3110199.txt", "subject": "8-oxoGuo", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Treatment decisions for stress-related conditions could be based on the level of 8-oxoGuo.", "chunk": 1}
{"article": "PMC3110199.txt", "subject": "cortisol excretion", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "increased risk for disease associated with psychological stress states", "chunk": 2}
{"article": "PMC3110199.txt", "subject": "cortisol excretion", "relationship": "RELATED_PROGNOSIS", "object": "cardiovascular mortality", "chunk": 2}
{"article": "PMC3110199.txt", "subject": "8-oxodG", "relationship": "RELATED_TO", "object": "oxidatively induced damage to DNA and RNA", "chunk": 2}
{"article": "PMC3110199.txt", "subject": "8-oxoGuo", "relationship": "RELATED_TO", "object": "oxidatively induced damage to DNA and RNA", "chunk": 2}
{"article": "PMC3110199.txt", "subject": "8-oxodG", "relationship": "RELATED_TO", "object": "oxidative damage to DNA ", "chunk": 2}
{"article": "PMC3110199.txt", "subject": "8-oxoGuo", "relationship": "RELATED_TO", "object": "oxidative damage to RNA ", "chunk": 2}
{"article": "PMC3110199.txt", "subject": "Cortisol", "relationship": "INDICATES_PRESENCE_OF", "object": "Oxidative Stress", "chunk": 3}
{"article": "PMC3110199.txt", "subject": "Cortisol", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Alzheimer's disease", "chunk": 3}
{"article": "PMC3110199.txt", "subject": "8-oxodG", "relationship": "INDICATES_PRESENCE_OF", "object": "DNA/RNA oxidation", "chunk": 3}
{"article": "PMC3110199.txt", "subject": "8-oxodG", "relationship": "MONITORED_DURING_TREATMENT", "object": "Oxidative stress", "chunk": 3}
{"article": "PMC3110199.txt", "subject": "cortisol", "relationship": "RELATED_PROGNOSIS", "object": "Marks of oxidatively generated DNA and RNA damage", "chunk": 4}
{"article": "PMC3110199.txt", "subject": "cortisol", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Oxidative stress", "chunk": 4}
{"article": "PMC3110199.txt", "subject": "8-oxodG", "relationship": "RELATED_TREATMENT", "object": "Analyzed for using high-performance liquid chromatography-tandem mass spectrometry (HPLC MS/MS)", "chunk": 4}
{"article": "PMC3110199.txt", "subject": "8-oxoGuo", "relationship": "RELATED_TREATMENT", "object": "Analyzed for using high-performance liquid chromatography-tandem mass spectrometry (HPLC MS/MS)", "chunk": 4}
{"article": "PMC3116821.txt", "subject": "Resveratrol", "relationship": "INDICATES_PRESENCE_OF", "object": "Neuroprotective effects in experimental animal models of injury or degeneration", "chunk": 2}
{"article": "PMC3116821.txt", "subject": "Resveratrol", "relationship": "INDICATES_PRESENCE_OF", "object": "Reduces incidence of hypertension, heart failure, ischemia heart disease in experimental animal models", "chunk": 2}
{"article": "PMC3116821.txt", "subject": "Resveratrol", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "The potential cardio-vascular benefit of resveratrol", "chunk": 2}
{"article": "PMC3116821.txt", "subject": "Resveratrol", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "The effect of resveratrol on the development of cancers in colon and skin", "chunk": 2}
{"article": "PMC3116821.txt", "subject": "insulin-like growth factor-1", "relationship": "INDICATES_PRESENCE_OF", "object": "Possible cancer preventive effect", "chunk": 3}
{"article": "PMC3116821.txt", "subject": "insulin-like growth factor binding protein-3", "relationship": "INDICATES_PRESENCE_OF", "object": "Possible cancer preventive effect", "chunk": 3}
{"article": "PMC3116821.txt", "subject": "Tumor necrosis factor (TNF) \u03b1", "relationship": "MONITORED_DURING_TREATMENT", "object": "Human acute or sub chronic (two weeks) intake of red wine, dealcoholized red wine or red grape juice ", "chunk": 5}
{"article": "PMC3116821.txt", "subject": "Interleukin (IL)-2", "relationship": "MONITORED_DURING_TREATMENT", "object": "Human acute or sub chronic (two weeks) intake of red wine, dealcoholized red wine or red grape juice ", "chunk": 5}
{"article": "PMC3116821.txt", "subject": "IL-4", "relationship": "MONITORED_DURING_TREATMENT", "object": " Human acute or sub chronic (two weeks) intake of red wine, dealcoholized red wine or red grape juice", "chunk": 5}
{"article": "PMC3116821.txt", "subject": "IL-6", "relationship": "RESPONDED_TO", "object": " Resveratrol 36 \u00b5g/day (combination of trans- and cis-Resv and cis-piceid) in the form of Chardonnay cava wine for 28 days", "chunk": 5}
{"article": "PMC3116821.txt", "subject": "high-sensitivity C-reactive protein (CRP)", "relationship": "RESPONDED_TO", "object": " Resveratrol 36 \u00b5g/day (combination of trans- and cis-Resv and cis-piceid) in the form of Chardonnay cava wine for 28 days", "chunk": 5}
{"article": "PMC3116821.txt", "subject": "intercellular adhesion molecule-1 (ICAM-1)", "relationship": "RESPONDED_TO", "object": " Resveratrol 36 \u00b5g/day (combination of trans- and cis-Resv and cis-piceid) in the form of Chardonnay cava wine for 28 days", "chunk": 5}
{"article": "PMC3116821.txt", "subject": "monocyte chemoattractant protein-1 (MCP-1)", "relationship": "RESPONDED_TO", "object": " Resveratrol 36 \u00b5g/day (combination of trans- and cis-Resv and cis-piceid) in the form of Chardonnay cava wine for 28 days", "chunk": 5}
{"article": "PMC3116821.txt", "subject": "TNF\u03b1", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Increased levels are associated with inflammation", "chunk": 7}
{"article": "PMC3116821.txt", "subject": "IL-1\u03b2", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Increased levels are associated with inflammation", "chunk": 7}
{"article": "PMC3116821.txt", "subject": "IL-6", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Increased levels are associated with inflammation", "chunk": 7}
{"article": "PMC3116821.txt", "subject": "MCP-1", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Increased levels are associated with inflammation", "chunk": 7}
{"article": "PMC3116821.txt", "subject": "COX-2", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Increased levels are associated with inflammation", "chunk": 7}
{"article": "PMC3116821.txt", "subject": "iNOS", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Increased levels are associated with inflammation", "chunk": 7}
{"article": "PMC3116821.txt", "subject": "inflammatory biomarkers", "relationship": "RELATED_TO", "object": "The effect of Resv", "chunk": 8}
{"article": "PMC3116821.txt", "subject": "Resv", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "The working group suggests that a standard Resv formulation should be performed.", "chunk": 8}
{"article": "PMC3156726.txt", "subject": "MMSE score", "relationship": "DIAGNOSTIC_OF", "object": "Dementia severity", "chunk": 2}
{"article": "PMC3156726.txt", "subject": "FAB score", "relationship": "INDICATES_PRESENCE_OF", "object": "Impairment in executive function", "chunk": 2}
{"article": "PMC3156726.txt", "subject": "FAB score of 18", "relationship": "INDICATES_PRESENCE_OF", "object": "Normal executive functions", "chunk": 2}
{"article": "PMC3156726.txt", "subject": "Stride time parameters", "relationship": "MONITORED_DURING_TREATMENT", "object": "Walking ability", "chunk": 2}
{"article": "PMC3202129.txt", "subject": "Repetitive transcranial magnetic stimulation (rTMS)", "relationship": "RELATED_TREATMENT", "object": "cognitive rehabilitation in AD", "chunk": 1}
{"article": "PMC3202129.txt", "subject": "Transcranial direct current stimulation (tDCS)", "relationship": "RELATED_TREATMENT", "object": "cognitive rehabilitation in AD", "chunk": 1}
{"article": "PMC3202129.txt", "subject": "rTMS", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "modulation of cortical excitability", "chunk": 1}
{"article": "PMC3202129.txt", "subject": "tDCS", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "modulation of cortical excitability", "chunk": 1}
{"article": "PMC3202129.txt", "subject": "high-frequency rTMS", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "enhancement of excitability in the targeted cortical region", "chunk": 1}
{"article": "PMC3202129.txt", "subject": "low-frequency rTMS", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "reduction of excitability in the targeted cortical region", "chunk": 1}
{"article": "PMC3202129.txt", "subject": "cathodal tDCS", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "reduction of excitability in the targeted cortical region", "chunk": 1}
{"article": "PMC3202129.txt", "subject": "anodal tDCS", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "enhancement of excitability in the targeted cortical region", "chunk": 1}
{"article": "PMC3206445.txt", "subject": "TACE activity", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's disease", "chunk": 1}
{"article": "PMC3206445.txt", "subject": "TACE activity", "relationship": "RELATED_TO", "object": "Elevated levels (cerebrospinalfluid)", "chunk": 1}
{"article": "PMC3206445.txt", "subject": "sTNFR1 (Soluble Tumor Necrosis Factor Receptor 1)", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer's disease", "chunk": 1}
{"article": "PMC3206445.txt", "subject": "sTNFR2 (Soluble Tumor Necrosis Factor Receptor 2)", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer's disease", "chunk": 1}
{"article": "PMC3206445.txt", "subject": "TACE activity", "relationship": "RELATED_ANALYSIS", "object": "Mild cognitive impairment", "chunk": 1}
{"article": "PMC3206445.txt", "subject": "sTNFR1 (Soluble Tumor Necrosis Factor Receptor 1)", "relationship": "RELATED_ANALYSIS", "object": "Mild cognitive impairment", "chunk": 1}
{"article": "PMC3206445.txt", "subject": "sTNFR2 (Soluble Tumor Necrosis Factor Receptor 2)", "relationship": "RELATED_ANALYSIS", "object": "Mild cognitive impairment", "chunk": 1}
{"article": "PMC3206445.txt", "subject": "sTNFR", "relationship": "RELATED_TREATMENT", "object": "measured", "chunk": 2}
{"article": "PMC3206445.txt", "subject": "sTNFR2", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "AD", "chunk": 2}
{"article": "PMC3206445.txt", "subject": "sTNFR1", "relationship": "INDICATES_PRESENCE_OF", "object": " Alzheimer's Disease", "chunk": 3}
{"article": "PMC3206445.txt", "subject": "sTNFR2", "relationship": "INDICATES_PRESENCE_OF", "object": " Alzheimer's Disease", "chunk": 3}
{"article": "PMC3206445.txt", "subject": "TACE", "relationship": "RELATED_TO", "object": "  Alzheimer's Disease", "chunk": 3}
{"article": "PMC3206445.txt", "subject": "sTNFR1", "relationship": "INDICATES_PRESENCE_OF", "object": "AD", "chunk": 4}
{"article": "PMC3206445.txt", "subject": "sTNFR2", "relationship": "INDICATES_PRESENCE_OF", "object": "Deficiency of TNFR2", "chunk": 4}
{"article": "PMC3206445.txt", "subject": "Elevated levels of TACE activity", "relationship": "INDICATES_PRESENCE_OF", "object": "AD", "chunk": 4}
{"article": "PMC3206445.txt", "subject": "Elevated levels of sTNFR1", "relationship": "ASSOCIATED_WITH", "object": "Increased A\u03b2 production", "chunk": 4}
{"article": "PMC3206445.txt", "subject": "Elevated levels of sTNFR2", "relationship": "ASSOCIATED_WITH", "object": "Impaired TNFR2 signaling pathway", "chunk": 4}
{"article": "PMC3206445.txt", "subject": "Elevated levels of TACE activity", "relationship": "ASSOCIATED_WITH", "object": "Increased sTNFR", "chunk": 4}
{"article": "PMC3206445.txt", "subject": "Increased TACE activity", "relationship": "ASSOCIATED_WITH", "object": "Upregulation of BACE", "chunk": 4}
{"article": "PMC3206445.txt", "subject": "sTNFRs and TACE activity", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Diagnostics targets to determine AD", "chunk": 4}
{"article": "PMC3216294.txt", "subject": "A\u03b2", "relationship": "INDICATES_PRESENCE_OF", "object": "Amyloid plaques", "chunk": 1}
{"article": "PMC3216294.txt", "subject": "A\u03b2", "relationship": "RELATED_TO", "object": "Cerebrovascular amyloidosis", "chunk": 1}
{"article": "PMC3216294.txt", "subject": "Apo B lipoproteins", "relationship": "RELATED_TO", "object": "Enriched with amyloid beta peptides", "chunk": 1}
{"article": "PMC3216294.txt", "subject": "Apo B lipoproteins", "relationship": "RELATED_TO", "object": "Found associated with triglyceride-rich lipoproteins (TRLs)", "chunk": 1}
{"article": "PMC3216294.txt", "subject": "S100\u03b2", "relationship": "MONITORED_DURING_TREATMENT", "object": "Plasma concentration as a marker of cerebrovascular inflammation", "chunk": 1}
{"article": "PMC3216294.txt", "subject": "SFA", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Dyslipidemia, endothelial dysfunction, inflammation, and oxidative stress", "chunk": 1}
{"article": "PMC3216294.txt", "subject": "DHA", "relationship": "RELATED_TO", "object": "Anti-inflammatory effects, cytoprotection", "chunk": 1}
{"article": "PMC3216294.txt", "subject": "S100\u03b2", "relationship": "DIAGNOSTIC_OF", "object": "Cerebrovascular inflammation", "chunk": 2}
{"article": "PMC3216294.txt", "subject": "S100\u03b2", "relationship": "INDICATES_PRESENCE_OF", "object": "Cerebrovascular inflammation", "chunk": 2}
{"article": "PMC3216294.txt", "subject": "S100\u03b2", "relationship": "RELATED_PROGNOSIS", "object": "Indicator of brain-to-blood leakage", "chunk": 3}
{"article": "PMC3216294.txt", "subject": "S100\u03b2", "relationship": "RELATED_TREATMENT", "object": "Used as a surrogate marker", "chunk": 3}
{"article": "PMC3216294.txt", "subject": "Plasma Cholesterol", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Hypercholesterolemia associated with vascular abnormalities", "chunk": 3}
{"article": "PMC3216294.txt", "subject": "apo B lipoprotein", "relationship": "DIAGNOSITC_OF", "object": "Brain parenchymal extravasation", "chunk": 3}
{"article": "PMC3216294.txt", "subject": "S100\u03b2", "relationship": "DIAGNOSITC_OF", "object": "BBB dysfunction", "chunk": 4}
{"article": "PMC3216294.txt", "subject": "S100\u03b2", "relationship": "MONITORED_DURING_TREATMENT", "object": "DHA diet intervention", "chunk": 4}
{"article": "PMC3216294.txt", "subject": "apo B", "relationship": "RELATED_PROGNOSIS", "object": "cerebral extravasation", "chunk": 4}
{"article": "PMC3216294.txt", "subject": "DHA", "relationship": "RELATED_TREATMENT", "object": "amplified", "chunk": 4}
{"article": "PMC3237323.txt", "subject": "amyloid beta peptides (A\u00df)", "relationship": "INDICATES_PRESENCE_OF", "object": "familial Alzheimer's disease pathology", "chunk": 1}
{"article": "PMC3237323.txt", "subject": "age", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "risk factor for AD", "chunk": 1}
{"article": "PMC3237323.txt", "subject": "Curcumin", "relationship": "RELATED_TREATMENT", "object": "transgenic AD mouse models effective", "chunk": 1}
{"article": "PMC3237323.txt", "subject": "J147", "relationship": "RELATED_TREATMENT", "object": "enhancement of memory in normal animals", "chunk": 1}
{"article": "PMC3237323.txt", "subject": "J147", "relationship": "RELATED_TREATMENT", "object": "prevention of memory deficits in AD transgenic mice", "chunk": 1}
{"article": "PMC3237323.txt", "subject": "J147", "relationship": "RELATED_TREATMENT", "object": "increase in brain derived neurotrophic factor (BDNF) levels", "chunk": 1}
{"article": "PMC3237323.txt", "subject": "J147", "relationship": "RELATED_TREATMENT", "object": "enhancement of LTP", "chunk": 1}
{"article": "PMC3237323.txt", "subject": "J147", "relationship": "RELATED_TREATMENT", "object": "synaptic protein preservation", "chunk": 1}
{"article": "PMC3237323.txt", "subject": "J147", "relationship": "RELATED_TREATMENT", "object": "reduction of markers for oxidative stress and inflammation", "chunk": 1}
{"article": "PMC3237323.txt", "subject": "J147", "relationship": "RELATED_TREATMENT", "object": "reduction of amyloid plaques", "chunk": 1}
{"article": "PMC3237323.txt", "subject": "J147", "relationship": "RELATED_TREATMENT", "object": "Treatment for  memory enhancement", "chunk": 4}
{"article": "PMC3237323.txt", "subject": "J147", "relationship": "RELATED_TREATMENT", "object": "treatment of rats for memory enhancement", "chunk": 4}
{"article": "PMC3237323.txt", "subject": "J147", "relationship": "GUIDES_TREATMENT_SELECTION", "object": " mode of action which may be distinct from the traditional memory enhancing drugs", "chunk": 4}
{"article": "PMC3237323.txt", "subject": "Acetylcholinesterase/Phosphodiesterase inhibitors", "relationship": "RELATED_TREATMENT", "object": "memory enhancing drugs", "chunk": 4}
{"article": "PMC3237323.txt", "subject": "A\u03b21\u201340", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Memory loss in AD mice", "chunk": 5}
{"article": "PMC3237323.txt", "subject": "A\u03b21\u201342", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Memory loss in AD mice", "chunk": 5}
{"article": "PMC3237323.txt", "subject": "J147", "relationship": "IS_RELATED_TREATMENT", "object": "Reduce A\u03b2 oligomers in soluble fraction", "chunk": 5}
{"article": "PMC3237323.txt", "subject": "J147", "relationship": "IS_RELATED_TREATMENT", "object": "Reduce soluble A\u03b21\u201340 and A\u03b21\u201342 levels", "chunk": 5}
{"article": "PMC3237323.txt", "subject": "A\u03b2", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "toxicity", "chunk": 6}
{"article": "PMC3237323.txt", "subject": "A\u03b21\u201340", "relationship": "INDICATES_TREATMENT_ELIGIBILITY", "object": "Reduced by J147", "chunk": 6}
{"article": "PMC3237323.txt", "subject": "A\u03b21\u201342", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "reduction in the soluble fraction of the hippocampus improves cognitive ability", "chunk": 6}
{"article": "PMC3237323.txt", "subject": "A\u03b2 polymers", "relationship": "RELATED_TREATMENT", "object": "Reduced by J147", "chunk": 6}
{"article": "PMC3237323.txt", "subject": "HO-1", "relationship": "IS_TARGET_OF_TREATMENT", "object": "J147 treatment decreased expression levels in huAPP/PS1 mice", "chunk": 6}
{"article": "PMC3237323.txt", "subject": "Iba-1", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Reduced by J147", "chunk": 6}
{"article": "PMC3237323.txt", "subject": "iNOS", "relationship": "RELATED_TREATMENT", "object": "Reduced by J147, although not statistically significantly", "chunk": 6}
{"article": "PMC3237323.txt", "subject": "5-LOX", "relationship": "IS_TARGET_OF_TREATMENT", "object": "J147 brought down to control levels", "chunk": 6}
{"article": "PMC3237323.txt", "subject": "HSP70", "relationship": "RELATED_TREATMENT", "object": "Decreased to control levels by J147", "chunk": 6}
{"article": "PMC3237323.txt", "subject": "HSP90", "relationship": "RELATED_TREATMENT", "object": "Decreased to control levels by J147", "chunk": 6}
{"article": "PMC3237323.txt", "subject": "HOP", "relationship": "RELATED_TREATMENT", "object": "Decreased to control levels by J147", "chunk": 6}
{"article": "PMC3237323.txt", "subject": "HSP70", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 7}
{"article": "PMC3237323.txt", "subject": "Drebrin", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 7}
{"article": "PMC3237323.txt", "subject": "Synapsin-1", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 7}
{"article": "PMC3237323.txt", "subject": "Synaptophysin", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 7}
{"article": "PMC3237323.txt", "subject": "BDNF", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Alzheimer's Disease", "chunk": 7}
{"article": "PMC3237323.txt", "subject": "J147", "relationship": "RELATED_TREATMENT", "object": "Alzheimer's Disease", "chunk": 7}
{"article": "PMC3237323.txt", "subject": "Homer-1", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "Alzheimer's Disease", "chunk": 7}
{"article": "PMC3237323.txt", "subject": "PSD95", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "Alzheimer's Disease", "chunk": 7}
{"article": "PMC3237323.txt", "subject": "BDNF", "relationship": "RELATED_PROGNOSIS", "object": "Enhance pro-BDNF, BDNF, and BDNF mRNA in the hippocampus", "chunk": 8}
{"article": "PMC3237323.txt", "subject": "BDNF", "relationship": "IS_TARGET_OF_TREATMENT", "object": "J147", "chunk": 8}
{"article": "PMC3237323.txt", "subject": "Synaptophysin", "relationship": "INDICATES_PRESENCE_OF", "object": "Synapse loss", "chunk": 8}
{"article": "PMC3237323.txt", "subject": "Drebrin", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Age and AD", "chunk": 8}
{"article": "PMC3237323.txt", "subject": "Synapsin-1", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Age and AD", "chunk": 8}
{"article": "PMC3237323.txt", "subject": "HO-1", "relationship": "RELATED_PROGNOSIS", "object": "Elevated in AD", "chunk": 8}
{"article": "PMC3237323.txt", "subject": "Iba-1", "relationship": "RELATED_PROGNOSIS", "object": "Elevated in AD mice", "chunk": 8}
{"article": "PMC3237323.txt", "subject": "iNOS", "relationship": "INDICATES_PRESENCE_OF", "object": "Toxic microglial enzyme", "chunk": 8}
{"article": "PMC3237323.txt", "subject": "5 LOX", "relationship": "RELATED_PROGNOSIS", "object": "Increased in AD", "chunk": 8}
{"article": "PMC3237323.txt", "subject": "HSP70", "relationship": "RELATED_TREATMENT", "object": "J147 reduces their expression", "chunk": 8}
{"article": "PMC3237323.txt", "subject": "HSP90", "relationship": "RELATED_TREATMENT", "object": "J147 reduces their expression", "chunk": 8}
{"article": "PMC3237323.txt", "subject": "HOP-1", "relationship": "RELATED_TREATMENT", "object": "J147 reduces their expression", "chunk": 8}
{"article": "PMC3237323.txt", "subject": "A\u03b21\u201342", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "A\u03b2 Toxicity to Hippocampal Neurons", "chunk": 9}
{"article": "PMC3237323.txt", "subject": "soluble A\u03b2 levels", "relationship": "RELATED_TO", "object": "reduced biochemical markers of inflammation", "chunk": 9}
{"article": "PMC3237323.txt", "subject": "amyloid plaque burden", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Quantifying amyloid plaque burden by immunohistochemistry with antibody 6bche", "chunk": 11}
{"article": "PMC3237323.txt", "subject": "A\u03b21-40", "relationship": "RELATED_TREATMENT", "object": "Levels were analyzed using ELISA kits and related to treatment", "chunk": 12}
{"article": "PMC3237323.txt", "subject": "A\u03b21-42", "relationship": "RELATED_TREATMENT", "object": "Levels were analyzed using ELISA kits and related to treatment", "chunk": 12}
{"article": "PMC3267736.txt", "subject": "Mini International Neuropsychiatric Interview (MINI)", "relationship": "USED_TO_DIAGNOSE", "object": "DSM-IV mental disorders", "chunk": 2}
{"article": "PMC3267736.txt", "subject": "Mini International Neuropsychiatric Interview (MINI)", "relationship": "INDICATES_PRESENCE_OF", "object": "Psychiatric disorders", "chunk": 2}
{"article": "PMC3267736.txt", "subject": "CES-D", "relationship": "RELATED_TREATMENT", "object": "Psychological distress", "chunk": 2}
{"article": "PMC3267736.txt", "subject": "CES-D", "relationship": "RELATED_PROGNOSIS", "object": "Presence of clinically significant depression", "chunk": 2}
{"article": "PMC3267736.txt", "subject": "HADS-A", "relationship": "RELATED_TREATMENT", "object": "Anxiety", "chunk": 2}
{"article": "PMC3267736.txt", "subject": "HADS-A", "relationship": "RELATED_PROGNOSIS", "object": "Presence of clinically significant anxiety", "chunk": 2}
{"article": "PMC3267736.txt", "subject": "HADS-A baseline score", "relationship": "PREDICTS_OUTCOME", "object": "Both groups", "chunk": 4}
{"article": "PMC3271959.txt", "subject": "Mini Mental State Examination score", "relationship": "RELATED_TREATMENT", "object": "Inclusion criteri for therapeutic application of low-frequency rTMS and intensive OT", "chunk": 2}
{"article": "PMC3271959.txt", "subject": "Fugl-Meyer Assessment", "relationship": "RELATED_TREATMENT", "object": "Inclusion criteri for therapeutic application of low-frequency rTMS and intensive OT", "chunk": 2}
{"article": "PMC3305524.txt", "subject": "Elevated cholesterol", "relationship": "INDICATES_PRESENCE_OF", "object": "Hypertension", "chunk": 3}
{"article": "PMC3305524.txt", "subject": "Elevated cholesterol", "relationship": "INDICATES_PRESENCE_OF", "object": "Asthma", "chunk": 3}
{"article": "PMC3305524.txt", "subject": "Elevated cholesterol", "relationship": "INDICATES_PRESENCE_OF", "object": "Diabetes", "chunk": 3}
{"article": "PMC3305524.txt", "subject": "Elevated cholesterol", "relationship": "INDICATES_PRESENCE_OF", "object": "Osteoarthritis", "chunk": 3}
{"article": "PMC3305524.txt", "subject": "Elevated cholesterol", "relationship": "INDICATES_PRESENCE_OF", "object": "Rheumatic disease, other", "chunk": 3}
{"article": "PMC3305524.txt", "subject": "Elevated cholesterol", "relationship": "INDICATES_PRESENCE_OF", "object": "Overweight", "chunk": 3}
{"article": "PMC3305524.txt", "subject": "Elevated cholesterol", "relationship": "INDICATES_PRESENCE_OF", "object": "Angina/coronary artery disease", "chunk": 3}
{"article": "PMC3305524.txt", "subject": "Elevated cholesterol", "relationship": "INDICATES_PRESENCE_OF", "object": "Depression/Anxiety", "chunk": 3}
{"article": "PMC3305524.txt", "subject": "Hypertension", "relationship": "INDICATES_PRESENCE_OF", "object": "Angina/coronary artery disease", "chunk": 3}
{"article": "PMC3305524.txt", "subject": "Hypertension", "relationship": "INDICATES_PRESENCE_OF", "object": "Diabetes", "chunk": 3}
{"article": "PMC3305524.txt", "subject": "Asthma", "relationship": "INDICATES_PRESENCE_OF", "object": "Allergies", "chunk": 3}
{"article": "PMC3305524.txt", "subject": "Diabetes", "relationship": "INDICATES_PRESENCE_OF", "object": "Depression/Anxiety", "chunk": 3}
{"article": "PMC3305524.txt", "subject": "Osteoarthritis", "relationship": "INDICATES_PRESENCE_OF", "object": "Rheumatic disease, other", "chunk": 3}
{"article": "PMC3305524.txt", "subject": "Overweight", "relationship": "INDICATES_PRESENCE_OF", "object": "Angina/coronary artery disease", "chunk": 3}
{"article": "PMC3305524.txt", "subject": "Overweight", "relationship": "INDICATES_PRESENCE_OF", "object": "Depression/Anxiety", "chunk": 3}
{"article": "PMC3305524.txt", "subject": "Angina/coronary artery disease", "relationship": "INDICATES_PRESENCE_OF", "object": "Depression/Anxiety", "chunk": 3}
{"article": "PMC3338462.txt", "subject": "\u03b2-amyloid (A\u03b2)", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Neuropathology in Tg mice", "chunk": 1}
{"article": "PMC3338462.txt", "subject": "\u03b2-amyloid (A\u03b2)", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "EMF treatment reverses A\u03b2 aggregation/deposition", "chunk": 1}
{"article": "PMC3338462.txt", "subject": "\u03b2-amyloid (A\u03b2)", "relationship": "PREDICTs_SURVIVAL", "object": "Reversing A\u03b2 aggregation/deposition prolongs survival", "chunk": 1}
{"article": "PMC3338462.txt", "subject": "\u03b2-amyloid (A\u03b2)", "relationship": "RELATED_PROGNOSIS", "object": "Brain A\u03b2 aggregation/deposition reflects cognitive decline", "chunk": 1}
{"article": "PMC3338462.txt", "subject": "A\u03b2 aggregation", "relationship": "ASSOCIATED_WITH", "object": "Cognitive impairment", "chunk": 2}
{"article": "PMC3338462.txt", "subject": "A\u03b2 aggregation", "relationship": "SUPPRESSED_BY", "object": "EMF treatment", "chunk": 2}
{"article": "PMC3338462.txt", "subject": "A\u03b2 efflux", "relationship": "INCREASED_BY", "object": "EMF treatment", "chunk": 2}
{"article": "PMC3338462.txt", "subject": "A\u03b2 oligomers", "relationship": "DISAGGREGATED_BY", "object": "EMF treatment", "chunk": 2}
{"article": "PMC3338462.txt", "subject": "Soluble A\u03b2", "relationship": "INCREASED_BY", "object": "EMF treatment", "chunk": 2}
{"article": "PMC3338462.txt", "subject": "Brain mitochondrial function", "relationship": "ENHANCED_BY", "object": "EMF treatment", "chunk": 2}
{"article": "PMC3338462.txt", "subject": "Neuronal activity", "relationship": "ENHANCED_BY", "object": "EMF treatment", "chunk": 2}
{"article": "PMC3338462.txt", "subject": "Cognitive benefit", "relationship": "ASSOCIATED_WITH", "object": "EMF treatment", "chunk": 2}
{"article": "PMC3338462.txt", "subject": "rCBF", "relationship": "INDICATES_PRESENCE_OF", "object": "EMF effects on brain function", "chunk": 4}
{"article": "PMC3338462.txt", "subject": "rCBF", "relationship": "RELATED_TO", "object": "EMF exposure", "chunk": 4}
{"article": "PMC3338462.txt", "subject": "rCBF", "relationship": "MEASURED_DURING", "object": "EMF treatment studies", "chunk": 4}
{"article": "PMC3338462.txt", "subject": "A\u03b2", "relationship": "RELATED_TO", "object": "EMF treatment", "chunk": 4}
{"article": "PMC3338462.txt", "subject": "A\u03b2 deposition", "relationship": "RELATED_TREATMENT", "object": "EMF treatment showed substantial decreases in A\u03b2 burden within both hippocampus and entorhinal cortex", "chunk": 5}
{"article": "PMC3338462.txt", "subject": "A\u03b2 deposition", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Poorer working memory performance was highly correlated with the extent of A\u03b2 deposition in both hippocampus and cortex.", "chunk": 5}
{"article": "PMC3338462.txt", "subject": "A\u03b2", "relationship": "MONITORED_DURING_TREATMENT", "object": "Analysis of plasma samples taken at euthanasia revealed no effects of EMF treatment on plasma A\u03b21\u201340 (4620\u00b1442 pg/ml for Tg vs. 4885\u00b1920 pg/ml for Tg+EMF; p\u200a=\u200a0.78) or A\u03b21\u201342 (1452\u00b1120 pg/ml for Tg vs. 1175\u00b1251 pg/ml; p\u200a=\u200a0.30)", "chunk": 5}
{"article": "PMC3338462.txt", "subject": "A\u03b2", "relationship": "INDICATES_PRESENCE_OF", "object": "Cerebral vasoconstriction", "chunk": 7}
{"article": "PMC3338462.txt", "subject": "A\u03b2", "relationship": "INDICATES_PRESENCE_OF", "object": "Vasoconstriction in the brain", "chunk": 7}
{"article": "PMC3338462.txt", "subject": "APPsw", "relationship": "RELATED_TREATMENT", "object": "long-term EMF treatment induced in mice", "chunk": 7}
{"article": "PMC3338462.txt", "subject": "APPsw+PS1", "relationship": "RELATED_TREATMENT", "object": "long-term EMF treatment induced in mice", "chunk": 7}
{"article": "PMC3338462.txt", "subject": "APPsw", "relationship": "RELATED_TREATMENT", "object": "sub-chronic EMF study ", "chunk": 7}
{"article": "PMC3338462.txt", "subject": "rCBF", "relationship": "PROMOTED_BY", "object": "high frequency EMF treatment during ON periods", "chunk": 7}
{"article": "PMC3338462.txt", "subject": "A\u03b21\u201340", "relationship": "MONITORED_DURING_TREATMENT", "object": "Measured in plasma.", "chunk": 8}
{"article": "PMC3338462.txt", "subject": "A\u03b21\u201342", "relationship": "MONITORED_DURING_TREATMENT", "object": "Measured in plasma.", "chunk": 8}
{"article": "PMC3338462.txt", "subject": "App", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Study focused on effects of EMF treatment on APPsw Tg mice. ", "chunk": 8}
{"article": "PMC3338462.txt", "subject": "rCBF", "relationship": "MONITORED_DURING_TREATMENT", "object": "Doppler recordings taken at 2 months into EMF treatment.", "chunk": 8}
{"article": "PMC3338462.txt", "subject": "rCBF", "relationship": "MONITORED_DURING_TREATMENT", "object": "EMF treatment", "chunk": 9}
{"article": "PMC3338462.txt", "subject": "A\u03b21\u201340", "relationship": "MONITORED_DURING_TREATMENT", "object": "Plasma samples", "chunk": 10}
{"article": "PMC3338462.txt", "subject": "A\u03b21\u201342", "relationship": "MONITORED_DURING_TREATMENT", "object": "Plasma samples", "chunk": 10}
{"article": "PMC3338462.txt", "subject": "A\u03b2", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Immune-labeled area captured (positive pixels) relative to the full area captured (total pixels)", "chunk": 10}
{"article": "PMC3362564.txt", "subject": "TNF receptor 1 (TNFR1)", "relationship": "RELATED_PROGNOSIS", "object": "Milder and more variable neurologic changes in brain aging", "chunk": 1}
{"article": "PMC3362564.txt", "subject": "TNF receptor 1 (TNFR1)", "relationship": "INDICATES_PRESENCE_OF", "object": "Elevated protein levels in the hippocampus of aged rats", "chunk": 1}
{"article": "PMC3362564.txt", "subject": "TNF receptor 1 (TNFR1)", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Blocking TNF/TNFR1 interactions with XPro1595", "chunk": 1}
{"article": "PMC3362564.txt", "subject": "TNF receptor 2 (TNFR2)", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Pathological processes", "chunk": 1}
{"article": "PMC3362564.txt", "subject": "L-type voltage sensitive Ca2+ channels (L-VSCCs)", "relationship": "RELATED_PROGNOSIS", "object": "Alterations in short and long-lasting forms of synaptic plasticity", "chunk": 1}
{"article": "PMC3362564.txt", "subject": "L-type voltage sensitive Ca2+ channels (L-VSCCs)", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Amyloid plaques and neuronal loss", "chunk": 1}
{"article": "PMC3362564.txt", "subject": "GluR1 type glutamate receptor", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Improving Morris Water Maze performance", "chunk": 1}
{"article": "PMC3362564.txt", "subject": "TNF receptors", "relationship": "TARGET_OF_TREATMENT", "object": "XPro1595", "chunk": 2}
{"article": "PMC3362564.txt", "subject": "NF\u03baB", "relationship": "INHIBITED_BY", "object": "XPro1595", "chunk": 2}
{"article": "PMC3362564.txt", "subject": "Microglial activation", "relationship": "INHIBITED_BY", "object": "XPro1595", "chunk": 2}
{"article": "PMC3362564.txt", "subject": "TNF-mediated activation", "relationship": "INHIBITED_BY", "object": "XPro1595", "chunk": 2}
{"article": "PMC3362564.txt", "subject": "TNFR1", "relationship": "RELATED_PROGNOSIS", "object": "Significantly increased ratio of TNFR1 to total TNFR in aged rats", "chunk": 4}
{"article": "PMC3362564.txt", "subject": "TNFR2", "relationship": "RELATED_PROGNOSIS", "object": "Significantly decreased membrane TNFR2 levels in aged rats", "chunk": 4}
{"article": "PMC3362564.txt", "subject": "solTNF", "relationship": "IS_TARGET_OF_TREATMENT", "object": "XPro1595 selectively inactivates soluble TNF (solTNF) trimers", "chunk": 4}
{"article": "PMC3362564.txt", "subject": "Iba-1", "relationship": "INDICATES_PRESENCE_OF", "object": "Microglial activation", "chunk": 4}
{"article": "PMC3362564.txt", "subject": "GFAP", "relationship": "INDICATES_PRESENCE_OF", "object": "Astrocyte activation", "chunk": 4}
{"article": "PMC3362564.txt", "subject": "GluR1", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Higher membrane levels of GluR1 were found in XPro1595-treated aged rats", "chunk": 5}
{"article": "PMC3362564.txt", "subject": "XPro1595", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Animal Treatment", "chunk": 5}
{"article": "PMC3362564.txt", "subject": "TNFR1", "relationship": "INDICATES_PRESENCE_OF", "object": "increased neurologic dysfunction", "chunk": 6}
{"article": "PMC3362564.txt", "subject": "TNFR1", "relationship": "ASSOCIATED_WITH", "object": "higher levels of excitotoxic damage in primary neurons", "chunk": 6}
{"article": "PMC3362564.txt", "subject": "TNF/TNFR1 signaling", "relationship": "RELATED_TO", "object": "reduced excitatory synaptic plasticity in area CA1", "chunk": 6}
{"article": "PMC3362564.txt", "subject": "XPro1595", "relationship": "RELATED_TREATMENT", "object": "cognitive decline during aging", "chunk": 6}
{"article": "PMC3362564.txt", "subject": "XPro1595", "relationship": "RELATED_TREATMENT", "object": "age-related neurologic dysfunction", "chunk": 6}
{"article": "PMC3362564.txt", "subject": "TNF/TNFR1 signaling", "relationship": "ASSOCIATED_WITH", "object": "increase in the expression of L-VSCC CaV1 pore forming subunits during aging", "chunk": 6}
{"article": "PMC3362564.txt", "subject": "CaV1.3 subunit", "relationship": "INDICATES_PRESENCE_OF", "object": "age-related increase in L-VSCC activity", "chunk": 6}
{"article": "PMC3362564.txt", "subject": "TNF", "relationship": "PREDICTS_SURVIVAL", "object": " Improved cell viability", "chunk": 7}
{"article": "PMC3362564.txt", "subject": "TNF", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "age-related neurologic dysfunction", "chunk": 7}
{"article": "PMC3362564.txt", "subject": "XPro1595", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "treatment for age-related neurologic dysfunction", "chunk": 7}
{"article": "PMC3389343.txt", "subject": "amyloid beta peptides peptides peptidesss-precursor protein", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's disease", "chunk": 2}
{"article": "PMC3389343.txt", "subject": "progranulin", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "underlying mechanisms for neurodegeneration", "chunk": 2}
{"article": "PMC3389343.txt", "subject": "MAPT mutations", "relationship": "RELATED_WITH_BETTER_OUTCOME", "object": "preferentially damage shorter anatomical pathways", "chunk": 2}
{"article": "PMC3389343.txt", "subject": "GRN mutations", "relationship": "RELATED_WITH_POOR_OUTCOME", "object": "catastrophic reamplification process, fronto-temporo-parietal atrophy", "chunk": 2}
{"article": "PMC3394709.txt", "subject": "ADAS-Cog", "relationship": "DIAGNOSTIC_OF", "object": "Alzheimer's Disease", "chunk": 2}
{"article": "PMC3394709.txt", "subject": "RBANS", "relationship": "DIAGNOSTIC_OF", "object": "Alzheimer's Disease", "chunk": 2}
{"article": "PMC3394709.txt", "subject": "WAIS", "relationship": "DIAGNOSTIC_OF", "object": "Alzheimer's Disease", "chunk": 2}
{"article": "PMC3394709.txt", "subject": "RT", "relationship": "INDICATES_PRESENCE_OF", "object": "Improvement in working memory and attention", "chunk": 3}
{"article": "PMC3394709.txt", "subject": "memory", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's disease", "chunk": 5}
{"article": "PMC3394709.txt", "subject": "memory", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Alzheimer's disease", "chunk": 5}
{"article": "PMC3394709.txt", "subject": "Hopkins Verbal Learning Test", "relationship": "MONITORED_DURING_TREATMENT", "object": "To assess the impact of memory training", "chunk": 6}
{"article": "PMC3394709.txt", "subject": "Rivermead Behavioral Memory Test", "relationship": "MONITORED_DURING_TREATMENT", "object": "To assess the impact of memory training", "chunk": 6}
{"article": "PMC3394709.txt", "subject": "Visual Verbal Learning Test", "relationship": "MONITORED_DURING_TREATMENT", "object": "To assess the impact of computer training and internet access", "chunk": 6}
{"article": "PMC3394709.txt", "subject": "Trail Making Test part B", "relationship": "MONITORED_DURING_TREATMENT", "object": "To assess the impact of a 24-week computer course training complex cognitive tasks", "chunk": 6}
{"article": "PMC3394709.txt", "subject": "Concept Shifting Task", "relationship": "MONITORED_DURING_TREATMENT", "object": "To assess the impact of computer training and internet access", "chunk": 6}
{"article": "PMC3394709.txt", "subject": "Letter-Digit Substitution Test", "relationship": "MONITORED_DURING_TREATMENT", "object": "To assess the impact of computer training and internet access", "chunk": 6}
{"article": "PMC3394709.txt", "subject": "Motor Choice Reaction Test", "relationship": "MONITORED_DURING_TREATMENT", "object": "To assess the impact of computer training and internet access", "chunk": 6}
{"article": "PMC3394709.txt", "subject": "Processing Speed", "relationship": "INDICATES_PRESENCE_OF", "object": "Improved performance in Pac-Man and Donkey Kong task", "chunk": 7}
{"article": "PMC3394709.txt", "subject": "Processing Speed", "relationship": "RELATED_PROGNOSIS", "object": "Faster reaction time observed post-training intervention", "chunk": 7}
{"article": "PMC3394709.txt", "subject": "Processing Speed", "relationship": "RELATED_PROGNOSIS", "object": "Improvement in UFOV group reported compared to Medal of Honor, Tetris, and no-contact control groups", "chunk": 7}
{"article": "PMC3394709.txt", "subject": "Reaction Time", "relationship": "PREDICTS_SURVIVAL", "object": "Measured as a dependent variable in studies evaluating the effects of video games", "chunk": 7}
{"article": "PMC3394709.txt", "subject": "Executive Function", "relationship": "INDICATES_PRESENCE_OF", "object": "Improved scores observed in participants engaging in video game training", "chunk": 7}
{"article": "PMC3394709.txt", "subject": "Attention", "relationship": "INDICATES_PRESENCE_OF", "object": "Improved performance on visual attention tasks after Medal of Honor video game training", "chunk": 7}
{"article": "PMC3394709.txt", "subject": "Attention", "relationship": "RELATED_PROGNOSIS", "object": "Reduced performance in Tetris compared to Medal of Honor and UFOV groups", "chunk": 7}
{"article": "PMC3394709.txt", "subject": "ADAS-Cog", "relationship": "INDICATES_TREATMENT_ELIGIBILITY", "object": "Lower scores linked less cognitive decline", "chunk": 8}
{"article": "PMC3397527.txt", "subject": "amyloid \u03b2 peptide (A\u03b2)", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Drug development for Alzheimer's disease ", "chunk": 1}
{"article": "PMC3397527.txt", "subject": "amyloid \u03b2 oligomers", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease (AD) ", "chunk": 1}
{"article": "PMC3397527.txt", "subject": "amyloid \u03b2 oligomers", "relationship": "RELATED_PROGNOSIS", "object": "increased neuronal death ", "chunk": 1}
{"article": "PMC3397527.txt", "subject": "amyloid \u03b2 oligomers", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": " membrane pore formation and ion channel/pors formation", "chunk": 1}
{"article": "PMC3397527.txt", "subject": "A\u03b21\u201342", "relationship": "INDICATES_PRESENCE_OF", "object": "Toxic oligomers", "chunk": 2}
{"article": "PMC3397527.txt", "subject": "A\u03b242 dimers", "relationship": "RELATED_TO", "object": "Greater tendency to form hydrophobic contacts and \u03b2-sheet structures", "chunk": 2}
{"article": "PMC3397527.txt", "subject": "A\u03b2 peptides", "relationship": "ASSOCIATED_WITH", "object": "Self-assembly on solid surfaces", "chunk": 2}
{"article": "PMC3397527.txt", "subject": "A\u03b2", "relationship": "USED_TO_STUDY", "object": "Adsorption and aggregation properties on various membrane models and surfaces", "chunk": 2}
{"article": "PMC3397527.txt", "subject": "A\u03b2 peptides", "relationship": "RESPONDED_TO", "object": "Changes in membrane properties, including order and fluidity", "chunk": 2}
{"article": "PMC3397527.txt", "subject": "A\u03b2 dimers", "relationship": "INFLUENCED_BY", "object": "Electrostatic interactions, hydrophobic effects, and water-mediated dewetting transition", "chunk": 2}
{"article": "PMC3397527.txt", "subject": "A\u03b2 peptides adsorption", "relationship": "CAUSES", "object": "Increase in surface pressure of the monolayer", "chunk": 2}
{"article": "PMC3397527.txt", "subject": "cholesterol", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "increasing the risk of Alzheimer\u2019s disease", "chunk": 3}
{"article": "PMC3397527.txt", "subject": "cholesterol", "relationship": "RELATED_TREATMENT", "object": "depletion of cholesterol has been shown to significantly reduce the amount of A\u03b2 and its accumulation", "chunk": 3}
{"article": "PMC3397527.txt", "subject": "gangliosides", "relationship": "RELATED_TREATMENT", "object": "depletion of cholesterol or gangliosides has been shown to significantly reduce the amount of A\u03b2 and its accumulation", "chunk": 3}
{"article": "PMC3397527.txt", "subject": "A\u03b2", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease", "chunk": 3}
{"article": "PMC3397527.txt", "subject": "A\u03b2 oligomers", "relationship": "INDICATES_PRESENCE_OF", "object": "Hexagonal annular channels in A\u03b2 containing membrane", "chunk": 4}
{"article": "PMC3397527.txt", "subject": "A\u03b2 oligomers", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Deterioration and loss of synapses", "chunk": 4}
{"article": "PMC3397527.txt", "subject": "A\u03b2 oligomers", "relationship": "RELATED_TREATMENT", "object": "Various NMDA receptor antagonists", "chunk": 4}
{"article": "PMC3397527.txt", "subject": "A\u03b2 oligomers", "relationship": "RELATED_TREATMENT", "object": "Omega-3 fatty acids and curcumin", "chunk": 4}
{"article": "PMC3397527.txt", "subject": "A\u03b2 oligomers", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Impairment to the transduction of signal in neuronal insulin receptors", "chunk": 4}
{"article": "PMC3397527.txt", "subject": "A\u03b2 oligomers", "relationship": "CAUSES", "object": "Overproduction of A\u03b2 peptides", "chunk": 4}
{"article": "PMC3397527.txt", "subject": "A\u03b2 oligomers", "relationship": "RELATED_TREATMENT", "object": "Drugs like 2-(2-(4-bromophenyl)-2-oxoethyl)-1-methyl pyridinium (S 24, 795)", "chunk": 4}
{"article": "PMC3397527.txt", "subject": "A\u03b2 oligomers", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Preventing the interaction between A\u03b2 and nAChRs", "chunk": 4}
{"article": "PMC3397527.txt", "subject": "A\u03b2 oligomers", "relationship": "RELATED_TO", "object": "Oxidative stress", "chunk": 4}
{"article": "PMC3397527.txt", "subject": "A\u03b2 oligomers", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Anti-oxidant compounds like walnut and turmeric extract", "chunk": 4}
{"article": "PMC3397527.txt", "subject": "Oxidative stress", "relationship": "INDICATES_PRESENCE_OF", "object": "Increased macroautophagy and lysosomal ensuing apoptosis", "chunk": 4}
{"article": "PMC3397527.txt", "subject": "Met-35 of A\u03b2", "relationship": "RELATED_TO", "object": "Oxidative stress", "chunk": 4}
{"article": "PMC3397527.txt", "subject": "A\u03b2 peptides", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's disease", "chunk": 5}
{"article": "PMC3397527.txt", "subject": "A\u03b2 oligomers", "relationship": "ASSOCIATED_WITH", "object": "Diseases such as Creutzfeldt\u2013Jakob disease and Alzheimer\u2019s disease", "chunk": 5}
{"article": "PMC3397527.txt", "subject": "\u03b2-sheet structure", "relationship": "IS_RELATED_TO", "object": "A\u03b2 oligomer aggregation behavior", "chunk": 5}
{"article": "PMC3397527.txt", "subject": "Curcumin", "relationship": "RELATED_TREATMENT", "object": "Alzheimer\u2019s disease", "chunk": 5}
{"article": "PMC3397527.txt", "subject": "Curcumin", "relationship": "RESPONDED_TO", "object": "Tau phosphorylation and insulin receptor inactivation induced by A\u03b2", "chunk": 5}
{"article": "PMC3397527.txt", "subject": "Curcumin", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "Cognitive deficits", "chunk": 5}
{"article": "PMC3397527.txt", "subject": "Curcumin", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "Insulin signaling", "chunk": 5}
{"article": "PMC3397527.txt", "subject": "Curcumin", "relationship": "RELATED_TREATMENT", "object": "Alzheimer\u2019s disease", "chunk": 5}
{"article": "PMC3397527.txt", "subject": "Oliogmers", "relationship": "LINKED_TO", "object": "Neurotoxicity", "chunk": 5}
{"article": "PMC3397527.txt", "subject": "A\u03b2 oligomers", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Targeting A\u03b2 oligomers for therapeutic intervention", "chunk": 6}
{"article": "PMC3397527.txt", "subject": "A\u03b2 peptides", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Neutralizing A\u03b2 peptides with antibodies", "chunk": 6}
{"article": "PMC3397527.txt", "subject": "A\u03b2", "relationship": "RELATED_TREATMENT", "object": "Development of therapies to reduce A\u03b2 aggregation and toxicity", "chunk": 6}
{"article": "PMC3407718.txt", "subject": "donepezil", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease", "chunk": 1}
{"article": "PMC3407718.txt", "subject": "galantamine", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease", "chunk": 1}
{"article": "PMC3407718.txt", "subject": "rivastigmine", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease", "chunk": 1}
{"article": "PMC3407718.txt", "subject": "memantine", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s disease", "chunk": 1}
{"article": "PMC3407718.txt", "subject": "Mini-mental State Examination (MMSE)", "relationship": "USED_TO_DIAGNOSE", "object": "Mild, moderate or severe Alzheimer's Disease", "chunk": 2}
{"article": "PMC3407718.txt", "subject": "Mini-mental State Examination (MMSE)", "relationship": "RELATED_PROGNOSIS", "object": "Severity of Alzheimer's Disease", "chunk": 2}
{"article": "PMC3407718.txt", "subject": "Diagnostic and Statistical Manual of Mental Disorders (DSM)", "relationship": "USED_TO_DIAGNOSE", "object": "Alzheimer's Disease", "chunk": 2}
{"article": "PMC3407718.txt", "subject": "National Minimum Data Set (NMDS)", "relationship": "USED_TO_DIAGNOSE", "object": "Alzheimer's Disease", "chunk": 2}
{"article": "PMC3407718.txt", "subject": "cognitive enhancers", "relationship": "RELATED_TREATMENT", "object": "eligible for cognitive enhancers", "chunk": 4}
{"article": "PMC3414444.txt", "subject": "dementia", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "higher risk of death in older patients hospitalized for acute illnesses", "chunk": 1}
{"article": "PMC3414444.txt", "subject": "dementia", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "a greater comorbid burden", "chunk": 1}
{"article": "PMC3414444.txt", "subject": "dementia", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "a higher number of adverse events during hospitalization", "chunk": 1}
{"article": "PMC3414444.txt", "subject": "dementia", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "suboptimal care for acute illnesses", "chunk": 1}
{"article": "PMC3414444.txt", "subject": "dementia", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "increased risk of acute organ dysfunction", "chunk": 1}
{"article": "PMC3414444.txt", "subject": "dementia", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "increased risk of severe sepsis", "chunk": 1}
{"article": "PMC3414444.txt", "subject": "dementia", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "increased risk of hospital mortality", "chunk": 1}
{"article": "PMC3416711.txt", "subject": "cholinesterase inhibitors", "relationship": "COMPARES_FAVORABLY_WITH", "object": "Alzheimer\u2019s disease", "chunk": 1}
{"article": "PMC3416711.txt", "subject": "cognitive stimulation", "relationship": "RELATED_TREATMENT", "object": "Recommended intervention for people with mild to moderate dementia", "chunk": 1}
{"article": "PMC3416711.txt", "subject": "Cognitive stimulation", "relationship": "INDICATES_PRESENCE_OF", "object": "benefits in cognition and quality of life", "chunk": 1}
{"article": "PMC3416711.txt", "subject": "Cognitive stimulation", "relationship": "RELATED_TO", "object": "the development of CST (Cognitive Stimulation Therapy)", "chunk": 1}
{"article": "PMC3425320.txt", "subject": "Alzheimer's dementia", "relationship": "DIAGNOSITC_OF", "object": "Increased expenditure for health and long-term care services", "chunk": 1}
{"article": "PMC3425320.txt", "subject": "donepezil", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Treatment of Alzheimer's dementia", "chunk": 2}
{"article": "PMC3425320.txt", "subject": "galantamine", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Treatment of Alzheimer's dementia", "chunk": 2}
{"article": "PMC3425320.txt", "subject": "rivastigmine", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Treatment of Alzheimer's dementia", "chunk": 2}
{"article": "PMC3425320.txt", "subject": "memantine", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Treatment of Alzheimer's dementia", "chunk": 2}
{"article": "PMC3425320.txt", "subject": "Diabetes mellitus", "relationship": "RELATED_TO_BETTER_OUTCOME", "object": "Control subjects had lower prevalnce.", "chunk": 4}
{"article": "PMC3437789.txt", "subject": "BMI", "relationship": "INDICATES_PRESENCE_OF", "object": "Obesity", "chunk": 1}
{"article": "PMC3437789.txt", "subject": "BMI", "relationship": "RELATED_PROGNOSIS", "object": "Higher BMI is associated with a greater risk of chronic conditions", "chunk": 1}
{"article": "PMC3437789.txt", "subject": "BMI", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "BMI criteria used to determine eligibility for the MOVE! program", "chunk": 1}
{"article": "PMC3437789.txt", "subject": "Weight (Weight Loss)", "relationship": "RELATED_TREATMENT", "object": "Intervention aimed at weight loss as a primary therapeutic goal", "chunk": 1}
{"article": "PMC3437789.txt", "subject": "Weight Loss - 5%", "relationship": "RELATED_PROGNOSIS", "object": "Associated with reduced risk of chronic conditions", "chunk": 1}
{"article": "PMC3437789.txt", "subject": "BMI", "relationship": "RELATED_PROGNOSIS", "object": "Higher BMI associated with likelihood of participation in MOVE! program", "chunk": 3}
{"article": "PMC3437789.txt", "subject": "BMI", "relationship": "DIAGNOSTIC_OF", "object": "Exclusion criteria for MOVE! program (BMI below the threshold for inclusion)", "chunk": 3}
{"article": "PMC3437789.txt", "subject": "Sex", "relationship": "RELATED_TREATMENT", "object": "Female sex associated with higher likelihood of participation in MOVE! program", "chunk": 3}
{"article": "PMC3437789.txt", "subject": "Age", "relationship": "RELATED_TREATMENT", "object": "Age younger than 55 associated with lower likelihood of participation in MOVE! program", "chunk": 3}
{"article": "PMC3437789.txt", "subject": "Cigarette smoking status", "relationship": "RELATED_TREATMENT", "object": "Current smoking associated with lower likelihood of participation in MOVE! program", "chunk": 3}
{"article": "PMC3437789.txt", "subject": "Marital status", "relationship": "RELATED_TREATMENT", "object": "Widowed status associated with lower likelihood of participation in MOVE! program", "chunk": 3}
{"article": "PMC3437789.txt", "subject": "Distance to medical center or CBOC", "relationship": "RELATED_TREATMENT", "object": "Living 30 miles or more from a medical center or CBOC associated with lower likelihood of participation in MOVE! program", "chunk": 3}
{"article": "PMC3437789.txt", "subject": "Facility type", "relationship": "RELATED_TREATMENT", "object": "Being at a community-based outpatient clinic (CBOC) AS opposed to a medical center associated with lower likelihood of participation in MOVE! program", "chunk": 3}
{"article": "PMC3437789.txt", "subject": "high-density lipoprotein (HDL) cholesterol", "relationship": "INDICATES_PRESENCE_OF", "object": "Implausible value if < 10 or > 120 mg/dL", "chunk": 6}
{"article": "PMC3437789.txt", "subject": "LDL cholesterol", "relationship": "INDICATES_PRESENCE_OF", "object": "Implausible value if < 30 or > 300 mg/dL", "chunk": 6}
{"article": "PMC3437789.txt", "subject": "systolic blood pressure", "relationship": "INDICATES_PRESENCE_OF", "object": "Implausible value if < 60 or > 250 mm Hg", "chunk": 6}
{"article": "PMC3437789.txt", "subject": "diastolic blood pressure", "relationship": "INDICATES_PRESENCE_OF", "object": "Implausible value if < 40 or > 140 mm Hg", "chunk": 6}
{"article": "PMC3460756.txt", "subject": "amyloid \u03b242 in the cerebral cerebral cerebral cerebral spinal fluid", "relationship": "INDICATES_PRESENCE_OF", "object": "A\u03b2 accumulation", "chunk": 3}
{"article": "PMC3460756.txt", "subject": "total tau and phosphorylated-tau in cerebral cerebral cerebral cerebral spinal fluid", "relationship": "INDICATES_PRESENCE_OF", "object": "Neuronal dysfunction", "chunk": 3}
{"article": "PMC3460756.txt", "subject": "amyloid tracer uptake in PET", "relationship": "INDICATES_PRESENCE_OF", "object": "A\u03b2 accumulation", "chunk": 3}
{"article": "PMC3460756.txt", "subject": "fluorodeoxyglucose PET", "relationship": "INDICATES_PRESENCE_OF", "object": "Neuronal dysfunction", "chunk": 3}
{"article": "PMC3460756.txt", "subject": "White matter integrity (DTI)", "relationship": "INDICATES_PRESENCE_OF", "object": "Neuronal dysfunction", "chunk": 3}
{"article": "PMC3460756.txt", "subject": "Functional connectivity (rsfMRI)", "relationship": "INDICATES_PRESENCE_OF", "object": "Neuronal dysfunction", "chunk": 3}
{"article": "PMC3460756.txt", "subject": "Whole brain volume", "relationship": "INDICATES_PRESENCE_OF", "object": "Neuronal dysfunction", "chunk": 3}
{"article": "PMC3460756.txt", "subject": "Hippocampal volume", "relationship": "INDICATES_PRESENCE_OF", "object": "Neuronal dysfunction", "chunk": 3}
{"article": "PMC3467226.txt", "subject": "glucose uptake", "relationship": "INDICATES_PRESENCE_OF", "object": "MB mediated increases in glucose uptake measured through PET", "chunk": 2}
{"article": "PMC3467226.txt", "subject": "CMRO2", "relationship": "INDICATES_PRESENCE_OF", "object": "MB mediated increases in CMRO2  measured through PET", "chunk": 2}
{"article": "PMC3467226.txt", "subject": "CBF", "relationship": "INDICATES_PRESENCE_OF", "object": "MB mediated increases in CBF measured through MRI", "chunk": 2}
{"article": "PMC3467226.txt", "subject": "CBF", "relationship": "INDICES_PRESENCE_OF", "object": "AD and PD pathology", "chunk": 3}
{"article": "PMC3467226.txt", "subject": "Glucose uptake", "relationship": "INDICATES_PRESENCE_OF", "object": "AD and PD pathology", "chunk": 3}
{"article": "PMC3467226.txt", "subject": "CMRO2", "relationship": "INDICATES_PRESENCE_OF", "object": "AD and PD pathology", "chunk": 3}
{"article": "PMC3467226.txt", "subject": "CBF", "relationship": "RELATED_TO", "object": "Hypoxia", "chunk": 3}
{"article": "PMC3467226.txt", "subject": "Glucose uptake", "relationship": "RELATED_TO", "object": "Hypoxia", "chunk": 3}
{"article": "PMC3467226.txt", "subject": "CMRO2", "relationship": "RELATED_TO", "object": "Hypoxia", "chunk": 3}
{"article": "PMC3467226.txt", "subject": "MB", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Neuroprotection under stroke", "chunk": 3}
{"article": "PMC3493328.txt", "subject": "donepezil 23\u2009mg/day", "relationship": "RELATED_TREATMENT", "object": "Alzheimer\u2019s disease ", "chunk": 1}
{"article": "PMC3493328.txt", "subject": "donepezil 23\u2009mg/day", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "increased from donepezil 10\u2009mg/day in the double-blind study", "chunk": 1}
{"article": "PMC3493328.txt", "subject": "donepezil 23\u2009mg/day", "relationship": "INDICATES_TREATMENT_ELIGIBILITY", "object": "completed the double-blind study", "chunk": 1}
{"article": "PMC3493328.txt", "subject": "donepezil 23 mg/day", "relationship": "RELATED_TREATMENT", "object": "Treatment provided during the extension study", "chunk": 2}
{"article": "PMC3493328.txt", "subject": "donepezil 23 mg/day", "relationship": "RELATED_TREATMENT", "object": "Treatment given in the double-blind phase for some participants", "chunk": 2}
{"article": "PMC3493328.txt", "subject": "donepezil 10 mg/day", "relationship": "RELATED_TREATMENT", "object": "Treatment given to some participants in the double-blind phase", "chunk": 2}
{"article": "PMC3493328.txt", "subject": "memantine", "relationship": "RELATED_TREATMENT", "object": "Concomitant medication taken by a third of the patients at the start of the extension study", "chunk": 2}
{"article": "PMC3493328.txt", "subject": "weight decreased", "relationship": "ASSOCIATED_WITH_TREATMENT", "object": "An AE with an incidence of 11.2% in the safety population", "chunk": 2}
{"article": "PMC3493328.txt", "subject": "weight loss \u22657%", "relationship": "ASSOCIATED_WITH_TREATMENT", "object": "An AE with an incidence of 11.1% in the safety population", "chunk": 2}
{"article": "PMC3493328.txt", "subject": "diarrhea", "relationship": "ASSOCIATED_WITH_TREATMENT", "object": "An AE with an incidence of 4.3% in the safety population", "chunk": 2}
{"article": "PMC3493328.txt", "subject": "nausea", "relationship": "ASSOCIATED_WITH_TREATMENT", "object": "An AE with an incidence of 3.5% in the safety population", "chunk": 2}
{"article": "PMC3493328.txt", "subject": "syncope", "relationship": "ASSOCIATED_WITH_TREATMENT", "object": "An AE with an incidence of 3.1% in the safety population", "chunk": 2}
{"article": "PMC3493328.txt", "subject": "vomiting", "relationship": "ASSOCIATED_WITH_TREATMENT", "object": "An AE with an incidence of 2.7% in the safety population", "chunk": 2}
{"article": "PMC3493328.txt", "subject": "anorexia", "relationship": "ASSOCIATED_WITH_TREATMENT", "object": "An AE with an incidence of 2.4% in the safety population", "chunk": 2}
{"article": "PMC3493328.txt", "subject": "bradycardia", "relationship": "ASSOCIATED_WITH_TREATMENT", "object": "An AE with an incidence of 1.2% in the safety population", "chunk": 2}
{"article": "PMC3493328.txt", "subject": "GI bleeding", "relationship": "ASSOCIATED_WITH_TREATMENT", "object": "An AE with an incidence of 0.8% in the safety population", "chunk": 2}
{"article": "PMC3493328.txt", "subject": "Weight Loss", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Mortality in AD patients", "chunk": 3}
{"article": "PMC3493328.txt", "subject": "Weight Loss", "relationship": "INDICATES_TREATMENT_ELIGIBILITY", "object": "Close monitoring in AD patients", "chunk": 3}
{"article": "PMC3493328.txt", "subject": "GI Bleeding", "relationship": "RELATED_TO", "object": "Gastrointestinal Symptoms", "chunk": 3}
{"article": "PMC3493328.txt", "subject": "GI Bleeding", "relationship": "ASSSOCIATED_WITH_POOR_OUTCOME", "object": "Fatal outcome in one patient", "chunk": 3}
{"article": "PMC3493328.txt", "subject": "Donepezil", "relationship": "RELATED_TREATMENT", "object": "Manage AEs when increasing dose to 23mg/day", "chunk": 3}
{"article": "PMC3512515.txt", "subject": "FPpeak", "relationship": "MONITORED_DURING_TREATMENT", "object": "Both pretreatment and post-treatment", "chunk": 3}
{"article": "PMC3512515.txt", "subject": "FPpeak", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Biofeedback training", "chunk": 3}
{"article": "PMC3512515.txt", "subject": "Force ratio (FPpeak and FLmax)", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Biofeedback training", "chunk": 3}
{"article": "PMC3520904.txt", "subject": "IL-1\u03b2", "relationship": "INDICATES_PRESENCE_OF", "object": "Neuroinflammation", "chunk": 1}
{"article": "PMC3520904.txt", "subject": "IL-1\u03b2", "relationship": "RELATED_TREATMENT", "object": "Lidocaine", "chunk": 1}
{"article": "PMC3520904.txt", "subject": "IL-1\u03b2", "relationship": "RELATED_TO", "object": "Impaired cognitive function", "chunk": 1}
{"article": "PMC3520904.txt", "subject": "Isoflurane", "relationship": "ASSOCIATED_WITH", "object": "Increased production of cytokines", "chunk": 1}
{"article": "PMC3520904.txt", "subject": "IL-1\u03b2", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive impairment in rats", "chunk": 2}
{"article": "PMC3520904.txt", "subject": "IL-6", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive impairment in rats", "chunk": 2}
{"article": "PMC3520904.txt", "subject": "Activated Caspase 3", "relationship": "RELATED_PROGNOSIS", "object": "Poor outcome in rats (cognitive impairment)", "chunk": 2}
{"article": "PMC3520904.txt", "subject": "IL-6", "relationship": "INDICATES_PRESENCE_OF", "object": "Increased Expression in Hippocampus and Cerebral Cortex after Isoflurane Exposure", "chunk": 3}
{"article": "PMC3520904.txt", "subject": "IL-6", "relationship": "RELATED_TO", "object": "NeuN Expression", "chunk": 3}
{"article": "PMC3520904.txt", "subject": "IL-6", "relationship": "RELATED_TO", "object": "GFAP Expression", "chunk": 3}
{"article": "PMC3520904.txt", "subject": "IL-6", "relationship": "RELATED_TO", "object": "Iba1 Expression", "chunk": 3}
{"article": "PMC3520904.txt", "subject": "Activated/cleaved caspase 3", "relationship": "INDICATES_PRESENCE_OF", "object": "Increased Expression in Hippocampus and Cerebral Cortex after Isoflurane Exposure", "chunk": 3}
{"article": "PMC3520904.txt", "subject": "Activated/cleaved caspase 3", "relationship": "RELATED_TO", "object": "NeuN Expression", "chunk": 3}
{"article": "PMC3520904.txt", "subject": "Activated/cleaved caspase 3", "relationship": "RELATED_TO", "object": "GFAP Expression", "chunk": 3}
{"article": "PMC3520904.txt", "subject": "Activated/cleaved caspase 3", "relationship": "RELATED_TO", "object": "Iba1 Expression", "chunk": 3}
{"article": "PMC3520904.txt", "subject": "CD-11b", "relationship": "INDICATES_PRESENCE_OF", "object": "Increased Expression in Hippocampus and Cerebral Cortex after Isoflurane Exposure", "chunk": 3}
{"article": "PMC3520904.txt", "subject": "CD-11b", "relationship": "RELATED_TO", "object": "NeuN Expression", "chunk": 3}
{"article": "PMC3520904.txt", "subject": "CD-11b", "relationship": "RELATED_TO", "object": "GFAP Expression", "chunk": 3}
{"article": "PMC3520904.txt", "subject": "CD-11b", "relationship": "RELATED_TO", "object": "Iba1 Expression", "chunk": 3}
{"article": "PMC3520904.txt", "subject": "IL-1\u03b2", "relationship": "INDICATES_PRESENCE_OF", "object": "Increased Expression in Hippocampus after Isoflurane Exposure", "chunk": 3}
{"article": "PMC3520904.txt", "subject": "TNF\u03b1", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Increased in Hippocampus and Cerebral Cortex after Isoflurane Exposure", "chunk": 3}
{"article": "PMC3520904.txt", "subject": "IL-1\u03b2", "relationship": "INDICATES_PRESENCE_OF", "object": "Neuroinflammation", "chunk": 4}
{"article": "PMC3520904.txt", "subject": "IL-1\u03b2", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Attenuating isoflurane-induced cognitive impairment", "chunk": 4}
{"article": "PMC3520904.txt", "subject": "IL-1\u03b2", "relationship": "RELATED_TREATMENT", "object": "Lidocaine", "chunk": 4}
{"article": "PMC3520904.txt", "subject": "IL-1\u03b2", "relationship": "MONITORED_DURING_TREATMENT", "object": "Isoflurane exposure", "chunk": 4}
{"article": "PMC3520904.txt", "subject": "IL-1\u03b2", "relationship": "BIOMARKER_DYNAMICS_UNDER_TREATMENT", "object": "Lidocaine attenuated its increase", "chunk": 4}
{"article": "PMC3520904.txt", "subject": "IL-6", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Decreased cognitive performance in humans", "chunk": 4}
{"article": "PMC3520904.txt", "subject": "activated caspase 3", "relationship": "BIOMARKER_DYNAMICS_UNDER_TREATMENT", "object": "may be a biomarker for apoptosis", "chunk": 5}
{"article": "PMC3520904.txt", "subject": "activated caspase 3", "relationship": "MONITORED_DURING_TREATMENT", "object": "Our data also indicate that isoflurane-induced cognitive impairment may be mainly on the learning process...", "chunk": 5}
{"article": "PMC3520904.txt", "subject": "IL-1\u03b2", "relationship": "RELATED_TREATMENT", "object": "Lidocaine may inhibit the nuclear factor \u03baB signaling to reduce proinflammatory cytokine production", "chunk": 5}
{"article": "PMC3520904.txt", "subject": "IL-1\u03b2", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "IL-1\u03b2 increase is a critical step for isoflurane-induced cognitive impairment", "chunk": 5}
{"article": "PMC3520904.txt", "subject": "IL-1\u03b2", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Lidocaine may attenuate the long-term cognitive impairment of aged rats after isoflurane exposure by inhibiting the early phase of mild brain inflammation.", "chunk": 5}
{"article": "PMC3520904.txt", "subject": "IL-1\u03b2", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Determining therapeutic interventions", "chunk": 6}
{"article": "PMC3520904.txt", "subject": "TNF\u03b1", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Determining therapeutic interventions", "chunk": 6}
{"article": "PMC3520904.txt", "subject": "IL-6", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Determining therapeutic interventions", "chunk": 6}
{"article": "PMC3520904.txt", "subject": "IL-1\u03b2", "relationship": "MONITORED_DURING_TREATMENT", "object": "Measuring treatment effectiveness", "chunk": 6}
{"article": "PMC3520904.txt", "subject": "TNF\u03b1", "relationship": "MONITORED_DURING_TREATMENT", "object": "Measuring treatment effectiveness", "chunk": 6}
{"article": "PMC3520904.txt", "subject": "IL-6", "relationship": "MONITORED_DURING_TREATMENT", "object": "Measuring treatment effectiveness", "chunk": 6}
{"article": "PMC3520904.txt", "subject": "IL-1\u03b2", "relationship": "RELATED_TREATMENT", "object": "ELISA kits for measuring rat IL-1\u03b2", "chunk": 7}
{"article": "PMC3520904.txt", "subject": "IL-1\u03b2", "relationship": "MONITORED_DURING_TREATMENT", "object": "Quantification of IL-1\u03b2 and TNF\u03b1 in each brain sample was standardized to the protein contents", "chunk": 7}
{"article": "PMC3520904.txt", "subject": "TNF\u03b1", "relationship": "RELATED_TREATMENT", "object": "ELISA kits for measuring rat IL-1\u03b2 and TNF\u03b1", "chunk": 7}
{"article": "PMC3520904.txt", "subject": "TNF\u03b1", "relationship": "MONITORED_DURING_TREATMENT", "object": "Quantification of IL-1\u03b2 and TNF\u03b1 in each brain sample was standardized to the protein contents", "chunk": 7}
{"article": "PMC3520904.txt", "subject": "IL-6", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "The primary antibodies used were: rabbit polyclonal anti-IL-6 antibody (1\u2236200;", "chunk": 7}
{"article": "PMC3520904.txt", "subject": "cleaved-caspase 3", "relationship": "MONITORED_DURING_TREATMENT", "object": "The protein band intensities of NeuN, cleaved-caspase 3, CD-11b, IL-6, synaptophysin and drebrin were normalized by the corresponding band intensities of \u03b2-actin from the same samples", "chunk": 7}
{"article": "PMC3520904.txt", "subject": "NeuN", "relationship": "MONITORED_DURING_TREATMENT", "object": "The protein band intensities of NeuN, cleaved-caspase 3, CD-11b, IL-6, synaptophysin and drebrin were normalized by the corresponding band intensities of \u03b2-actin from the same samples", "chunk": 7}
{"article": "PMC3523068.txt", "subject": "Hippocampus volume", "relationship": "RELATED_PROGNOSIS", "object": "Conversion to mild cognitive impairment", "chunk": 4}
{"article": "PMC3523068.txt", "subject": "Volume loss in CA1 and subiculum", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive decline and conversion to mild cognitive impairment", "chunk": 4}
{"article": "PMC3523068.txt", "subject": "Decreased entorrhinal cortex volume", "relationship": "RELATED_PROGNOSIS", "object": "Significant cognitive decline", "chunk": 4}
{"article": "PMC3523068.txt", "subject": "Decreased entorrhinal cortex volume and  hippocampus volume", "relationship": "PREDICTS_SURVIVAL", "object": "Cognitive decline in CN subjects with 80% accuracy", "chunk": 4}
{"article": "PMC3523068.txt", "subject": "Reduced volume of the anteromedial temporal cortex", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive decline", "chunk": 4}
{"article": "PMC3523068.txt", "subject": "Decreased gray-matter volume in the angular gyrus of parietal lobe", "relationship": "RELATED_PROGNOSIS", "object": "Mild cognitive impairment development", "chunk": 4}
{"article": "PMC3523068.txt", "subject": "Prefrontal cortex atrophy", "relationship": "RELATED_PROGNOSIS", "object": "Dementia onset over a 6-year period", "chunk": 4}
{"article": "PMC3523068.txt", "subject": "Subtle cortical thinning in seven to nine preselected neocortical regions", "relationship": "RELATED_PROGNOSIS", "object": "Increased risk for AD development", "chunk": 4}
{"article": "PMC3523068.txt", "subject": "Subtle cortical thinning in seven to nine preselected neocortical regions", "relationship": "RELATED_PROGNOSIS", "object": "Loss of hippocampus volume", "chunk": 4}
{"article": "PMC3523068.txt", "subject": "cerebral cerebral cerebral cerebral spinal fluid A\u03b242/tau ratio and amyloid load measured by PiB binding", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Detection of cortical thinning", "chunk": 4}
{"article": "PMC3523068.txt", "subject": "Decreased cerebral cerebral cerebral cerebral spinal fluid A\u03b242 levels", "relationship": "DIAGNOSITC_OF", "object": "Early markers of amyloid formation in preclinical phase of AD", "chunk": 4}
{"article": "PMC3523068.txt", "subject": "Increased PiB-PET A\u03b2 brain load", "relationship": "DIAGNOSITC_OF", "object": "Early markers of amyloid formation in preclinical phase of AD", "chunk": 4}
{"article": "PMC3523068.txt", "subject": "Abnormalities in FDG-PET and fMRI patterns", "relationship": "DIAGNOSITC_OF", "object": "Markers of synaptic dysfunction and neurodegeneration in preclinical phase of AD", "chunk": 4}
{"article": "PMC3523068.txt", "subject": "High cerebral cerebral cerebral cerebral spinal fluid t-tau and p-tau levels or atrophy on structural MRI", "relationship": "DIAGNOSITC_OF", "object": "Markers of neurodegeneration in preclinical phase of AD", "chunk": 4}
{"article": "PMC3523068.txt", "subject": "A\u03b2 deposits", "relationship": "INDICATES_PRESENCE_OF", "object": "Asymptomatic cerebral amyloidosis", "chunk": 5}
{"article": "PMC3523068.txt", "subject": "A\u03b2 deposits", "relationship": "RELATED_PROGNOSIS", "object": "AD-type dementia", "chunk": 5}
{"article": "PMC3523068.txt", "subject": "early AD biomarkers", "relationship": "INDICATES_PRESENCE_OF", "object": "Preclinical, presymptomatic, or asymptomatic AD", "chunk": 5}
{"article": "PMC3523068.txt", "subject": "early AD biomarkers", "relationship": "PREDICTS_SURVIVAL", "object": "Clinical disease onset", "chunk": 5}
{"article": "PMC3523068.txt", "subject": "early AD biomarkers", "relationship": "RELATED_PROGNOSIS", "object": "Risk of AD-type dementia", "chunk": 5}
{"article": "PMC3523068.txt", "subject": "A\u03b2 deposits", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Diagnosis and treatment of Alzheimer's disease", "chunk": 5}
{"article": "PMC3523068.txt", "subject": "A\u03b242 cerebral spinal fluid levels", "relationship": "DIAGNOSITC_OF", "object": "preclinical AD", "chunk": 6}
{"article": "PMC3523068.txt", "subject": "PiB-PET", "relationship": "DIAGNOSITC_OF", "object": "preclinical AD", "chunk": 6}
{"article": "PMC3523068.txt", "subject": "A\u03b2 burden", "relationship": "MONITORED_DURING_TREATMENT", "object": "preclinical AD", "chunk": 6}
{"article": "PMC3523068.txt", "subject": "A\u03b2 deposits", "relationship": "RELATED_WITH_BIOPHYSICAL", "object": "extrapyramidal symptoms", "chunk": 6}
{"article": "PMC3523068.txt", "subject": "APOE \u03b54 allele", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "AD risk", "chunk": 6}
{"article": "PMC3523068.txt", "subject": "APOE \u03b53 genotype", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "AD risk", "chunk": 6}
{"article": "PMC3523068.txt", "subject": "Amyloid markers", "relationship": "INDICATES_PRESENCE_OF", "object": "Preclinical Alzheimer's disease", "chunk": 7}
{"article": "PMC3523068.txt", "subject": "Neuronal injury markers", "relationship": "INDICATES_PRESENCE_OF", "object": "preclinical Alzheimer's disease", "chunk": 7}
{"article": "PMC3534053.txt", "subject": "GAD67", "relationship": "INDICATES_PRESENCE_OF", "object": "Presence of GABAergic interneurons", "chunk": 2}
{"article": "PMC3534053.txt", "subject": "BrdU", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Labels new GABAergic interneurons", "chunk": 2}
{"article": "PMC3534053.txt", "subject": "GABA", "relationship": "RELATED_TO", "object": "Functioning of GABAergic Interneurons", "chunk": 2}
{"article": "PMC3534053.txt", "subject": "parvalbumin", "relationship": "RELATED_TO", "object": "Functioning of GABAergic Interneurons", "chunk": 2}
{"article": "PMC3534053.txt", "subject": "somatostatin", "relationship": "RELATED_TO", "object": "Functioning of GABAergic Interneurons", "chunk": 2}
{"article": "PMC3534053.txt", "subject": "neuropeptide Y (NPY)", "relationship": "RELATED_TO", "object": "Functioning of GABAergic Interneurons", "chunk": 2}
{"article": "PMC3534053.txt", "subject": "BrdU", "relationship": "MONITORED_DURING_TREATMENT", "object": "Tracking of new GABAergic interneuron generation", "chunk": 2}
{"article": "PMC3534053.txt", "subject": "GAD67-positive interneurons", "relationship": "RELATED_TO", "object": "Spatial learning abilities", "chunk": 3}
{"article": "PMC3534053.txt", "subject": "GAD67-positive interneurons", "relationship": "MONITORED_DURING_TREATMENT", "object": "Age-dependent effects of apoE isoform on GABAergic interneurons", "chunk": 3}
{"article": "PMC3534053.txt", "subject": "somatostatin-positive interneurons", "relationship": "MONITORED_DURING_TREATMENT", "object": "Age-dependent effects of apoE isoform on GABAergic interneurons", "chunk": 3}
{"article": "PMC3534053.txt", "subject": "Female apoE4-KI mice", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Spatial learning and memory deficits", "chunk": 3}
{"article": "PMC3534053.txt", "subject": "GAD67-positive interneurons", "relationship": "RELATED_PROGNOSIS", "object": "Spatial learning deficits in female apoe4-KI mice at 16 months of age", "chunk": 4}
{"article": "PMC3534053.txt", "subject": "GAD67-positive hilar interneurons", "relationship": "RELATED_PROGNOSIS", "object": "Learning performance of female apoE-KI mice", "chunk": 4}
{"article": "PMC3534053.txt", "subject": "GAD67-positive hilar interneurons", "relationship": "INDICATES_PRESENCE_OF", "object": "Aged female apoe4-KI mice having significantly reduced numbers", "chunk": 4}
{"article": "PMC3534053.txt", "subject": "GAD67-positive hilar interneurons", "relationship": "RELATED_TREATMENT", "object": "Determination of the therapeutic approach.", "chunk": 4}
{"article": "PMC3534053.txt", "subject": "GAD67-positive hilar interneurons", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Treatment for spatial learning deficits", "chunk": 4}
{"article": "PMC3534053.txt", "subject": "apoe4", "relationship": "INDICATES_PRESENCE_OF", "object": "Observed spatial learning deficits in female apoE-KI mice at 16 months of age", "chunk": 5}
{"article": "PMC3534053.txt", "subject": "somatostatin-positive hilar interneurons", "relationship": "RELATED_PROGNOSIS", "object": "spatial learning deficits in female apoe4-KI mice at 16 months of age", "chunk": 5}
{"article": "PMC3534053.txt", "subject": "somatostatin-positive hilar interneurons", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Spatial learning deficits", "chunk": 5}
{"article": "PMC3534053.txt", "subject": "somatostatin-positive hilar interneurons", "relationship": "RELATED_PROGNOSIS", "object": "Correlated with the observed spatial learning deficits", "chunk": 5}
{"article": "PMC3534053.txt", "subject": "somatostatin-positive hilar interneurons", "relationship": "BIOMARKER_DYNAMICS_UNDER_TREATMENT", "object": "May be affected by the presence or absence of apoe4 and the course of aging gender differences", "chunk": 5}
{"article": "PMC3534053.txt", "subject": "NPY-positive hilar interneurons", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 6}
{"article": "PMC3534053.txt", "subject": "NPY-positive hilar interneurons", "relationship": "RELATED_PROGNOSIS", "object": "Learning ability", "chunk": 6}
{"article": "PMC3534053.txt", "subject": "Parvalbumin-positive hilar interneurons", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 6}
{"article": "PMC3534053.txt", "subject": "Parvalbumin-positive hilar interneurons", "relationship": "RELATED_PROGNOSIS", "object": "Learning ability", "chunk": 6}
{"article": "PMC3534053.txt", "subject": "GAD67", "relationship": "RELATED_TREATMENT", "object": "GABAergic interneurogenesis", "chunk": 7}
{"article": "PMC3534053.txt", "subject": "NeuN", "relationship": "PROVIDES_INFORMATION", "object": "Total number of neurons", "chunk": 7}
{"article": "PMC3534053.txt", "subject": "GAD67", "relationship": "RELATED_TREATMENT", "object": "an accurate reflection of the number and distribution of GABAergic interneurons", "chunk": 7}
{"article": "PMC3534053.txt", "subject": "calretinin", "relationship": "RELATED_TREATMENT", "object": "excitatory mossy cells", "chunk": 7}
{"article": "PMC3534053.txt", "subject": "calretinin", "relationship": "INDICATES_PRESENCE_OF", "object": "excitatory mossy cells", "chunk": 7}
{"article": "PMC3534053.txt", "subject": "GAD67", "relationship": "RELATED_PROGNOSIS", "object": "Age-related decline in GAD67-positive interneurons observed in the entorhinal cortex of female apoE-KI mice", "chunk": 8}
{"article": "PMC3534053.txt", "subject": "APOE", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "ApoE genotype had no effect on the dentate gyrus, CA3, or CA1", "chunk": 8}
{"article": "PMC3534053.txt", "subject": "GABAergic interneurons", "relationship": "RELATED_PROGNOSIS", "object": "Numbers of GABAergic interneurons in the entorhinal cortex decrease as a natural function of age in females and males", "chunk": 8}
{"article": "PMC3534053.txt", "subject": "GAD67", "relationship": "RELATED_PROGNOSIS", "object": "Age-related increase in cells positive for GAD67 was noted among male apoE-KI mice", "chunk": 8}
{"article": "PMC3534053.txt", "subject": "Somatostatin", "relationship": "RELATED_PROGNOSIS", "object": "Age-related increase in cells positive for GAD67 was noted among male apoE-KI mice, likely due to increases in somatostatin-positive interneurons", "chunk": 8}
{"article": "PMC3534053.txt", "subject": "Parvalbumin", "relationship": "RELATED_PROGNOSIS", "object": "An age-related increase in cells positive for GAD67 was noted among male apoE-KI mice, likely due to increases in somatostatin-positive and parvalbumin-positive interneurons", "chunk": 8}
{"article": "PMC3534053.txt", "subject": "NeuropeptideY", "relationship": "RELATED_PROGNOSIS", "object": "Age effect on NPY-positive interneurons in CA3 subfield was not found", "chunk": 8}
{"article": "PMC3534053.txt", "subject": "NPY", "relationship": "RELATED_PROGNOSIS", "object": " Female apoE-KI mice showed an age-related decline in NPY-positive interneurons in the CA1", "chunk": 8}
{"article": "PMC3534053.txt", "subject": "Parvalbumin", "relationship": "RELATED_PROGNOSIS", "object": "Female apoE-KI mice showed an age-related decline in parvalbumin-positive interneurons in the CA1", "chunk": 8}
{"article": "PMC3534053.txt", "subject": "GAD67", "relationship": "RELATED_PROGNOSIS", "object": "An age-dependent increase in GAD67-positive interneurons was noted among male apoE-KI mice", "chunk": 8}
{"article": "PMC3534053.txt", "subject": "GABAergic interneurons", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive dysfunction", "chunk": 10}
{"article": "PMC3534053.txt", "subject": "estrogen", "relationship": "RELATED_TREATMENT", "object": "Maintaining higher numbers of GABAergic interneurons", "chunk": 10}
{"article": "PMC3534053.txt", "subject": "GABAergic interneurons", "relationship": "BIOMARKER_DYNAMICS_UNDER_TREATMENT", "object": "Estrogen", "chunk": 10}
{"article": "PMC3534053.txt", "subject": "tau", "relationship": "RELATED_TREATMENT", "object": "Amelioration of learning and memory impairments", "chunk": 10}
{"article": "PMC3534053.txt", "subject": "apoe4(\u0394272\u2013299)", "relationship": "INDICATES_PRESENCE_OF", "object": "Neurodegeneration", "chunk": 10}
{"article": "PMC3534053.txt", "subject": "apoe4(\u0394272\u2013299)", "relationship": "INDICATES_PRESENCE_OF", "object": "High levels of hyperphosphorylated tau", "chunk": 10}
{"article": "PMC3534053.txt", "subject": "apoe4(\u0394272\u2013299)", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive dysfunction", "chunk": 10}
{"article": "PMC3534053.txt", "subject": "apoe4(\u0394272\u2013299)", "relationship": "RELATED_PROGNOSIS", "object": "Impairments of hilar GABAergic interneurons", "chunk": 10}
{"article": "PMC3534053.txt", "subject": "apoe4", "relationship": "RELATED_PROGNOSIS", "object": "Increased network excitability", "chunk": 10}
{"article": "PMC3534053.txt", "subject": "apoe4", "relationship": "RELATED_PROGNOSIS", "object": "Stress-induced subclinical epileptiform activity", "chunk": 10}
{"article": "PMC3534053.txt", "subject": "GAD67", "relationship": "INDICATES_PRESENCE_OF", "object": "GABAergic interneurons", "chunk": 11}
{"article": "PMC3534053.txt", "subject": "somatostatin", "relationship": "INDICATES_PRESENCE_OF", "object": "GABAergic interneurons", "chunk": 11}
{"article": "PMC3534053.txt", "subject": "neuropeptide Y", "relationship": "INDICATES_PRESENCE_OF", "object": "GABAergic interneurons", "chunk": 11}
{"article": "PMC3534053.txt", "subject": "parvalbumin", "relationship": "INDICATES_PRESENCE_OF", "object": "GABAergic interneurons", "chunk": 11}
{"article": "PMC3534121.txt", "subject": "18 kDa translocator protein (TSPO)", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Surrogate marker of efficacy of treatment on microglial activation", "chunk": 1}
{"article": "PMC3534121.txt", "subject": "18 kDa translocator protein (TSPO)", "relationship": "INDICATES_PRESENCE_OF", "object": "Inflammation", "chunk": 1}
{"article": "PMC3534121.txt", "subject": "18 kDa translocator protein (TSPO)", "relationship": "RELATED_TO", "object": "Microglial Activation", "chunk": 1}
{"article": "PMC3534121.txt", "subject": "18F-DPA-714", "relationship": "USED_TO_DIAGNOSE", "object": "ALS", "chunk": 2}
{"article": "PMC3534121.txt", "subject": "18F-DPA-714", "relationship": "RELATED_TREATMENT", "object": "ALS", "chunk": 2}
{"article": "PMC3534121.txt", "subject": "18F-DPA-714", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "ALS", "chunk": 2}
{"article": "PMC3534121.txt", "subject": "18F-DPA-714", "relationship": "MONITORED_DURING_TREATMENT", "object": "ALS", "chunk": 2}
{"article": "PMC3534121.txt", "subject": "18F-DPA-714", "relationship": "INDICATES_PRESENCE_OF", "object": "Microglial activation", "chunk": 3}
{"article": "PMC3534121.txt", "subject": "18F-DPA-714", "relationship": "RELATED_PROGNOSIS", "object": "Degeneration in the motor cortex, supplementary motor area, and temporal cortex in ALS patients", "chunk": 3}
{"article": "PMC3534121.txt", "subject": "18F-DPA-714", "relationship": "RELATED_TREATMENT", "object": "A TSPO agonist", "chunk": 3}
{"article": "PMC3534121.txt", "subject": "18F-DPA-714", "relationship": "RELATED_TREATMENT", "object": "Imaging microglial activation in ALS patients", "chunk": 3}
{"article": "PMC3534121.txt", "subject": "TSPO", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Choice of radioligand for PET imaging", "chunk": 4}
{"article": "PMC3534121.txt", "subject": "TSPO", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Microglial activation reduction", "chunk": 4}
{"article": "PMC3534121.txt", "subject": "18F-DPA-714", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Pet imaging to assess neuroinflammatory process", "chunk": 4}
{"article": "PMC3534121.txt", "subject": "18F-DPA-714", "relationship": "LEVELS_REFLECT_RESPONSE", "object": "Response to treatment", "chunk": 4}
{"article": "PMC3534121.txt", "subject": "18F-DPA-714", "relationship": "PREDICTS_SURVIVAL", "object": "Prognosis of ALS disease", "chunk": 4}
{"article": "PMC3534121.txt", "subject": "TDP-43", "relationship": "DIAGNOSITC_OF", "object": "ALS", "chunk": 4}
{"article": "PMC3534121.txt", "subject": "18F-DPA-714", "relationship": "INDICATES_TREATMENT_ELIGIBILITY", "object": "Assesse microglial activation", "chunk": 5}
{"article": "PMC3534121.txt", "subject": "18F-DPA-714", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Ability to assess microglial activation in vivo", "chunk": 5}
{"article": "PMC3534121.txt", "subject": "18F-DPA-714", "relationship": "MONITORED_DURING_TREATMENT", "object": "Effective monitoring of treatment", "chunk": 5}
{"article": "PMC3534121.txt", "subject": "TSPO", "relationship": "RELATED_TO", "object": "Microglial activation", "chunk": 5}
{"article": "PMC3543237.txt", "subject": "nerve growth factor (NGF)", "relationship": "RELATED_TREATMENT", "object": "Alzheimer's disease", "chunk": 1}
{"article": "PMC3543237.txt", "subject": "nerve growth factor (NGF)", "relationship": "RELATED_TREATMENT", "object": "peripheral neuropathies", "chunk": 1}
{"article": "PMC3543237.txt", "subject": "NGF", "relationship": "INDICATES_PRESENCE_OF", "object": "Dysfunction and degeneration of PNS neurons/fibers in diabetes", "chunk": 2}
{"article": "PMC3543237.txt", "subject": "NGF", "relationship": "RELATED_TREATMENT", "object": "Treatment of peripheral neuropathies", "chunk": 2}
{"article": "PMC3543237.txt", "subject": "NGF", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Treatment of peripheral neuropathies", "chunk": 2}
{"article": "PMC3543237.txt", "subject": "NGF", "relationship": "RELATED_PROGNOSIS", "object": "Neuroprotective effect and potential to reverse neuropathic signs", "chunk": 2}
{"article": "PMC3543237.txt", "subject": "NGF", "relationship": "PREDICTOR", "object": "Neuropathic symptoms associated with diabetes", "chunk": 2}
{"article": "PMC3543237.txt", "subject": "NGF", "relationship": "RELATED_TREATMENT", "object": "Treatment of Parkinson's Disease", "chunk": 4}
{"article": "PMC3543237.txt", "subject": "NGF", "relationship": "RELATED_TREATMENT", "object": "Treatment of skin ulcers", "chunk": 4}
{"article": "PMC3543237.txt", "subject": "NGF", "relationship": "RELATED_TREATMENT", "object": "Treatment of Hypoxic-ischemic Perinatal Brain Injury", "chunk": 4}
{"article": "PMC3543237.txt", "subject": "NGF", "relationship": "RELATED_TREATMENT", "object": "Treatment of Traumatic Brain Injury", "chunk": 4}
{"article": "PMC3543237.txt", "subject": "NGF", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Treatment of Parkinson's Disease", "chunk": 4}
{"article": "PMC3543237.txt", "subject": "NGF", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Skin Trauma", "chunk": 4}
{"article": "PMC3543237.txt", "subject": "NGF", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Skin Diseases", "chunk": 4}
{"article": "PMC3543237.txt", "subject": "NGF", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Epidermal Derangements", "chunk": 4}
{"article": "PMC3543237.txt", "subject": "NGF", "relationship": "RELATED_TREATMENT", "object": "Treatment of diabetic foot ulcers", "chunk": 5}
{"article": "PMC3543237.txt", "subject": "NGF", "relationship": "RELATED_TREATMENT", "object": "Treatment of vasculitic ulcers", "chunk": 5}
{"article": "PMC3543237.txt", "subject": "NGF", "relationship": "RELATED_TREATMENT", "object": "Treatment of pressure ulcers", "chunk": 5}
{"article": "PMC3543237.txt", "subject": "NGF", "relationship": "RELATED_TREATMENT", "object": "Treatment of lower limb crush syndrome", "chunk": 5}
{"article": "PMC3543237.txt", "subject": "VEGF", "relationship": "RELATED_TREATMENT", "object": "Promote vascular-endothelial growth factor (VEGF) and neo-vascularization", "chunk": 5}
{"article": "PMC3543237.txt", "subject": "NGF", "relationship": "RELATED_TREATMENT", "object": "Neovascularization", "chunk": 5}
{"article": "PMC3543237.txt", "subject": "ERG", "relationship": "RELATED_TREATMENT", "object": "Improved amplitude observed in patients with NGF treatment", "chunk": 6}
{"article": "PMC3543237.txt", "subject": "NGF", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Used in treating several eye conditions", "chunk": 6}
{"article": "PMC3543237.txt", "subject": "NGF", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Gene therapy aims to deliver NGF to achieve therapeutic benefits", "chunk": 6}
{"article": "PMC3543237.txt", "subject": "NGF", "relationship": "RELATED_TREATMENT", "object": "Systemically delivered NGF can result in adverse effects like pain", "chunk": 6}
{"article": "PMC3543237.txt", "subject": "NGF", "relationship": "RELATED_TREATMENT", "object": "Treatment of major central neurodegenerative disorders and peripheral neuropathies", "chunk": 7}
{"article": "PMC3543237.txt", "subject": "NGF", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "NGF-based therapy", "chunk": 7}
{"article": "PMC3543237.txt", "subject": "mNGF", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Treatment of Optic glioma", "chunk": 7}
{"article": "PMC3543237.txt", "subject": "mNGF", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Delivering to the ocular surface", "chunk": 7}
{"article": "PMC3543237.txt", "subject": "NF-\u03baB", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "potential NGF-based therapies", "chunk": 8}
{"article": "PMC3543237.txt", "subject": "NGF", "relationship": "IS_TARGET_OF_TREATMENT", "object": "NGF therapy", "chunk": 8}
{"article": "PMC3543237.txt", "subject": "NGF", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "development of innovative NGF-based therapies", "chunk": 8}
{"article": "PMC3543237.txt", "subject": "NGF", "relationship": "RELATED_TREATMENT", "object": "care of chronic inflammatory or autoimmune diseases", "chunk": 8}
{"article": "PMC3581819.txt", "subject": "Touch threshold", "relationship": "INDICATES_PRESENCE_OF", "object": "Fine-touch sensitivity", "chunk": 3}
{"article": "PMC3581819.txt", "subject": "2-point discrimination threshold", "relationship": "INDICATES_PRESENCE_OF", "object": "Spatial 2-point discrimination", "chunk": 3}
{"article": "PMC3581819.txt", "subject": "Postural performance", "relationship": "RELATED_PROGNOSIS", "object": "Function and efficiency improvement in movement", "chunk": 5}
{"article": "PMC3581819.txt", "subject": "R-BANS", "relationship": "RELATED_PROGNOSIS", "object": "Cognition/attention", "chunk": 7}
{"article": "PMC3581819.txt", "subject": "FAIR", "relationship": "RELATED_PROGNOSIS", "object": "Cognition/attention", "chunk": 7}
{"article": "PMC3581819.txt", "subject": "RSPMa", "relationship": "RELATED_PROGNOSIS", "object": "General intelligence", "chunk": 7}
{"article": "PMC3581819.txt", "subject": "Touch-threshold", "relationship": "RELATED_PROGNOSIS", "object": "Tactile performance", "chunk": 7}
{"article": "PMC3581819.txt", "subject": "2-Point-discrimination-threshold", "relationship": "RELATED_PROGNOSIS", "object": "Tactile performance", "chunk": 7}
{"article": "PMC3581819.txt", "subject": "Haptic object recognition", "relationship": "RELATED_PROGNOSIS", "object": "Tactile performance", "chunk": 7}
{"article": "PMC3581819.txt", "subject": "VO2peak", "relationship": "RELATED_PROGNOSIS", "object": "Cardio-pulmonary performance", "chunk": 7}
{"article": "PMC3581819.txt", "subject": "Brain-derived neurotrophic factor (BDNF)", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Enriched environmental conditions may increase BDNF levels, which exert neuroprotective effects.", "chunk": 9}
{"article": "PMC3581819.txt", "subject": "Brain-derived neurotrophic factor (BDNF)", "relationship": "RELATED_TREATMENT", "object": "Studies suggest that physical activity and social interaction can increase BDNF levels.", "chunk": 9}
{"article": "PMC3652205.txt", "subject": "salivary cortisol", "relationship": "MONITORED_DURING_TREATMENT", "object": "intervention", "chunk": 1}
{"article": "PMC3652205.txt", "subject": "morning cortisol level", "relationship": "MODIfIED_BY", "object": "Intervention", "chunk": 1}
{"article": "PMC3652205.txt", "subject": "salivary cortisol", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Measuring salivary cortisol  became a way to access whether the mindfulness techniques were effective in reducing stress.", "chunk": 4}
{"article": "PMC3652205.txt", "subject": "salivary cortisol", "relationship": "MONITORED_DURING_TREATMENT", "object": "Salivary cortisol levels were monitored as a physiological variable to see how the participants responded to the mindfulness techniques.", "chunk": 4}
{"article": "PMC3652205.txt", "subject": "salivary cortisol", "relationship": "LEVELS_REFLECT_RESPONSE", "object": "Changes in salivary cortisol levels were used to reflect the effectiveness of the mindfulness intervention in reducing stress.", "chunk": 4}
{"article": "PMC3652205.txt", "subject": "HPA axis", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Elevations in the HPA axis are associated with hippocampal volume loss and memory impairment, potentially increasing the risk of dementia.", "chunk": 4}
{"article": "PMC3652205.txt", "subject": "cortisol", "relationship": "RELATED_PROGNOSIS", "object": "cortisol levels are associated with stress", "chunk": 5}
{"article": "PMC3652205.txt", "subject": "cortisol", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "high levels of cortisol can lead to poor outcomes", "chunk": 5}
{"article": "PMC3652205.txt", "subject": "cortisol", "relationship": "MONITORED_DURING_TREATMENT", "object": "cortisol levels were monitored during the study", "chunk": 5}
{"article": "PMC3652205.txt", "subject": "GABA", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "increased GABA concentration is associated with improvements in mood", "chunk": 5}
{"article": "PMC3652205.txt", "subject": "adrenalin", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "reductions in adrenalin are associated with better outcomes", "chunk": 5}
{"article": "PMC3652205.txt", "subject": "noradrenalin", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "reductions in noradrenalin are associated with better outcomes", "chunk": 5}
{"article": "PMC3652205.txt", "subject": "serotonin", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "increased serotonin is associated with better outcomes", "chunk": 5}
{"article": "PMC3652205.txt", "subject": "melatonin", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "increased melatonin is associated with better outcomes", "chunk": 5}
{"article": "PMC3662311.txt", "subject": "AnxA1", "relationship": "INDICATES_PRESENCE_OF", "object": "Neutrophil apoptosis", "chunk": 2}
{"article": "PMC3662311.txt", "subject": "AnxA1", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Induction of neutrophil apoptosis", "chunk": 2}
{"article": "PMC3662311.txt", "subject": "AnxA1", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Leukocyte infiltration", "chunk": 2}
{"article": "PMC3662311.txt", "subject": "R-roscovitine", "relationship": "RELATED_PROGNOSIS", "object": "Severity of inflammation", "chunk": 2}
{"article": "PMC3662311.txt", "subject": "PS", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "PS/PC liposomes are used in treatment", "chunk": 3}
{"article": "PMC3662311.txt", "subject": "PS", "relationship": "RELATED_TO_TREATMENT", "object": " PS/PC liposomes are used for its therapeutic effects", "chunk": 3}
{"article": "PMC3662311.txt", "subject": "resolving lipid mediators", "relationship": "INDICATES_PRESENCE_OF", "object": "pro-resolving effects", "chunk": 6}
{"article": "PMC3662311.txt", "subject": "resolvin bche gene gene", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "decreased neutrophil tissue infiltration, pro-inflammatory gene expression and improved survival", "chunk": 6}
{"article": "PMC3662311.txt", "subject": "Resolvin D1", "relationship": "RELATED_TREATMENT", "object": "delivery strategy with  aspirin-triggered", "chunk": 6}
{"article": "PMC3662311.txt", "subject": "5-epi-LXA4", "relationship": "RELATED_TREATMENT", "object": " induces resolution in a mouse model of lung injury", "chunk": 6}
{"article": "PMC3662311.txt", "subject": "ectoine", "relationship": "RELATED_TREATMENT", "object": "prevent the anti-apoptotic mechanisms that extend neutrophil life span in an inflammatory microenvironment", "chunk": 6}
{"article": "PMC3662311.txt", "subject": "PD098059", "relationship": "RELATED_TREATMENT", "object": "counteract GM-cerebral cerebral cerebral spinal fluid-induced neutrophil survival", "chunk": 6}
{"article": "PMC3662311.txt", "subject": "AnxA1, resolvins", "relationship": "RELATED_TREATMENT", "object": " induce efferocytosis", "chunk": 6}
{"article": "PMC3662311.txt", "subject": "LXA4", "relationship": "RELATED_TREATMENT", "object": " induce efferocytosis", "chunk": 6}
{"article": "PMC3662311.txt", "subject": "AnxA5-RGD complexes", "relationship": "RELATED_TREATMENT", "object": "promote cell clearance and secretion of IL-10", "chunk": 6}
{"article": "PMC3662311.txt", "subject": "PS-containing liposomes ", "relationship": "RELATED_TREATMENT", "object": "mimic the phagocyte stimulation achieved by apoptotic cells and induce secretion of pro-resolution mediators", "chunk": 6}
{"article": "PMC3662311.txt", "subject": "resolvin bche gene gene (RX-10001)", "relationship": "RELATED_TREATMENT", "object": "tested in numerous inflammatory diseases including dry eye, retinal disease, asthma, inflammatory bowel diseases, rheumatic arthritis and cardiovascular diseases", "chunk": 6}
{"article": "PMC3662311.txt", "subject": "RX-100045", "relationship": "RELATED_TREATMENT", "object": "successfully completed the phase II study in dry eye patients and is scheduled to enter a phase III randomized, placebo-controlled, multi-centre study", "chunk": 6}
{"article": "PMC3662311.txt", "subject": "LXA4-based compound", "relationship": "RELATED_TREATMENT", "object": "tested for the topical treatment of eczema", "chunk": 6}
{"article": "PMC3662311.txt", "subject": "AP214", "relationship": "RELATED_TREATMENT", "object": "effectively reduces acute kidney injury associated with major cardiac surgery", "chunk": 6}
{"article": "PMC3675142.txt", "subject": "DR", "relationship": "ASSOCIATED_WITH", "object": "demyelination and axonal degeneration", "chunk": 2}
{"article": "PMC3675142.txt", "subject": "FA", "relationship": "USED_TO_DIAGNOSE", "object": "Differentiate between patients and controls", "chunk": 3}
{"article": "PMC3675142.txt", "subject": "DR", "relationship": "USED_TO_DIAGNOSE", "object": "Differentiate between patients and controls", "chunk": 3}
{"article": "PMC3675142.txt", "subject": "GM volume", "relationship": "USED_TO_DIAGNOSE", "object": "Differentiate between patients and controls", "chunk": 3}
{"article": "PMC3675142.txt", "subject": "GM volume", "relationship": "RELATED_PROGNOSIS", "object": "Mild cognitive impairment patients had, on average, less total GM volume (normalized to ICV) than CN", "chunk": 4}
{"article": "PMC3675142.txt", "subject": "WM volume", "relationship": "RELATED_PROGNOSIS", "object": "Differences in total WM volume (also normalized to ICV) were not significant", "chunk": 4}
{"article": "PMC3675142.txt", "subject": "FA", "relationship": "USED_TO_DIAGNOSE", "object": "Classifications based on FA or DR alone were significant", "chunk": 4}
{"article": "PMC3675142.txt", "subject": "DR", "relationship": "USED_TO_DIAGNOSE", "object": "Classifications based on FA or DR alone were significant", "chunk": 4}
{"article": "PMC3675142.txt", "subject": "FA", "relationship": "INDICATES_PRESENCE_OF", "object": "Mild cognitive impairment", "chunk": 5}
{"article": "PMC3675142.txt", "subject": "DR", "relationship": "INDICATES_PRESENCE_OF", "object": "Mild cognitive impairment", "chunk": 5}
{"article": "PMC3675142.txt", "subject": "GM volume", "relationship": "INDICATES_PRESENCE_OF", "object": "Mild cognitive impairment", "chunk": 5}
{"article": "PMC3675142.txt", "subject": "FA, DR, GM volume", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive impairment", "chunk": 5}
{"article": "PMC3675142.txt", "subject": "DTI", "relationship": "RELATED_TREATMENT", "object": "Could contribute to predicting treatment efficacy", "chunk": 5}
{"article": "PMC3682121.txt", "subject": "Beta rhythm (15\u201330 Hz)", "relationship": "DIAGNOSITC_OF", "object": "Motor regions", "chunk": 5}
{"article": "PMC3682121.txt", "subject": "Beta synchrony", "relationship": "INDICATES_PRESENCE_OF", "object": "Slower voluntary movement", "chunk": 5}
{"article": "PMC3682121.txt", "subject": "20 Hz tACS", "relationship": "INDICATES_PRESENCE_OF", "object": "Slower voluntary movement", "chunk": 5}
{"article": "PMC3682121.txt", "subject": "70 Hz tACS", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "Increased performance", "chunk": 5}
{"article": "PMC3682121.txt", "subject": "10 Hz tACS", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "Increased behavioral variability", "chunk": 5}
{"article": "PMC3682121.txt", "subject": "theta oscillations", "relationship": "INDICATES_PRESENCE_OF", "object": "Power increase in the slow oscillation frequency band", "chunk": 7}
{"article": "PMC3682121.txt", "subject": "theta oscillations", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": " Improved learning performance", "chunk": 7}
{"article": "PMC3682121.txt", "subject": "theta phase-coupling", "relationship": "RELATED_TO", "object": "Cognitive performance in a working memory task", "chunk": 7}
{"article": "PMC3682121.txt", "subject": "gamma oscillations", "relationship": "IS_TARGET_OF_TREATMENT", "object": "40 Hz tACS", "chunk": 7}
{"article": "PMC3682121.txt", "subject": "40 Hz tACS with 180\u00b0 interhemispheric phase difference", "relationship": "RELATED_TREATMENT", "object": "Reduced perception of horizontal motion", "chunk": 7}
{"article": "PMC3691311.txt", "subject": "uric acid levels", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "increased cardiovascular risks, heart failure, and stroke", "chunk": 1}
{"article": "PMC3691311.txt", "subject": "uric acid levels", "relationship": "PREDICTS_SURVIVAL", "object": "death in patients at high risk of cardiovascular disease", "chunk": 1}
{"article": "PMC3691311.txt", "subject": "uric acid levels", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "hypertension", "chunk": 1}
{"article": "PMC3691311.txt", "subject": "uric acid levels", "relationship": "PREDICT_SURVIVAL", "object": "death in patients with cardiovascular disease", "chunk": 1}
{"article": "PMC3691311.txt", "subject": "uric acid levels", "relationship": "INDICATES_PRESENCE_OF", "object": "tissue hypoxia", "chunk": 1}
{"article": "PMC3691311.txt", "subject": "SpO2", "relationship": "RELATED_PROGNOSIS", "object": "OSAS severity", "chunk": 1}
{"article": "PMC3691311.txt", "subject": "uric acid", "relationship": "INDICATES_PRESENCE_OF", "object": "OSAS", "chunk": 2}
{"article": "PMC3691311.txt", "subject": "uric acid", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Exclusion of participants receiving uric acid-lowering medications", "chunk": 2}
{"article": "PMC3691311.txt", "subject": "uric acid", "relationship": "INDICATES_PRESENCE_OF", "object": "Hyperuricemia", "chunk": 3}
{"article": "PMC3691311.txt", "subject": "uric acid", "relationship": "RELATED_DYNAMICS", "object": "levels reflect response", "chunk": 3}
{"article": "PMC3691311.txt", "subject": "uric acid", "relationship": "RELATED_PROGNOSIS", "object": "Association with OSAS risk", "chunk": 3}
{"article": "PMC3691311.txt", "subject": "uric acid", "relationship": "RELATED_TREATMENT", "object": "Predictor", "chunk": 3}
{"article": "PMC3691311.txt", "subject": "uric acid levels", "relationship": "INDICATES_PRESENCE_OF", "object": "OSAS", "chunk": 4}
{"article": "PMC3691311.txt", "subject": "hyperuricemia", "relationship": "RELATED_TO", "object": "OSAS", "chunk": 4}
{"article": "PMC3691311.txt", "subject": "uric acid levels", "relationship": "RELATED_PROGNOSIS", "object": "OSAS", "chunk": 4}
{"article": "PMC3691311.txt", "subject": "BMI", "relationship": "RELATED_PROGNOSIS", "object": "uric acid levels", "chunk": 4}
{"article": "PMC3691311.txt", "subject": "age", "relationship": "RELATED_PROGNOSIS", "object": "uric acid levels", "chunk": 4}
{"article": "PMC3691311.txt", "subject": "AHI", "relationship": "RELATED_PROGNOSIS", "object": "uric acid levels", "chunk": 4}
{"article": "PMC3691311.txt", "subject": "minimum SpO2", "relationship": "RELATED_PROGNOSIS", "object": "uric acid levels", "chunk": 4}
{"article": "PMC3691311.txt", "subject": "triglycerides", "relationship": "RELATED_PROGNOSIS", "object": "uric acid levels", "chunk": 4}
{"article": "PMC3691311.txt", "subject": "creatinine", "relationship": "RELATED_PROGNOSIS", "object": "uric acid levels", "chunk": 4}
{"article": "PMC3691311.txt", "subject": "SBP", "relationship": "RELATED_PROGNOSIS", "object": "uric acid levels", "chunk": 4}
{"article": "PMC3691311.txt", "subject": "k+", "relationship": "RELATED_PROGNOSIS", "object": "uric acid levels", "chunk": 4}
{"article": "PMC3691311.txt", "subject": "desaturation index", "relationship": "RELATED_PROGNOSIS", "object": "uric acid levels", "chunk": 4}
{"article": "PMC3691311.txt", "subject": "desaturation time", "relationship": "RELATED_PROGNOSIS", "object": "uric acid levels", "chunk": 4}
{"article": "PMC3691311.txt", "subject": "glucose", "relationship": "RELATED_PROGNOSIS", "object": "uric acid levels", "chunk": 4}
{"article": "PMC3691311.txt", "subject": "LDL", "relationship": "RELATED_PROGNOSIS", "object": "uric acid levels", "chunk": 4}
{"article": "PMC3691311.txt", "subject": "HDL", "relationship": "RELATED_PROGNOSIS", "object": "uric acid levels", "chunk": 4}
{"article": "PMC3691311.txt", "subject": "uric acid levels", "relationship": "INDICATES_PRESENCE_OF", "object": "Obstructive Sleep Apnea Syndrome (OSAS)", "chunk": 5}
{"article": "PMC3691311.txt", "subject": "uric acid levels", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Cardiovascular morbidity and mortality", "chunk": 5}
{"article": "PMC3691311.txt", "subject": "uric acid levels", "relationship": "RELATED_PROGNOSIS", "object": "Prevents intermittent hypoxia-induced vascular dysfunction", "chunk": 5}
{"article": "PMC3691311.txt", "subject": "uric acid levels", "relationship": "RESPONDED_TO", "object": "Treatment of sleep disordered breathing", "chunk": 5}
{"article": "PMC3691311.txt", "subject": "uric acid levels", "relationship": "MONITORED_DURING_TREATMENT", "object": "Treatment of sleep disordered breathing", "chunk": 5}
{"article": "PMC3691311.txt", "subject": "uric acid levels", "relationship": "BIOMARKER_DYNAMICS_UNDER_TREATMENT", "object": "Treatment of sleep disordered breathing", "chunk": 5}
{"article": "PMC3695013.txt", "subject": "BrainAGE", "relationship": "PREDICTS_SURVIVAL", "object": "Conversion to AD", "chunk": 1}
{"article": "PMC3695013.txt", "subject": "BrainAGE", "relationship": "RELATED_PROGNOSIS", "object": "Conversion to AD", "chunk": 1}
{"article": "PMC3695013.txt", "subject": "BrainAGE", "relationship": "INDICATES_PRESENCE_OF", "object": "Accelerated atrophy", "chunk": 1}
{"article": "PMC3695013.txt", "subject": "BrainAGE", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Treatment options", "chunk": 1}
{"article": "PMC3695013.txt", "subject": "A\u03b242", "relationship": "DIAGNOSTIC_OF", "object": "Early detection of AD", "chunk": 1}
{"article": "PMC3695013.txt", "subject": "PiB amyloid imaging", "relationship": "DIAGNOSTIC_OF", "object": "Early detection of AD", "chunk": 1}
{"article": "PMC3695013.txt", "subject": "A\u03b242", "relationship": "INDICATES_PRESENCE_OF", "object": "A\u03b2 plaques in the brain", "chunk": 2}
{"article": "PMC3695013.txt", "subject": "low concentrations of cerebral spinal fluid A\u03b242", "relationship": "RELATED_TO", "object": "Clinical diagnosis of AD", "chunk": 2}
{"article": "PMC3695013.txt", "subject": "cerebral tau", "relationship": "RELATED_PROGNOSIS", "object": "Severity of cognitive impairment", "chunk": 2}
{"article": "PMC3695013.txt", "subject": "BrainAGE", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Prediction of conversion from mild cognitive impairment to AD", "chunk": 2}
{"article": "PMC3695013.txt", "subject": "BrainAGE", "relationship": "RELATED_TREATMENT", "object": "Early detection of abnormal brain changes", "chunk": 2}
{"article": "PMC3695013.txt", "subject": "BrainAGE", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Predicting conversion from mild cognitive impairment to AD", "chunk": 2}
{"article": "PMC3695013.txt", "subject": "A\u03b242", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease conversion from mild cognitive impairment", "chunk": 3}
{"article": "PMC3695013.txt", "subject": "T-Tau", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease conversion from mild cognitive impairment", "chunk": 3}
{"article": "PMC3695013.txt", "subject": "P-Tau", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease conversion from mild cognitive impairment", "chunk": 3}
{"article": "PMC3695013.txt", "subject": "Hippocampus volumes", "relationship": "COMPARED_BETWEEN_DIAGNOSTIC_GROUPS", "object": "Baseline", "chunk": 4}
{"article": "PMC3695013.txt", "subject": "Cerebral spinal fluid biomarker levels", "relationship": "COMPARED_BETWEEN_DIAGNOSTIC_GROUPS", "object": "Baseline", "chunk": 4}
{"article": "PMC3695013.txt", "subject": "BrainAGE score", "relationship": "COMPARED_BETWEEN_DIAGNOSTIC_GROUPS", "object": "Baseline", "chunk": 4}
{"article": "PMC3695013.txt", "subject": "MMSE scores", "relationship": "COMPARED_BETWEEN_DIAGNOSTIC_GROUPS", "object": "Baseline", "chunk": 4}
{"article": "PMC3695013.txt", "subject": "CDR-SB scores", "relationship": "COMPARED_BETWEEN_DIAGNOSTIC_GROUPS", "object": "Baseline", "chunk": 4}
{"article": "PMC3695013.txt", "subject": "ADAS scores", "relationship": "COMPARED_BETWEEN_DIAGNOSTIC_GROUPS", "object": "Baseline", "chunk": 4}
{"article": "PMC3695013.txt", "subject": "BrainAGE scores", "relationship": "RELATED_PROGNOSIS", "object": "Conversion to AD in mild cognitive impairment subjects ", "chunk": 5}
{"article": "PMC3695013.txt", "subject": "BrainAGE scores", "relationship": "PREDICTS_SURVIVAL", "object": "Time to conversion to AD", "chunk": 5}
{"article": "PMC3695013.txt", "subject": "BrainAGE scores", "relationship": "DIAGNOSTIC_OF", "object": "Mild cognitive impairment", "chunk": 5}
{"article": "PMC3695013.txt", "subject": "BrainAGE score", "relationship": "INDICATES_PRESENCE_OF", "object": "AD risk", "chunk": 6}
{"article": "PMC3695013.txt", "subject": "BrainAGE score", "relationship": "RELATED_PROGNOSIS", "object": "AD development", "chunk": 6}
{"article": "PMC3695013.txt", "subject": "BrainAGE score", "relationship": "RELATED_TREATMENT_SELECTION", "object": "Diagnosis", "chunk": 6}
{"article": "PMC3695013.txt", "subject": "BrainAGE score", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Treatment selection within the mild cognitive impairment  + cerebro-spinal fluid cohort", "chunk": 6}
{"article": "PMC3695013.txt", "subject": "BrainAGE score", "relationship": "MONITORED_DURING_TREATMENT", "object": "AD treatment", "chunk": 6}
{"article": "PMC3695013.txt", "subject": "BrainAGE score", "relationship": "BIOMARKER_DYNAMICS_UNDER_TREATMENT", "object": "Predicts the proportion of time within a 1250 day observation period when individuals will remain AD free", "chunk": 6}
{"article": "PMC3695013.txt", "subject": "T-Tau", "relationship": "INDICATES_PRESENCE_OF", "object": "AD risk at the time of the baseline measurement", "chunk": 6}
{"article": "PMC3695013.txt", "subject": "T-Tau concentration", "relationship": "RELATED_PROGNOSIS", "object": "Probability of converting to AD", "chunk": 6}
{"article": "PMC3695013.txt", "subject": "A\u03b242", "relationship": "INDICATES_PRESENCE_OF", "object": "AD risk at the time of the baseline measurement", "chunk": 6}
{"article": "PMC3695013.txt", "subject": "P-Tau", "relationship": "INDICATES_PRESENCE_OF", "object": "AD risk at the time of the baseline measurement", "chunk": 6}
{"article": "PMC3695013.txt", "subject": "A\u03b242/P-Tau", "relationship": "INDICATES_PRESENCE_OF", "object": "AD Risk", "chunk": 6}
{"article": "PMC3695013.txt", "subject": "T-Tau", "relationship": "INDICATES_PRESENCE_OF", "object": "AD", "chunk": 7}
{"article": "PMC3695013.txt", "subject": "P-Tau", "relationship": "INDICATES_PRESENCE_OF", "object": "AD", "chunk": 7}
{"article": "PMC3695013.txt", "subject": "A\u03b242", "relationship": "INDICATES_PRESENCE_OF", "object": "AD", "chunk": 7}
{"article": "PMC3695013.txt", "subject": "A\u03b242/P-Tau", "relationship": "INDICATES_PRESENCE_OF", "object": "AD", "chunk": 7}
{"article": "PMC3695013.txt", "subject": "BrainAGE", "relationship": "RELATED_TO", "object": "Risk of developing AD", "chunk": 7}
{"article": "PMC3695013.txt", "subject": "BrainAGE", "relationship": "INDICATES_PRESENCE_OF", "object": "Pathological brain aging", "chunk": 8}
{"article": "PMC3695013.txt", "subject": "BrainAGE", "relationship": "PREDICTS_SURVIVAL", "object": "AD-free status", "chunk": 8}
{"article": "PMC3695013.txt", "subject": "BrainAGE", "relationship": "RELATED_PROGNOSIS", "object": "Future cognitive decline", "chunk": 8}
{"article": "PMC3695013.txt", "subject": "APOE \u03b54 allele", "relationship": "INDICATES_PRESENCE_OF", "object": "Modification of cognitive functioning", "chunk": 8}
{"article": "PMC3695013.txt", "subject": "APOE \u03b54 allele", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "GM reduction in AD patients", "chunk": 8}
{"article": "PMC3695013.txt", "subject": "APOE \u03b54 allele", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "GM reduction in healthy subjects", "chunk": 8}
{"article": "PMC3695013.txt", "subject": "Hippocampus volume", "relationship": "RELATED_TREATMENT", "object": "Risk factor for AD", "chunk": 8}
{"article": "PMC3706879.txt", "subject": "A\u03b21-42", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Alzheimer's Disease pathology accumulation", "chunk": 1}
{"article": "PMC3706879.txt", "subject": "A\u03b21-40", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Alzheimer's Disease pathology accumulation", "chunk": 1}
{"article": "PMC3706879.txt", "subject": "Amyloid beta peptides (A\u03b2)", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "J147 targets amyloid beta peptides to reduce its accumulation", "chunk": 1}
{"article": "PMC3706879.txt", "subject": "BDNF", "relationship": "RELATED_PROGNOSIS", "object": "Improved cognitive function in AD mice", "chunk": 1}
{"article": "PMC3706879.txt", "subject": "BDNF", "relationship": "INDICTES_PRESENCE_OF", "object": "Neuroprotective effects", "chunk": 1}
{"article": "PMC3706879.txt", "subject": "BDNF-responsive proteins", "relationship": "RELATED_PROGNOSIS", "object": "Improved cognitive function in AD mice", "chunk": 1}
{"article": "PMC3706879.txt", "subject": "J147", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Potential disease-modifying treatment for AD due to its ability to reverse cognitive deficits", "chunk": 1}
{"article": "PMC3706879.txt", "subject": "NGF", "relationship": "RELATED_PROGNOSIS", "object": "Improved cognitive function in AD mice", "chunk": 1}
{"article": "PMC3706879.txt", "subject": "NGF", "relationship": "RELATED_TREATMENT", "object": "J147 administration", "chunk": 1}
{"article": "PMC3706879.txt", "subject": "\u03b2-actin", "relationship": "USED_TO_DIAGNOSE", "object": "Monitor protein expression in cell lysates", "chunk": 2}
{"article": "PMC3706879.txt", "subject": "CREB", "relationship": "USED_TO_DIAGNOSE", "object": "Investigate neuronal activity and transcriptional changes", "chunk": 2}
{"article": "PMC3706879.txt", "subject": "Egr-3", "relationship": "USED_TO_DIAGNOSE", "object": "Assess neuronal plasticity and stress response", "chunk": 2}
{"article": "PMC3706879.txt", "subject": "A\u03b21-40", "relationship": "RELATED_TREATMENT", "object": "Measure levels in hippocampus, treated with 10 \u03bcM J147, as part of a commercial screening for molecular targets and 'off target' effects", "chunk": 4}
{"article": "PMC3706879.txt", "subject": "A\u03b21-42", "relationship": "RELATED_TREATMENT", "object": "Measure levels in hippocampus, treated with 10 \u03bcM J147, as part of a commercial screening for molecular targets and 'off target' effects", "chunk": 4}
{"article": "PMC3706879.txt", "subject": "J147", "relationship": "RELATED_TREATMENT", "object": "Cognitive deficit rescue in aged Alzheimer's disease mice", "chunk": 5}
{"article": "PMC3706879.txt", "subject": "J147", "relationship": "INDICATES_TREATMENT_ELIGIBILITY", "object": "Mice with neurodegenerative disease state", "chunk": 5}
{"article": "PMC3706879.txt", "subject": "huAPP/PS1 mice", "relationship": "DIAGNOTSIC_OF", "object": "Alzheimer's Disease", "chunk": 5}
{"article": "PMC3706879.txt", "subject": "huAPP/PS1 mice", "relationship": "INDICATES_PRESENCE_OF", "object": "Pathological hallmarks of AD", "chunk": 5}
{"article": "PMC3706879.txt", "subject": "huAPP/PS1 mice", "relationship": "INDICATES_PRESENCE_OF", "object": "Clear deficits in spatial memory", "chunk": 5}
{"article": "PMC3706879.txt", "subject": "huAPP/PS1 mice", "relationship": "INDICATES_PRESENCE_OF", "object": "Impaired spatial navigational memory", "chunk": 6}
{"article": "PMC3706879.txt", "subject": "AD mice", "relationship": "RELATED_TREATMENT", "object": "J147 treatment", "chunk": 6}
{"article": "PMC3706879.txt", "subject": "AD mice", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Disinhibition phenotype", "chunk": 6}
{"article": "PMC3706879.txt", "subject": "AD mice", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Impaired spatial navigational memory", "chunk": 6}
{"article": "PMC3706879.txt", "subject": "AD mice + J147", "relationship": "RELATED_PROGNOSIS", "object": "Faster escape latency in 2-day water maze", "chunk": 6}
{"article": "PMC3706879.txt", "subject": "AD mice", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Reduced freezing response in contextual fear conditioning", "chunk": 6}
{"article": "PMC3706879.txt", "subject": "J147", "relationship": "RESPONDED_TO", "object": "AD Mice", "chunk": 6}
{"article": "PMC3706879.txt", "subject": "AD mice + J147", "relationship": "RELATED_PROGNOSIS", "object": "Increased freezing response in contextual fear conditioning", "chunk": 6}
{"article": "PMC3706879.txt", "subject": "AD mice + J147", "relationship": "RELATED_TREATMENT", "object": "This exhibited a phenotype that was completely rescued by treatment with J147", "chunk": 6}
{"article": "PMC3706879.txt", "subject": "(AD mice)", "relationship": "MONITORED_DURING_TREATMENT", "object": "Time spent in the open arms elevated plus maze", "chunk": 6}
{"article": "PMC3706879.txt", "subject": "A\u03b21-42", "relationship": "RELATED_TREATMENT", "object": "Reduced by J147", "chunk": 7}
{"article": "PMC3706879.txt", "subject": "A\u03b21-40", "relationship": "RELATED_TREATMENT", "object": "Reduced by J147", "chunk": 7}
{"article": "PMC3706879.txt", "subject": "BACE", "relationship": "RELATED_TREATMENT", "object": "Down-regulated by J147", "chunk": 7}
{"article": "PMC3706879.txt", "subject": "APP", "relationship": "RELATED_TREATMENT", "object": "Increased by J147", "chunk": 7}
{"article": "PMC3706879.txt", "subject": "BDNF", "relationship": "RELATED_TREATMENT", "object": "Increased by J147", "chunk": 7}
{"article": "PMC3706879.txt", "subject": "proNGF", "relationship": "RELATED_TREATMENT", "object": "Increased by J147", "chunk": 7}
{"article": "PMC3706879.txt", "subject": "mature NGF", "relationship": "RELATED_TREATMENT", "object": "Increased by J147", "chunk": 7}
{"article": "PMC3706879.txt", "subject": "proBDNF", "relationship": "RELATED_TREATMENT", "object": "Increased by J147", "chunk": 7}
{"article": "PMC3706879.txt", "subject": "mature BDNF", "relationship": "RELATED_TREATMENT", "object": "Increased by J147", "chunk": 7}
{"article": "PMC3706879.txt", "subject": "BDNF", "relationship": "RELATED_TREATMENT", "object": "J147 treatment", "chunk": 8}
{"article": "PMC3706879.txt", "subject": "BDNF", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "Increased BDNF levels", "chunk": 8}
{"article": "PMC3706879.txt", "subject": "BDNF", "relationship": "IS_TARGET_OF_TREATMENT", "object": "J147", "chunk": 8}
{"article": "PMC3706879.txt", "subject": "NGF", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Neurite outgrowth", "chunk": 8}
{"article": "PMC3706879.txt", "subject": "Homer-1", "relationship": "RELATED_TREATMENT", "object": "J147 treatment", "chunk": 8}
{"article": "PMC3706879.txt", "subject": "Egr3", "relationship": "RELATED_TREATMENT", "object": "J147 treatment", "chunk": 8}
{"article": "PMC3706879.txt", "subject": "Egr3", "relationship": "PROVIDES_INGREDIENT_FOR_TREATMENT", "object": "Neurite outgrowth", "chunk": 8}
{"article": "PMC3706879.txt", "subject": "Egr3", "relationship": "RELATED_PROGNOSIS", "object": "Synaptic plasticity, learning, and memory.", "chunk": 8}
{"article": "PMC3706879.txt", "subject": "CREB", "relationship": "RELATED_TREATMENT", "object": "J147 treatment", "chunk": 8}
{"article": "PMC3706879.txt", "subject": "CREB", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "Limits inflammation", "chunk": 8}
{"article": "PMC3706879.txt", "subject": "acetylcholinesterase inhibitor", "relationship": "RELATED_TREATMENT", "object": "donepezil, which transiently improves cognition in AD", "chunk": 9}
{"article": "PMC3706879.txt", "subject": "NGF", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "It is required for cholinergic neurons", "chunk": 9}
{"article": "PMC3706879.txt", "subject": "NGF", "relationship": "RELATED_PROGNOSIS", "object": "Therefore, the effect of J147 on the cholinergic system was investigated", "chunk": 9}
{"article": "PMC3706879.txt", "subject": "cholinergic neurons", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Cholinergic neurons are among the first to be lost in AD", "chunk": 9}
{"article": "PMC3706879.txt", "subject": "acetylcholine", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "acetylcholine is the therapeutic target for most FDA approved drugs for AD", "chunk": 9}
{"article": "PMC3706879.txt", "subject": "J147", "relationship": "INDICATES_TREATMENT_ELIGIBILITY", "object": "This finding is important considering the accumulating evidence that soluble A\u03b2 directly causes cognitive dysfunction and the fact that improved cognition in 3xTg AD mice can manifest without a reduction in A\u03b2 plaque load", "chunk": 10}
{"article": "PMC3706879.txt", "subject": "J147", "relationship": "RELATED_TREATMENT", "object": "Our data (Figures 1 and Figure 2) support this hypothesis.", "chunk": 10}
{"article": "PMC3706879.txt", "subject": "J147", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "To test the efficacy of J147 in a much more rigorous preclinical AD model, we treated mice using a therapeutic strategy more accurately reflecting the human symptomatic stage.", "chunk": 10}
{"article": "PMC3706879.txt", "subject": "J147", "relationship": "IS_TARGET_OF_TREATMENT", "object": "The goal was to investigate the ability of J147 to rescue cognitive impairment at a late stage in the disease as an indicator of its potential to rescue cognitive impairment in humans with AD.", "chunk": 10}
{"article": "PMC3706879.txt", "subject": "proNGF", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 11}
{"article": "PMC3706879.txt", "subject": "proNGF", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Neuronal degeneration", "chunk": 11}
{"article": "PMC3706879.txt", "subject": "NGF", "relationship": "RELATED_TREATMENT", "object": "Stimulating cholinergic function", "chunk": 11}
{"article": "PMC3706879.txt", "subject": "BDNF", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Reduced with age and in the AD brain", "chunk": 11}
{"article": "PMC3706879.txt", "subject": "BDNF", "relationship": "RELATED_PROGNOSIS", "object": "Normal cognitive function", "chunk": 11}
{"article": "PMC3706879.txt", "subject": "BDNF", "relationship": "RELATED_TREATMENT", "object": "Neurodegenerative disorders, neuropathies and peripheral nerve injury", "chunk": 11}
{"article": "PMC3706879.txt", "subject": "A\u03b2", "relationship": "DIAGNOSITC_OF", "object": "Alzheimer's disease", "chunk": 11}
{"article": "PMC3706879.txt", "subject": "A\u03b2", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's disease", "chunk": 12}
{"article": "PMC3706879.txt", "subject": "BDNF", "relationship": "IS_TARGET_OF_TREATMENT", "object": "J147", "chunk": 12}
{"article": "PMC3706879.txt", "subject": "NGF", "relationship": "IS_TARGET_OF_TREATMENT", "object": "J147", "chunk": 12}
{"article": "PMC3712995.txt", "subject": "24OH", "relationship": "RELATED_PROGNOSIS", "object": "Increased levels are associated with improved spatial memory in the Morris water maze test", "chunk": 2}
{"article": "PMC3712995.txt", "subject": "24OH", "relationship": "RELATED_PROGNOSIS", "object": "Increased levels in serum", "chunk": 3}
{"article": "PMC3712995.txt", "subject": "24OH", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Previous studies with the heterozygotes [5] showed increased levels in the brain", "chunk": 3}
{"article": "PMC3712995.txt", "subject": "24OH", "relationship": "RELATED_TREATMENT", "object": "CYP46A1 overexpression reported to increase 24OH levels", "chunk": 3}
{"article": "PMC3712995.txt", "subject": "lanosterol", "relationship": "INDICATES_PRESENCE_OF", "object": "Increased levels in homozygous overexpressing females brain", "chunk": 3}
{"article": "PMC3712995.txt", "subject": "lanosterol", "relationship": "RELATED_TREATMENT", "object": "Increased levels suggest increased cholesterol synthesis in the brain", "chunk": 3}
{"article": "PMC3712995.txt", "subject": "NMDAR1", "relationship": "INDICATES_PRESENCE_OF", "object": "Increased synaptic proteins in hippocampus of CYP46A1 mice", "chunk": 4}
{"article": "PMC3712995.txt", "subject": "p-NMDAR2A", "relationship": "INDICATES_PRESENCE_OF", "object": "Increased synaptic proteins in hippocampus of CYP46A1 mice", "chunk": 4}
{"article": "PMC3712995.txt", "subject": "PSD95", "relationship": "INDICATES_PRESENCE_OF", "object": "Increased synaptic proteins in hippocampus of CYP46A1 mice", "chunk": 4}
{"article": "PMC3712995.txt", "subject": "Synapthophysin", "relationship": "INDICATES_PRESENCE_OF", "object": "Increased synaptic proteins in hippocampus of CYP46A1 mice", "chunk": 4}
{"article": "PMC3712995.txt", "subject": "Synapsin-1", "relationship": "INDICATES_PRESENCE_OF", "object": "Increased synaptic proteins in hippocampus of CYP46A1 mice", "chunk": 4}
{"article": "PMC3712995.txt", "subject": "\u03b2-amyloid", "relationship": "RELATED_TO", "object": "cholesterol synthesis in AD", "chunk": 5}
{"article": "PMC3712995.txt", "subject": "\u03b2-amyloid", "relationship": "ASSOCIATED_WITH_BAD_OUTCOME", "object": "Increased production of \u03b2-amyloid", "chunk": 5}
{"article": "PMC3712995.txt", "subject": "cholesterol", "relationship": "INDICATES_PRESENCE_OF", "object": "membrane dysfunction in Huntingtons disease", "chunk": 5}
{"article": "PMC3712995.txt", "subject": "CYP46A1", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "potential therapeutic target for cognitive enhancement", "chunk": 5}
{"article": "PMC3712995.txt", "subject": "24OH", "relationship": "RELATED_PROGNOSIS", "object": "better cognition and synaptic plasticity", "chunk": 5}
{"article": "PMC3733998.txt", "subject": "AV-45", "relationship": "USED_TO_DIAGNOSE", "object": "Prodromal Alzheimer's Disease", "chunk": 1}
{"article": "PMC3733998.txt", "subject": "AV45", "relationship": "INDICATES_PRESENCE_OF", "object": "Amyloid pathology", "chunk": 1}
{"article": "PMC3733998.txt", "subject": "\u03b2-amyloid", "relationship": "ASSOCIATED_WITH", "object": "Memory decline", "chunk": 1}
{"article": "PMC3733998.txt", "subject": "A\u03b242", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease (AD)", "chunk": 2}
{"article": "PMC3733998.txt", "subject": "A\u03b242/A\u03b240", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Diagnosis of AD", "chunk": 2}
{"article": "PMC3733998.txt", "subject": "A\u03b242", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer's Disease diagnosis", "chunk": 2}
{"article": "PMC3733998.txt", "subject": "T-Tau", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer's Disease diagnosis", "chunk": 2}
{"article": "PMC3733998.txt", "subject": "P-Tau", "relationship": "DIAGNOSTIC_OF", "object": "Alzheimer's Disease", "chunk": 2}
{"article": "PMC3733998.txt", "subject": "P-Tau", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 2}
{"article": "PMC3733998.txt", "subject": "AV-45", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Treatment of Alzheimer's Disease", "chunk": 3}
{"article": "PMC3733998.txt", "subject": "ApoE genotype", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Prodromal AD identification and treatment decisions", "chunk": 4}
{"article": "PMC3733998.txt", "subject": "AV-45 binding", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 4}
{"article": "PMC3733998.txt", "subject": "P-Tau", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Abnormal cerebrospinal fluid profile", "chunk": 4}
{"article": "PMC3733998.txt", "subject": "IATI", "relationship": "RELATED_TREATMENT", "object": "Treatment of prodromal AD", "chunk": 4}
{"article": "PMC3733998.txt", "subject": "A\u03b240 concentration", "relationship": "RELATED_PROGNOSIS", "object": "Diagnosis of prodromal AD", "chunk": 4}
{"article": "PMC3733998.txt", "subject": "CDR scale", "relationship": "DIAGNOSITC_OF", "object": "Prodromal Alzheimer's Disease", "chunk": 4}
{"article": "PMC3733998.txt", "subject": "FCSRT sum of free recalls", "relationship": "INDICATES_PRESENCE_OF", "object": "A decline in memory function, possibly related to prodromal AD.", "chunk": 4}
{"article": "PMC3733998.txt", "subject": "FCSRT sum of free + cued recalls", "relationship": "INDICATES_PRESENCE_OF", "object": "A decline in memory function, possibly related to prodromal AD.", "chunk": 4}
{"article": "PMC3733998.txt", "subject": "MMSE", "relationship": "DIAGNOSITC_OF", "object": "Cognitive impairment, potentially indicative of prodromal AD", "chunk": 4}
{"article": "PMC3733998.txt", "subject": "Temporal atrophy", "relationship": "PREDICTS_SURVIVAL", "object": "Overall survival time in prodromal AD", "chunk": 4}
{"article": "PMC3733998.txt", "subject": "Hippocampus atrophy", "relationship": "RELATED_PROGNOSIS", "object": "Progression stage of prodromal AD", "chunk": 4}
{"article": "PMC3733998.txt", "subject": "Temporo-parietal hypometabolism", "relationship": "INDICATES_PRESENCE_OF", "object": "Prodromal Alzheimer's Disease", "chunk": 4}
{"article": "PMC3733998.txt", "subject": "AV-45 uptake", "relationship": "INDICATES_PRESENCE_OF", "object": "Cerebral amyloid load", "chunk": 5}
{"article": "PMC3733998.txt", "subject": "AV-45 uptake", "relationship": "RELATED_PROGNOSIS", "object": "Memory performance declines", "chunk": 5}
{"article": "PMC3733998.txt", "subject": "AV-45 uptake", "relationship": "RELATED_TREATMENT", "object": "Early, pre-demential diagnosis of AD", "chunk": 5}
{"article": "PMC3733998.txt", "subject": "AV-45 uptake", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Focus on gray matter uptake", "chunk": 5}
{"article": "PMC3733998.txt", "subject": "PiB binding", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive decline", "chunk": 5}
{"article": "PMC3733998.txt", "subject": "AV-45", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Early, pre-demential diagnosis", "chunk": 5}
{"article": "PMC3733998.txt", "subject": "Cerebral amyloid load", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Memory decline", "chunk": 5}
{"article": "PMC3733998.txt", "subject": "High cerebral amyloid load", "relationship": "INDICATES_PRESENCE_OF", "object": "Prodromal AD", "chunk": 5}
{"article": "PMC3733998.txt", "subject": "\u03b2-amyloid load", "relationship": "RELATED_TO", "object": "Memory performance decline", "chunk": 5}
{"article": "PMC3733998.txt", "subject": "A\u03b240 concentration", "relationship": "INDICATES_PRESENCE_OF", "object": "cerebral cerebral cerebral cerebral spinal fluid profile", "chunk": 6}
{"article": "PMC3741576.txt", "subject": "A\u03b2", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's disease", "chunk": 2}
{"article": "PMC3741576.txt", "subject": "A\u03b2", "relationship": "RELATED_TREATMENT", "object": "Removal of A\u03b2 in parenchyma", "chunk": 2}
{"article": "PMC3741576.txt", "subject": "A\u03b2", "relationship": "ASSOCIATED_WITH", "object": "Neuronal death", "chunk": 2}
{"article": "PMC3741576.txt", "subject": "A\u03b2", "relationship": "IS_CAUSE_OF", "object": "Inflammation in Alzheimer's disease", "chunk": 2}
{"article": "PMC3741576.txt", "subject": "reactive oxygen species (ROS)", "relationship": "INDICATES_PRESENCE_OF", "object": "Inflammation in Alzheimer's disease", "chunk": 2}
{"article": "PMC3741576.txt", "subject": "pro-inflammatory cytokines (TNF\u03b1, IL-1\u03b2 and IL-6)", "relationship": "INDICATES_PRESENCE_OF", "object": "Inflammation in Alzheimer's disease", "chunk": 2}
{"article": "PMC3741576.txt", "subject": "PGs (PGE2)", "relationship": "INDICATES_PRESENCE_OF", "object": "Inflammation in Alzheimer's disease", "chunk": 2}
{"article": "PMC3741576.txt", "subject": "IL-1, IL-6, TNF", "relationship": "RELATED_PROGNOSIS", "object": "Neuronal injury", "chunk": 2}
{"article": "PMC3741576.txt", "subject": "A\u03b2", "relationship": "PREDICTS_SURVIVAL", "object": "Microglial phagocytosis is limited", "chunk": 2}
{"article": "PMC3741576.txt", "subject": "A\u03b2", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Accumulation of amyloid fibrils in lysosomal compartments of macrophages", "chunk": 2}
{"article": "PMC3741576.txt", "subject": "microglial activation", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Immunomodulatory interventions", "chunk": 2}
{"article": "PMC3741576.txt", "subject": "astrocyte activation", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Neuroprotective therapies", "chunk": 2}
{"article": "PMC3741576.txt", "subject": "Microglial cells", "relationship": "MONITORED_DURING_TREATMENT", "object": "AD treatment", "chunk": 2}
{"article": "PMC3741576.txt", "subject": "reactive oxygen species", "relationship": "BIOMARKER_DYNAMICS_UNDER_TREATMENT", "object": "AD treatment", "chunk": 2}
{"article": "PMC3741576.txt", "subject": "pro-inflammatory cytokines", "relationship": "BIOMARKER_DYNAMICS_UNDER_TREATMENT", "object": "AD treatment", "chunk": 2}
{"article": "PMC3741576.txt", "subject": "A\u03b2 oligomeric forms", "relationship": "INDICATES_PRESENCE_OF", "object": "Astrocyte activation", "chunk": 3}
{"article": "PMC3741576.txt", "subject": "A\u03b2 peptides", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Receptors on astrocytes", "chunk": 3}
{"article": "PMC3741576.txt", "subject": "A\u03b2 aggregates", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Increased expression and alteration of APP processing", "chunk": 3}
{"article": "PMC3741576.txt", "subject": "A\u03b2 aggregates", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Tau phosphorylation", "chunk": 3}
{"article": "PMC3741576.txt", "subject": "A\u03b2 aggregates", "relationship": "RELATED_TO", "object": "Pathological aggregation", "chunk": 3}
{"article": "PMC3741576.txt", "subject": "a\u03b2", "relationship": "INDICATES_PRESENCE_OF", "object": "Inflammation molecular mediators", "chunk": 3}
{"article": "PMC3741576.txt", "subject": "C1q", "relationship": "RELATED_TO", "object": "Classical complement pathway activation", "chunk": 3}
{"article": "PMC3741576.txt", "subject": "C1q", "relationship": "INDICATES_PRESENCE_OF", "object": "Increased immunoreactivity", "chunk": 3}
{"article": "PMC3741576.txt", "subject": "C1q", "relationship": "ASSOCIATED_WITH", "object": "Phagocytosis of A\u03b2", "chunk": 3}
{"article": "PMC3741576.txt", "subject": "C1q", "relationship": "RELATED_TO", "object": "T-cell response regulation", "chunk": 3}
{"article": "PMC3741576.txt", "subject": "C1q", "relationship": "RELATED_TO", "object": "T-helper lymphocyte differentiation", "chunk": 3}
{"article": "PMC3741576.txt", "subject": "C1q", "relationship": "RELATED_TO", "object": "Adaptive immune response", "chunk": 3}
{"article": "PMC3741576.txt", "subject": "C1q", "relationship": "BIOMARKER_DYNAMICS_UNDER_TREATMENT", "object": "Phagocytosis of A\u03b2 decrease in rat culture with the presence of A\u03b2 1\u201342 and nano molar concentration of C1q", "chunk": 3}
{"article": "PMC3741576.txt", "subject": "TNF-\u03b1", "relationship": "INDICATES_PRESENCE_OF", "object": "Inflammation-related proteins", "chunk": 3}
{"article": "PMC3741576.txt", "subject": "IL-6", "relationship": "INDICATES_PRESENCE_OF", "object": "Inflammation-related proteins ", "chunk": 3}
{"article": "PMC3741576.txt", "subject": "IL-1", "relationship": "INDICATES_PRESENCE_OF", "object": "Inflammation-related proteins", "chunk": 3}
{"article": "PMC3741576.txt", "subject": "C1q", "relationship": "RELATED_TO_TREATMENT", "object": "Microglial activation", "chunk": 4}
{"article": "PMC3741576.txt", "subject": "sCrry", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Overexpression of soluble form of protein related to complement receptor (sCrry)", "chunk": 4}
{"article": "PMC3741576.txt", "subject": "A\u03b2 aggregates", "relationship": "RELATED_TREATMENT", "object": "Use of C5aR antagonist (C5aR or CD88)", "chunk": 4}
{"article": "PMC3741576.txt", "subject": "C5a receptor antagonist (C5aR or CD88)", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Reduces the amount of A\u03b2 aggregates and hyperphosphorylated tau protein", "chunk": 4}
{"article": "PMC3741576.txt", "subject": "C3", "relationship": "RELATED_PROGNOSIS", "object": "Associated with microglial activation", "chunk": 4}
{"article": "PMC3741576.txt", "subject": "A\u03b2 synthetic peptides", "relationship": "INDICATES_PRESENCE_OF", "object": "Increase in C3 synthesis to 5 to 10-fold", "chunk": 4}
{"article": "PMC3741576.txt", "subject": "CR1", "relationship": "RELATED_TO_TREATMENT", "object": "Phagocytosis", "chunk": 4}
{"article": "PMC3741576.txt", "subject": "C3b and C4b", "relationship": "RELATED_TREATMENT", "object": "Binding facilitates phagocytosis", "chunk": 4}
{"article": "PMC3741576.txt", "subject": "C5", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Excitotoxicity and apoptosis activation in the central nervous system", "chunk": 4}
{"article": "PMC3741576.txt", "subject": "C5a receptor antagonist (C5aR or CD88)", "relationship": "RELATED_PROGNOSIS", "object": "Reduces the amount of A\u03b2 aggregates and hyperphosphorylated tau protein", "chunk": 4}
{"article": "PMC3741576.txt", "subject": "Cytokines", "relationship": "DIAGNOSITC_OF", "object": "Development of neurodegenerative disorders", "chunk": 4}
{"article": "PMC3741576.txt", "subject": "IL-1\u03b2, IL-6, IL-10, TNF-\u03b1, and TGF-\u03b2", "relationship": "INDICATES_PRESENCE_OF", "object": "Elevated levels in AD patient tissues and cerebrospinal fluid", "chunk": 4}
{"article": "PMC3741576.txt", "subject": "TNF-\u03b1", "relationship": "RELATED_PROGNOSIS", "object": "Direct role remains uncertain in AD", "chunk": 4}
{"article": "PMC3741576.txt", "subject": "TNF-\u03b1", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Stimulates NF-\u03baB transcription factor which induces pro-inflammatory molecules expression", "chunk": 4}
{"article": "PMC3741576.txt", "subject": "IL-6", "relationship": "RELATED_PROGNOSIS", "object": "Proposed to play a role in the development of AD pathology", "chunk": 4}
{"article": "PMC3741576.txt", "subject": "IL-1", "relationship": "INDICATES_PRESENCE_OF", "object": "An increase in APP-\u03b2 mRNA expression in endothelial cells", "chunk": 4}
{"article": "PMC3741576.txt", "subject": "IL-1", "relationship": "RELATES_TO_TREATMENT", "object": "Promotion of dystrophic neurite formation in A\u03b2 diffuse deposits", "chunk": 4}
{"article": "PMC3741576.txt", "subject": "S100\u03b2", "relationship": "RELATED_TREATMENT", "object": "Production and increase in reactive astrocytes", "chunk": 4}
{"article": "PMC3741576.txt", "subject": "TGF-\u03b2 1", "relationship": "INDICATES_PRESENCE_OF", "object": "Neurodegenerative disorders", "chunk": 5}
{"article": "PMC3741576.txt", "subject": "TGF-\u03b2 1", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Amyloidogenesis in the meninges and cerebral vasculature", "chunk": 5}
{"article": "PMC3741576.txt", "subject": "TGF levels", "relationship": "RELATED_PROGNOSIS", "object": "Alzheimer's disease", "chunk": 5}
{"article": "PMC3741576.txt", "subject": "TGF-\u03b2 receptor type II (T\u03b2 RII)", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Neuroprotective functions", "chunk": 5}
{"article": "PMC3741576.txt", "subject": "CCL2", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive decline", "chunk": 5}
{"article": "PMC3741576.txt", "subject": "IL-8 (CXCL8)", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Brain-derived neurotrophic factor (BDNF) production", "chunk": 5}
{"article": "PMC3741576.txt", "subject": "COX-2", "relationship": "PREDICTS_DEATH", "object": "Neurotoxicity", "chunk": 5}
{"article": "PMC3741576.txt", "subject": "COX-2", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Increased active Caspase-3", "chunk": 5}
{"article": "PMC3741576.txt", "subject": "COX-2", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "increased amyloid plaque formation", "chunk": 5}
{"article": "PMC3741576.txt", "subject": "COX-2", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "increased prostaglandin E2 production", "chunk": 5}
{"article": "PMC3741576.txt", "subject": "COX-2 inhibition", "relationship": "RELATED_TREATMENT", "object": "therapy for AD", "chunk": 6}
{"article": "PMC3741576.txt", "subject": "IL-1\u03b2", "relationship": "INDICATES_PRESENCE_OF", "object": "inflammation in early stages of AD", "chunk": 6}
{"article": "PMC3741576.txt", "subject": "COX-2 levels", "relationship": "MONITORED_DURING_TREATMENT", "object": "treatment of AD", "chunk": 6}
{"article": "PMC3741576.txt", "subject": "NO", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "synaptic transmission dysfunction, protein and lipid oxidative damage, excitotoxicity, and neuronal death", "chunk": 6}
{"article": "PMC3741576.txt", "subject": "NOS inhibitors", "relationship": "RESPONDED_TO", "object": "reduced Tau phosphorylation levels", "chunk": 6}
{"article": "PMC3741576.txt", "subject": "COX-2", "relationship": "LEVELS_REFLECT_RESPONSE", "object": "response to inflammatory cytokines and A\u03b2", "chunk": 6}
{"article": "PMC3741576.txt", "subject": "NSAIDs", "relationship": "RELATED_TREATMENT", "object": "treatment of AD", "chunk": 6}
{"article": "PMC3741576.txt", "subject": "NSAIDs", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "treatment strategy for AD", "chunk": 6}
{"article": "PMC3741576.txt", "subject": "A\u03b2 levels", "relationship": "RELATED_TO", "object": "Reduced by NSAIDs use in Tg2576 mice", "chunk": 7}
{"article": "PMC3741576.txt", "subject": "MMSE scores", "relationship": "INDICATES_PRESENCE_OF", "object": "Decrease associated with NSAIDs use", "chunk": 7}
{"article": "PMC3741576.txt", "subject": "A\u03b21\u221240", "relationship": "RELATED_TREATMENT", "object": "Stimulate non-amyloidogenic APP-processing pathway by NSAIDs", "chunk": 7}
{"article": "PMC3741576.txt", "subject": "A\u03b21\u221242", "relationship": "RELATED_TREATMENT", "object": "Stimulate non-amyloidogenic APP-processing pathway by NSAIDs", "chunk": 7}
{"article": "PMC3741576.txt", "subject": "IL-1\u03b2", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Levels reduced by Triflusal", "chunk": 7}
{"article": "PMC3741576.txt", "subject": "TNF-\u03b1", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Levels reduced by Triflusal", "chunk": 7}
{"article": "PMC3741576.txt", "subject": "A\u03b2 42", "relationship": "PREDICT_SURVIVAL", "object": "Increase observed in 5XFAD mice treated with ibuprofen", "chunk": 7}
{"article": "PMC3741576.txt", "subject": "Glucocorticoid Receptor (GR)", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Binding of glucocorticoids to GR mediates anti-inflammatory effects", "chunk": 7}
{"article": "PMC3741576.txt", "subject": "cortisol", "relationship": "RELATED_PROGNOSIS", "object": "Increased levels associated with increased AD risk", "chunk": 7}
{"article": "PMC3741576.txt", "subject": "NP size (NPS)", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "While Triflusal impacted inflammation and cellular markers, it did not impact NP size", "chunk": 7}
{"article": "PMC3741576.txt", "subject": "cortisol", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 8}
{"article": "PMC3741576.txt", "subject": "APP", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Therapeutic strategy for AD", "chunk": 8}
{"article": "PMC3741576.txt", "subject": "A\u03b2", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Anti-A\u03b2 immunotherapy", "chunk": 8}
{"article": "PMC3741576.txt", "subject": "A\u03b2", "relationship": "RELATED_PROGNOSIS", "object": "Severity of Alzheimer's Disease", "chunk": 8}
{"article": "PMC3741576.txt", "subject": "corticosterone", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Outcome of Alzheimer's Disease", "chunk": 8}
{"article": "PMC3741576.txt", "subject": "caspase 3", "relationship": "INDICATES_PRESENCE_OF", "object": "Pro-apoptotic environment", "chunk": 8}
{"article": "PMC3741576.txt", "subject": "cytochrome c", "relationship": "INDICATES_PRESENCE_OF", "object": "Pro-apoptotic environment", "chunk": 8}
{"article": "PMC3741576.txt", "subject": "IL-1", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Outcome of Alzheimer's Disease", "chunk": 8}
{"article": "PMC3741576.txt", "subject": "TNF-\u03b1", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Outcome of Alzheimer's Disease", "chunk": 8}
{"article": "PMC3741576.txt", "subject": "prednisone", "relationship": "RELATED_TREATMENT", "object": "Treatment for Alzheimer's Disease", "chunk": 8}
{"article": "PMC3741576.txt", "subject": "3D6", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Treatment for Alzheimer's Disease", "chunk": 8}
{"article": "PMC3741576.txt", "subject": "7B6", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Treatment for Alzheimer's Disease", "chunk": 8}
{"article": "PMC3741576.txt", "subject": "Bapineuzumab", "relationship": "RELATED_TREATMENT", "object": "Treatment for Alzheimer's Disease", "chunk": 8}
{"article": "PMC3741576.txt", "subject": "AN1792", "relationship": "RELATED_TREATMENT", "object": "Treatment for Alzheimer's Disease", "chunk": 8}
{"article": "PMC3741576.txt", "subject": "QS-21", "relationship": "RELATED_TREATMENT", "object": "Treatment for Alzheimer's Disease", "chunk": 8}
{"article": "PMC3741576.txt", "subject": "hTau", "relationship": "IS_TARGET_OF_TREATMENT", "object": "Immunotherapy", "chunk": 9}
{"article": "PMC3741576.txt", "subject": "Neurofibrillary tangless", "relationship": "ASSOCIATED_WITH_TREATMENT", "object": "Reduced by 40% in number following hTau peptide immunization", "chunk": 9}
{"article": "PMC3741576.txt", "subject": "PHF1", "relationship": "RELATED_TREATMENT", "object": "Peripheral administration as antibody in immunotherapy for Tau", "chunk": 9}
{"article": "PMC3741576.txt", "subject": "MC1", "relationship": "RELATED_TREATMENT", "object": "Peripheral administration as antibody in immunotherapy for Tau", "chunk": 9}
{"article": "PMC3741576.txt", "subject": "A\u03b2", "relationship": "RELATED_TREATMENT", "object": "Immunotherapy, particularly active immunotherapy", "chunk": 9}
{"article": "PMC3741576.txt", "subject": "APP", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Expression is governed by NF-\u03baB which is influenced by pro-inflammatory cytokines", "chunk": 9}
{"article": "PMC3741576.txt", "subject": "BACbche gene", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Expression is governed by NF-\u03baB which is influenced by pro-inflammatory cytokines", "chunk": 9}
{"article": "PMC3741576.txt", "subject": "PSEN1", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Expression is governed by NF-\u03baB which is influenced by pro-inflammatory cytokines", "chunk": 9}
{"article": "PMC3741576.txt", "subject": "IL-1\u03b2", "relationship": "BIOMARKER_DYNAMICS_UNDER_TREATMENT", "object": "Can activate apoptotic pathways and microglia leading to a negative feedback cycle", "chunk": 9}
{"article": "PMC3741576.txt", "subject": "TNF-\u03b1", "relationship": "BIOMARKER_DYNAMICS_UNDER_TREATMENT", "object": "Binding to TNFR1 can activate both NF-\u03baB survival pathway and apoptotic pathways", "chunk": 9}
{"article": "PMC3741576.txt", "subject": "TNF-\u03b1", "relationship": "MONITORED_DURING_TREATMENT", "object": "Levels may indicate treatment efficacy or toxicity", "chunk": 9}
{"article": "PMC3741576.txt", "subject": "IL-6", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Levels may indicate disease progression and worse clinical outcomes", "chunk": 9}
{"article": "PMC3748063.txt", "subject": "Sensory nerve conduction velocity", "relationship": "DIAGNOSTIC_OF", "object": "CTS", "chunk": 2}
{"article": "PMC3748063.txt", "subject": "Distal motor latency", "relationship": "RELATED_PROGNOSIS", "object": "Severity of CTS", "chunk": 2}
{"article": "PMC3748063.txt", "subject": "Sensory response", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Grade of median nerve impairment for CTS", "chunk": 2}
{"article": "PMC3748063.txt", "subject": "S2PD", "relationship": "INDICATES_PRESENCE_OF", "object": "Innervation density of slowly adapting nerve fibers", "chunk": 2}
{"article": "PMC3748063.txt", "subject": "M2PD", "relationship": "INDICATES_PRESENCE_OF", "object": "Innervation density of quickly adapting nerve fibers", "chunk": 2}
{"article": "PMC3748063.txt", "subject": "SWM test", "relationship": "INDICATES_PRESENCE_OF", "object": "Touch-pressure threshold", "chunk": 2}
{"article": "PMC3748063.txt", "subject": "FPPeak", "relationship": "INDICATES_PRESENCE_OF", "object": "Sensory status", "chunk": 3}
{"article": "PMC3748063.txt", "subject": "force ratio", "relationship": "INDICATES_PRESENCE_OF", "object": "Sensory status", "chunk": 3}
{"article": "PMC3748063.txt", "subject": "FPPeak", "relationship": "RELATED_TO", "object": "Traditional sensibility tests", "chunk": 3}
{"article": "PMC3748063.txt", "subject": "force ratio", "relationship": "RELATED_TO", "object": "Traditional sensibility tests", "chunk": 3}
{"article": "PMC3748063.txt", "subject": "FPPeak", "relationship": "RELATED_PROGNOSIS", "object": "Grades of CTS severity based on nerve conduction study", "chunk": 3}
{"article": "PMC3748063.txt", "subject": "force ratio", "relationship": "RELATED_PROGNOSIS", "object": "Grades of CTS severity based on nerve conduction study", "chunk": 3}
{"article": "PMC3748825.txt", "subject": "Caregiver burden", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Interventions aimed at supporting caregivers of AD patients", "chunk": 1}
{"article": "PMC3748825.txt", "subject": "Caregiver burden", "relationship": "RELATED_TREATMENT", "object": "Specific interventions aimed at supporting caregivers of AD patients", "chunk": 1}
{"article": "PMC3748825.txt", "subject": "Caregiver burden", "relationship": "INDICATES_PRESENCE_OF", "object": "High levels of stress", "chunk": 1}
{"article": "PMC3748825.txt", "subject": "Caregiver burden", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Higher risk of developing mood disorders, depression, insomnia and a lower quality of life", "chunk": 1}
{"article": "PMC3748825.txt", "subject": "cholinesterase inhibitors", "relationship": "RELATED_TREATMENT", "object": "prescribing cholinesterase inhibitors, memantine and atypical antipsychotics", "chunk": 3}
{"article": "PMC3748825.txt", "subject": "memantine", "relationship": "RELATED_TREATMENT", "object": "prescribing cholinesterase inhibitors, memantine and atypical antipsychotics", "chunk": 3}
{"article": "PMC3748825.txt", "subject": "atypical antipsychotics", "relationship": "RELATED_TREATMENT", "object": "prescribing cholinesterase inhibitors, memantine and atypical antipsychotics", "chunk": 3}
{"article": "PMC3748825.txt", "subject": "MMSE", "relationship": "SELECTED_BASED_ON", "object": "Alzheimer patient characteristics", "chunk": 5}
{"article": "PMC3748825.txt", "subject": "CDR", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": " Choice of interventions for AD patients", "chunk": 7}
{"article": "PMC3748825.txt", "subject": "ADL", "relationship": "INDICATES_PRESENCE_OF", "object": "Dementia severity", "chunk": 7}
{"article": "PMC3748825.txt", "subject": "IADL", "relationship": "INDICATES_PRESENCE_OF", "object": "Dementia severity", "chunk": 7}
{"article": "PMC3761088.txt", "subject": "APOE4", "relationship": "RELATED_PROGNOSIS", "object": "impaired cognitive function, AD and", "chunk": 2}
{"article": "PMC3761088.txt", "subject": "APOE4", "relationship": "INDICATES_TREATMENT_ELIGIBILITY", "object": "Memory-impaired adults with the episolon4 allele", "chunk": 2}
{"article": "PMC3761088.txt", "subject": "Intranasal insulin", "relationship": "RELATED_TREATMENT", "object": "Alzheimer's Disease", "chunk": 2}
{"article": "PMC3761088.txt", "subject": "Intranasal insulin", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "targeting the brain insulin pathway", "chunk": 2}
{"article": "PMC3761088.txt", "subject": "Intranasal insulin", "relationship": "RELATED_PROGNOSIS", "object": "reduced general cognitive decline", "chunk": 2}
{"article": "PMC3761088.txt", "subject": "FDG-PET", "relationship": "INDICATES_PRESENCE_OF", "object": "preserved metabolic integrity of the brain", "chunk": 2}
{"article": "PMC3761088.txt", "subject": "leptin", "relationship": "RELATED_TREATMENT", "object": "treat obesity", "chunk": 3}
{"article": "PMC3761088.txt", "subject": "leptin", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Intranasal delivery method for", "chunk": 3}
{"article": "PMC3761088.txt", "subject": "oxytocin", "relationship": "RELATED_TREATMENT", "object": "improve social behavior", "chunk": 3}
{"article": "PMC3761088.txt", "subject": "oxytocin", "relationship": "RELATED_TREATMENT", "object": "treat social anxiety disorder (SAD)", "chunk": 3}
{"article": "PMC3761088.txt", "subject": "oxytocin", "relationship": "RELATED_TREATMENT", "object": "attenuated BPD stress reactivity", "chunk": 3}
{"article": "PMC3761088.txt", "subject": "oxytocin", "relationship": "RELATED_TREATMENT", "object": "improve schizophrenia-induced social deficits", "chunk": 3}
{"article": "PMC3761088.txt", "subject": "oxytocin", "relationship": "RELATED_TREATMENT", "object": "reduce food intake and body weight", "chunk": 3}
{"article": "PMC3761088.txt", "subject": "oxytocin", "relationship": "RELATED_TREATMENT", "object": "facilitate weight loss", "chunk": 3}
{"article": "PMC3761088.txt", "subject": "hypocretin-1 (orexin A)", "relationship": "RELATED_TREATMENT", "object": "treat narcolepsy", "chunk": 3}
{"article": "PMC3761088.txt", "subject": "hypocretin-1 (orexin A)", "relationship": "RELATED_TREATMENT", "object": "reduce cognitive performance deficits resulting from sleep deprivation", "chunk": 3}
{"article": "PMC3761088.txt", "subject": "hypocretin-1 (orexin A)", "relationship": "RELATED_TREATMENT", "object": "stabilize rapid eye movement (REM) sleep", "chunk": 3}
{"article": "PMC3761088.txt", "subject": "hypocretin-1 (orexin A)", "relationship": "RELATED_TREATMENT", "object": "reduce wake to REM transitions in narcoleptics", "chunk": 3}
{"article": "PMC3761088.txt", "subject": "hypocretin-1 (orexin A)", "relationship": "RELATED_TREATMENT", "object": "improve olfactory dysfunction", "chunk": 3}
{"article": "PMC3761088.txt", "subject": "Intranasal stem cell treatment", "relationship": "RELATED_TREATMENT", "object": "Parkinson\u2019s disease, AD, Huntington\u2019s disease, stroke", "chunk": 4}
{"article": "PMC3761088.txt", "subject": "Intranasal stem cell treatment", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Noninvasive treatment option for central nervous system disorders", "chunk": 4}
{"article": "PMC3761088.txt", "subject": "Intranasal mesenchymal stem cells (MSCs)", "relationship": "RELATED_PROGNOSIS", "object": "Increased sensorimotor function following cerebral hypoxia-ischemia in mice", "chunk": 4}
{"article": "PMC3761088.txt", "subject": "Intranasal mesenchymal stem cells (MSCs)", "relationship": "RELATED_TREATMENT", "object": "Reduced gray and white matter loss in mice following cerebral hypoxia-ischemia", "chunk": 4}
{"article": "PMC3761088.txt", "subject": "Intranasal mesenchymal stem cells (MSCs)", "relationship": "RELATED_TREATMENT", "object": "Increased tyrosine hydroxylase and prevention of dopamine loss in the lesioned striatum and substantia nigra in rats with Parkinson\u2019s disease", "chunk": 4}
{"article": "PMC3761088.txt", "subject": "Intranasal mesenchymal stem cells (MSCs)", "relationship": "RELATED_TREATMENT", "object": "Decreased concentrations of multiple proinflammatory cytokines in the lesioned side of rats with Parkinson\u2019s disease", "chunk": 4}
{"article": "PMC3761088.txt", "subject": "Intranasal mesenchymal stem cells (MSCs)", "relationship": "RELATED_TREATMENT", "object": "Significant improvement in motor function in rats with Parkinson\u2019s disease", "chunk": 4}
{"article": "PMC3767625.txt", "subject": "A\u03b2 deposition", "relationship": "INDICATES_PRESENCE_OF", "object": "Mild cognitive impairment", "chunk": 2}
{"article": "PMC3767625.txt", "subject": "A\u03b2/tau level ratios", "relationship": "PREDICTS_SURVIVAL", "object": "Decline to CDR>0 from CDR=0", "chunk": 2}
{"article": "PMC3767625.txt", "subject": "apoe4 carrier status", "relationship": "RELATED_PROGNOSIS", "object": "Conversion to mild cognitive impairment", "chunk": 2}
{"article": "PMC3767625.txt", "subject": "apoe4 carrier status", "relationship": "DIAGNOSTIC_OF", "object": "Alzheimer\u2019s Disease", "chunk": 3}
{"article": "PMC3767625.txt", "subject": "apoe4 carrier status", "relationship": "RELATED_TREATMENT", "object": "None", "chunk": 3}
{"article": "PMC3767625.txt", "subject": "cerebral spinal fluid A\u03b2 level", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer\u2019s Disease", "chunk": 3}
{"article": "PMC3767625.txt", "subject": "Hippocampus Volume", "relationship": "RELATED_PROGNOSIS", "object": "Conversion to Mild Cognitive Impairment", "chunk": 4}
{"article": "PMC3767625.txt", "subject": "Entorhinal Volume", "relationship": "RELATED_PROGNOSIS", "object": "Conversion to Mild Cognitive Impairment", "chunk": 4}
{"article": "PMC3767625.txt", "subject": "Posterior Cingulate Metabolism", "relationship": "RELATED_PROGNOSIS", "object": "Conversion to Mild Cognitive Impairment", "chunk": 4}
{"article": "PMC3767625.txt", "subject": "apoe4", "relationship": "INDICATES_PRESENCE_OF", "object": "Mild cognitive impairment   converters", "chunk": 5}
{"article": "PMC3767625.txt", "subject": "MRglc", "relationship": "RELATED_TREATMENT", "object": "Treatment for cognitive decline", "chunk": 5}
{"article": "PMC3767625.txt", "subject": "hypometabolism in the hippocampal and entorhinal cortices", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Cognitive decline", "chunk": 5}
{"article": "PMC3767625.txt", "subject": "hippocampus volume", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Treatment for AD", "chunk": 5}
{"article": "PMC3767625.txt", "subject": "ERC thickness", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Treatment for AD", "chunk": 5}
{"article": "PMC3767625.txt", "subject": "MRglc reductions in ERC", "relationship": "PREDICTS_SURVIVAL", "object": "Survival from cognitive decline", "chunk": 5}
{"article": "PMC3767625.txt", "subject": "rate of atrophy in the medial temporal lobe", "relationship": "PREDICTS_SURVIVAL", "object": "Survival from cognitive decline", "chunk": 5}
{"article": "PMC3767625.txt", "subject": "hippocampal volume", "relationship": "PREDICTS_MORTALITY", "object": "Mortality from dementia", "chunk": 5}
{"article": "PMC3767625.txt", "subject": "cortical thickness measures", "relationship": "PREDICTS_SURVIVAL", "object": "Survival from AD progression", "chunk": 5}
{"article": "PMC3767625.txt", "subject": "maps of regional grey matter distribution", "relationship": "PREDICTS_SURVIVAL", "object": "Survival from AD progression", "chunk": 5}
{"article": "PMC3767625.txt", "subject": "multimodal biomarkers derived from combined MRI and FDG-PET", "relationship": "PREDICTS_SURVIVAL", "object": "Survival from AD progression", "chunk": 5}
{"article": "PMC3767625.txt", "subject": "neurophysiological measurements", "relationship": "PREDICTS_SURVIVAL", "object": "Survival from further cognitive decline", "chunk": 5}
{"article": "PMC3832588.txt", "subject": "RBANS", "relationship": "INDICATES_PRESENCE_OF", "object": "Dementia in the elderly", "chunk": 3}
{"article": "PMC3832588.txt", "subject": "RBANS", "relationship": "RELATED_TREATMENT", "object": "Evaluation of elderly patients with abnormal cognitive decline", "chunk": 3}
{"article": "PMC3832588.txt", "subject": "RBANS", "relationship": "RELATED_PROGNOSIS", "object": "scores improved by a similar magnitude pre and post training, ...", "chunk": 4}
{"article": "PMC3832588.txt", "subject": "RBANS total scale index scores", "relationship": "PREDICTED_TREATMENT_EFFECT", "object": "Improvements in memory and attention in healthy elderly.", "chunk": 5}
{"article": "PMC3835777.txt", "subject": "tumor-necrosis-factor- (TNF-) \u03b1", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Neurotoxic and neurodegenerative outcomes", "chunk": 1}
{"article": "PMC3835777.txt", "subject": "TNF-\u03b1", "relationship": "RELATED_TREATMENT", "object": "Enhances synaptic strength", "chunk": 1}
{"article": "PMC3835777.txt", "subject": "IL1\u03b2", "relationship": "RELATES_TO", "object": "Long-term potentiation (LTP)", "chunk": 1}
{"article": "PMC3835777.txt", "subject": "IL1\u03b2", "relationship": "RELATED_TREATMENT", "object": "Induction of long-term potentiation", "chunk": 1}
{"article": "PMC3835777.txt", "subject": "Microglial ", "relationship": "INDICATES_PRESENCE_OF", "object": "Inflammation", "chunk": 1}
{"article": "PMC3835777.txt", "subject": "IL1\u03b2", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Chronic inflammation", "chunk": 1}
{"article": "PMC3835777.txt", "subject": "M2 phenotype", "relationship": "RELATED_TREATMENT", "object": "Neuroprotection, recovery, and repair", "chunk": 1}
{"article": "PMC3835777.txt", "subject": "M1 phenotype", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "neurotoxicity and neurodegenerative outcomes", "chunk": 1}
{"article": "PMC3835777.txt", "subject": "Microglia", "relationship": "PREDICTS_SURVIVAL", "object": "Predicts the potential for neurodegenerative processes", "chunk": 1}
{"article": "PMC3835777.txt", "subject": "C1q", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Microglia-synapse interactions in postnatal brain development", "chunk": 2}
{"article": "PMC3835777.txt", "subject": "C3", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Microglia-synapse interactions in postnatal brain development", "chunk": 2}
{"article": "PMC3835777.txt", "subject": "CR3", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Microglia-synapse interactions in postnatal brain development", "chunk": 2}
{"article": "PMC3835777.txt", "subject": "tPA", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Stability of synaptic adhesion molecules", "chunk": 2}
{"article": "PMC3835777.txt", "subject": "tPA", "relationship": "INDICATES_PRESENCE_OF", "object": "Synaptic Growth", "chunk": 3}
{"article": "PMC3835777.txt", "subject": "MMP-9", "relationship": "INDICATES_PRESENCE_OF", "object": "Synaptic Growth", "chunk": 3}
{"article": "PMC3835777.txt", "subject": "tPA", "relationship": "ASSOCIATED_WITH", "object": "Decreased N-cadherin levels ", "chunk": 3}
{"article": "PMC3835777.txt", "subject": "MMP-9", "relationship": "ASSOCIATED_WITH", "object": "Decreased N-cadherin levels ", "chunk": 3}
{"article": "PMC3835777.txt", "subject": "tPA", "relationship": "REGULATES", "object": "MMP Activity", "chunk": 3}
{"article": "PMC3835777.txt", "subject": "Cx43", "relationship": "INDICATES_PRESENCE_OF", "object": "Increased Functional Syncytium", "chunk": 3}
{"article": "PMC3835777.txt", "subject": "Cx36", "relationship": "RELATED_PROGNOSIS", "object": "No upregulation during microglial activation", "chunk": 3}
{"article": "PMC3835777.txt", "subject": "Cx36", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Blocking Cx hemichannels might help block microglial glutamate release", "chunk": 3}
{"article": "PMC3835777.txt", "subject": "Cx43", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Exaggerated neuronal activation and excitotoxicity", "chunk": 3}
{"article": "PMC3835777.txt", "subject": "Cx hemichannels", "relationship": "RELATED_PROGNOSIS", "object": "May indirectly affect neuronal activity and survival", "chunk": 3}
{"article": "PMC3835777.txt", "subject": "P2X4", "relationship": "INDICATES_PRESENCE_OF", "object": "Primary Channel upregulated in Activated Microglia", "chunk": 3}
{"article": "PMC3836814.txt", "subject": "Methylene Blue (MB)", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Treatment of ischemic stroke", "chunk": 1}
{"article": "PMC3836814.txt", "subject": "Methylene Blue (MB)", "relationship": "RELATED_TREATMENT", "object": "Potential treatment for ischemic stroke", "chunk": 1}
{"article": "PMC3836814.txt", "subject": "Methylene Blue (MB)", "relationship": "RELATED_TREATMENT", "object": "Diagnosis and treatment of methemoglobinemia", "chunk": 1}
{"article": "PMC3836814.txt", "subject": "Methylene Blue (MB)", "relationship": "RELATED_TREATMENT", "object": "Treatment of cyanide poisoning", "chunk": 1}
{"article": "PMC3836814.txt", "subject": "ADC", "relationship": "RELATED_TO", "object": " lesion volume ", "chunk": 2}
{"article": "PMC3836814.txt", "subject": "CBF", "relationship": "RELATED_TO", "object": " lesion volume ", "chunk": 2}
{"article": "PMC3836814.txt", "subject": "MB", "relationship": "RELATED_TREATMENT", "object": "treatment of ischemic stroke", "chunk": 3}
{"article": "PMC3836814.txt", "subject": "MB", "relationship": "ASSOCIATED_WITH_BETTER_OUTCOME", "object": "general improvement in neurological status", "chunk": 3}
{"article": "PMC3836814.txt", "subject": "MB", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "treatment protocol based on  published results", "chunk": 3}
{"article": "PMC3836814.txt", "subject": "MB", "relationship": "PREDICTED_SURVIVAL", "object": "sustainable energy (ATP) production in mitochondrial respiration", "chunk": 3}
{"article": "PMC3859216.txt", "subject": "Mild cognitive impairment", "relationship": "DIAGNOSITC_OF", "object": "probable Alzheimer\u2019s disease", "chunk": 1}
{"article": "PMC3859216.txt", "subject": "language changes", "relationship": "INDICATES_PRESENCE_OF", "object": "prodromal stages of Alzheimer\u2019s disease", "chunk": 1}
{"article": "PMC3859216.txt", "subject": "subtle changes in language communication ability", "relationship": "INDICATES_PRESENCE_OF", "object": "years or even decades before cognitive deterioration", "chunk": 1}
{"article": "PMC3859216.txt", "subject": "disease-specific language abnormalities", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "enhancing clinicians\u2019 ability to distinguish probable Alzheimer\u2019s disease", "chunk": 1}
{"article": "PMC3863786.txt", "subject": "Long chain omega-3 polyunsaturated fatty acids (O3PUFA)", "relationship": "RELATED_WITH_BETTER_OUTCOME", "object": "Less WMH in cross-sectional studies", "chunk": 1}
{"article": "PMC3863786.txt", "subject": "Long chain omega-3 polyunsaturated fatty acids (O3PUFA)", "relationship": "RELATED_WITH_BETTER_OUTCOME", "object": "Less executive decline per year of aging", "chunk": 1}
{"article": "PMC3863786.txt", "subject": "apoe4 allele", "relationship": "INDICATES_PRESENCE_OF", "object": " Dementia risk", "chunk": 1}
{"article": "PMC3863786.txt", "subject": "White matter hyperintensities (WMH)", "relationship": "DIAGNOSITC_OF", "object": "Small vessel disease and dementia risk", "chunk": 1}
{"article": "PMC3863786.txt", "subject": "White matter hyperintensities (WMH)", "relationship": "RELATED_TO", "object": "Cognitive impairment", "chunk": 1}
{"article": "PMC3863786.txt", "subject": "White matter hyperintensities (WMH)", "relationship": "PREDICTED_BY", "object": "Longitudinal examination of executive decline", "chunk": 1}
{"article": "PMC3863786.txt", "subject": "Patients previously diagnosed with a minor cognitive impairment (MCI)", "relationship": "RELATED_TO", "object": "An increased risk for developing Alzheimer's disease and other dementias.", "chunk": 1}
{"article": "PMC3863786.txt", "subject": "O3PUFA", "relationship": "INDICATES_PRESENCE_OF", "object": "Cognitive decline", "chunk": 2}
{"article": "PMC3863786.txt", "subject": "O3PUFA", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Cognitive decline", "chunk": 2}
{"article": "PMC3863786.txt", "subject": "O3PUFA", "relationship": "RELATED_TREATMENT", "object": "Cognitive decline", "chunk": 2}
{"article": "PMC3863786.txt", "subject": "WMH", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Cognitive decline", "chunk": 2}
{"article": "PMC3863786.txt", "subject": "apoe4", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive decline", "chunk": 3}
{"article": "PMC3863786.txt", "subject": "O3PUFA", "relationship": "INDICATES_PRESENCE_OF", "object": "Less executive decline", "chunk": 3}
{"article": "PMC3863786.txt", "subject": "O3PUFA", "relationship": "INDICATES_PRESENCE_OF", "object": "Less white matter hyperintensity", "chunk": 3}
{"article": "PMC3863786.txt", "subject": "O3PUFA", "relationship": "RELATED_TREATMENT", "object": "Delay in age-dependent executive decline", "chunk": 3}
{"article": "PMC3863786.txt", "subject": "WMH", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Worse executive function", "chunk": 3}
{"article": "PMC3863786.txt", "subject": "O3PUFA", "relationship": "RELATED_PROGNOSIS", "object": "Stable executive function over time", "chunk": 4}
{"article": "PMC3863786.txt", "subject": "O3PUFA", "relationship": "RELATED_PROGNOSIS", "object": "Delayed age-dependent executive decline", "chunk": 4}
{"article": "PMC3863786.txt", "subject": "O3PUFA", "relationship": "RELATED_TREATMENT", "object": "Neuroprotection", "chunk": 4}
{"article": "PMC3863786.txt", "subject": "O3PUFA ", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Treatment for age-related cognitive decline in cognitively intact individuals", "chunk": 4}
{"article": "PMC3863786.txt", "subject": "DHA", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Treatment: Alzheimer's Disease", "chunk": 5}
{"article": "PMC3869082.txt", "subject": "Perceived Stress Scale of 14 items (PSS-14)", "relationship": "INDICATES_TREATMENT_ELIGIBILITY", "object": "Inclusion in the trial", "chunk": 2}
{"article": "PMC3869082.txt", "subject": "Mini-Mental State Examination (MMSE)", "relationship": "USED_TO_DIAGNOSE", "object": "Global cognitive status of patients with AD", "chunk": 4}
{"article": "PMC3914466.txt", "subject": "Presenilin-1 gene", "relationship": "RELATED_TREATMENT", "object": "Analyzing their mutation to predict the development of Alzheimer's Disease", "chunk": 1}
{"article": "PMC3914466.txt", "subject": "delta- and theta-band", "relationship": "INDICATES_PRESENCE_OF", "object": "Mild Cognitive Impairment and Alzheimer's Disease", "chunk": 2}
{"article": "PMC3914466.txt", "subject": "alpha- and beta-band", "relationship": "INDICATES_PRESENCE_OF", "object": "Reduced power in", "chunk": 2}
{"article": "PMC3914466.txt", "subject": "increased gamma-band power", "relationship": "ASSOCIATED_WITH", "object": "Mild Cognitive Impairment and Alzheimer's Disease", "chunk": 2}
{"article": "PMC3914466.txt", "subject": "severe slowing of background activity", "relationship": "ASSOCIATED_WITH", "object": "Alzheimer's Disease", "chunk": 2}
{"article": "PMC3914466.txt", "subject": "decrease of power at fast (alpha and beta) EEG frequency ranges", "relationship": "ASSOCIATED_WITH", "object": "Alzheimer's Disease", "chunk": 2}
{"article": "PMC3914466.txt", "subject": "Increase in the slow frequency", "relationship": "RELATED_PROGNOSIS", "object": "Degree of cognitive impairment", "chunk": 2}
{"article": "PMC3914466.txt", "subject": "posterior alpha (8\u201312\u2009Hz) and/or beta (13\u201330\u2009Hz) frequencies", "relationship": "INDICATES_PRESENCE_OF", "object": "Decreased power for", "chunk": 2}
{"article": "PMC3914466.txt", "subject": "delta and theta", "relationship": "INDICATES_PRESENCE_OF", "object": "Increased power for", "chunk": 2}
{"article": "PMC3914466.txt", "subject": "decrease of the individual alpha frequency (IAF) peak in power density", "relationship": "ASSOCIATED_WITH", "object": "Early stages of Alzheimer's Disease (even preclinical)", "chunk": 2}
{"article": "PMC3914466.txt", "subject": "electroencephalographic patterns", "relationship": "RELATED_TO", "object": "Early stages of Alzheimer's Disease. ", "chunk": 2}
{"article": "PMC3914466.txt", "subject": "quantitative EEG analysis", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Identifying subjects who will develop Alzheimer's Disease more rapidly", "chunk": 2}
{"article": "PMC3914466.txt", "subject": "theta band", "relationship": "INDICATES_PRESENCE_OF", "object": "Probable AD", "chunk": 3}
{"article": "PMC3914466.txt", "subject": "alpha power", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Probable AD", "chunk": 3}
{"article": "PMC3914466.txt", "subject": "EEG", "relationship": "INDICATES_PRESENCE_OF", "object": "Functional disturbances", "chunk": 5}
{"article": "PMC3914466.txt", "subject": "EEG", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Clinical treatment for AD", "chunk": 5}
{"article": "PMC3914466.txt", "subject": "D2", "relationship": "RELATED_PROGNOSIS", "object": "Prediction of the disease's course", "chunk": 5}
{"article": "PMC3914466.txt", "subject": "MMSE", "relationship": "DIAGNOSITC_OF", "object": "Alzheimer's Disease", "chunk": 5}
{"article": "PMC3914466.txt", "subject": "IAF", "relationship": "DIAGNOSITC_OF", "object": "Alzheimer's Disease", "chunk": 5}
{"article": "PMC3914466.txt", "subject": "Global D2", "relationship": "DIAGNOSITC_OF", "object": "Differentiating Normal, ACr, and Probable AD", "chunk": 5}
{"article": "PMC3914466.txt", "subject": "Regional D2", "relationship": "DIAGNOSITC_OF", "object": "Differentiating Normal, ACr, and Probable AD", "chunk": 5}
{"article": "PMC3914466.txt", "subject": "Slow bands", "relationship": "DIAGNOSITC_OF", "object": "Differentiating Normal, ACr, and Probable AD", "chunk": 5}
{"article": "PMC3914466.txt", "subject": "Fast bands", "relationship": "DIAGNOSITC_OF", "object": "Differentiating Normal, ACr, and Probable AD", "chunk": 5}
{"article": "PMC3923761.txt", "subject": "P300 latency", "relationship": "INDICATES_PRESENCE_OF", "object": "significant positive correlation with reaction times", "chunk": 3}
{"article": "PMC3923761.txt", "subject": "P300 latency", "relationship": "RELATED_PROGNOSIS", "object": "P300 latency shows a significant positive correlation with reaction times", "chunk": 3}
{"article": "PMC3923761.txt", "subject": "P300 latency", "relationship": "RELATED_PROGNOSIS", "object": "Age-related development", "chunk": 5}
{"article": "PMC3923761.txt", "subject": "P300 amplitude", "relationship": "RELATED_PROGNOSIS", "object": "Age-related development", "chunk": 5}
{"article": "PMC3923761.txt", "subject": "P300 latency", "relationship": "RELATED_PROGNOSIS", "object": "Reaching a minimum in adolescence", "chunk": 5}
{"article": "PMC3923761.txt", "subject": "P300 amplitude", "relationship": "RELATED_PROGNOSIS", "object": "Reaching maximum around 21 years of age", "chunk": 5}
{"article": "PMC3923761.txt", "subject": "Reaction time", "relationship": "RELATED_PROGNOSIS", "object": "Fastest reaction times estimated at around 32 years of age", "chunk": 5}
{"article": "PMC3923761.txt", "subject": "P300 latency", "relationship": "RELATED_PROGNOSIS", "object": "information processing efficiency or effectiveness", "chunk": 6}
{"article": "PMC3923761.txt", "subject": "P300 latency", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "increasing P300 latency is observed in older age.", "chunk": 6}
{"article": "PMC3923761.txt", "subject": "P300 amplitude", "relationship": "RELATED_PROGNOSIS", "object": "cognitive resources", "chunk": 6}
{"article": "PMC3923761.txt", "subject": "P300 amplitude", "relationship": "RELATED_TREATMENT", "object": "Paradigm properties", "chunk": 6}
{"article": "PMC3923761.txt", "subject": "P300 amplitude", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Habituation, Stimulus Loudness", "chunk": 6}
{"article": "PMC3923761.txt", "subject": "P300 amplitude", "relationship": "MONITORED_DURING_TREATMENT", "object": " Oddball Paradigm tasks", "chunk": 6}
{"article": "PMC3923761.txt", "subject": "fractional anisotropy (FA)", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Myelination and organization of white matter bundles", "chunk": 6}
{"article": "PMC3935919.txt", "subject": "Age", "relationship": "RELATED_PROGNOSIS", "object": "Higher performance on melodic memory task", "chunk": 14}
{"article": "PMC3935919.txt", "subject": "Age", "relationship": "RELATED_PROGNOSIS", "object": "Lower levels of self-reported musical sophistication", "chunk": 14}
{"article": "PMC3935919.txt", "subject": "Musical Training", "relationship": "RELATED_PROGNOSIS", "object": "Better performance on melodic memory task", "chunk": 14}
{"article": "PMC3935919.txt", "subject": "musical training", "relationship": "RELATED_PROGNOSIS", "object": "higher scores on melodic memory task", "chunk": 15}
{"article": "PMC3935919.txt", "subject": "musical training", "relationship": "RELATED_PROGNOSIS", "object": "higher scores on beat perception task", "chunk": 15}
{"article": "PMC3935919.txt", "subject": "musical training", "relationship": "RELATED_TREATMENT", "object": "greater wealth", "chunk": 15}
{"article": "PMC3935919.txt", "subject": "musical training", "relationship": "RELATED_TREATMENT", "object": "more active musical engagement", "chunk": 15}
{"article": "PMC3935919.txt", "subject": "musical training", "relationship": "RELATED_TREATMENT", "object": "better test performance", "chunk": 15}
{"article": "PMC3935919.txt", "subject": "musical training", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "selecting treatment based on musical training level", "chunk": 15}
{"article": "PMC3940003.txt", "subject": "A\u03b2 plaques", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's disease", "chunk": 2}
{"article": "PMC3940003.txt", "subject": "A\u03b2 plaques", "relationship": "ASSOCIATED_WITH", "object": "cerebral amyloid angiopathy", "chunk": 2}
{"article": "PMC3940003.txt", "subject": "CD163", "relationship": "RELATED_PROGNOSIS", "object": "Inflammatory component diseases like HIV encephalitis, SIV encephalitis, multiple sclerosis and head injury", "chunk": 2}
{"article": "PMC3940003.txt", "subject": "AT8 staining", "relationship": "DIAGNOSITC_OF", "object": "Alzheimer\u2019s disease", "chunk": 2}
{"article": "PMC3940003.txt", "subject": "4G8 staining", "relationship": "DIAGNOSITC_OF", "object": "Alzheimer\u2019s disease", "chunk": 2}
{"article": "PMC3940003.txt", "subject": "Alpha-synuclein", "relationship": "USED_TO_DIAGNOSE", "object": "Diagnosing Parkinson's Disease with dementia", "chunk": 3}
{"article": "PMC3940003.txt", "subject": "Tau", "relationship": "USED_TO_DIAGNOSE", "object": "Diagnosing dementia with Lewy bodies", "chunk": 3}
{"article": "PMC3940003.txt", "subject": "Abeta", "relationship": "USED_TO_DIAGNOSE", "object": "Diagnosing Alzheimer's Disease", "chunk": 3}
{"article": "PMC3940003.txt", "subject": "CD163 immunoreactivity", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 4}
{"article": "PMC3940003.txt", "subject": "CD163 immunoreactivity", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "Alzheimer's Disease", "chunk": 4}
{"article": "PMC3940003.txt", "subject": "CD163", "relationship": "RELATED_PROGNOSIS", "object": "Immunoreactive %area in different brain regions of AD and PD cases", "chunk": 5}
{"article": "PMC3940003.txt", "subject": "CD163", "relationship": "INDICATES_PRESENCE_OF", "object": "Microglia in brain regions", "chunk": 5}
{"article": "PMC3940003.txt", "subject": "CD163", "relationship": "RELATED_TREATMENT", "object": "Double immunofluorescence labeling", "chunk": 5}
{"article": "PMC3940003.txt", "subject": "CD163", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Comparison with other markers like Iba1 and MRC1 to differentiate from PVM", "chunk": 5}
{"article": "PMC3940003.txt", "subject": "CD163", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "The presence of CD163 immunoreactive microglia", "chunk": 6}
{"article": "PMC3940003.txt", "subject": "CD163 immunoreactive microglia", "relationship": "INDICATES_TREATMENT_ELIGIBILITY", "object": "migrate from the periphery", "chunk": 6}
{"article": "PMC3940003.txt", "subject": "CD163 immunoreactive microglia", "relationship": "RELATED_TREATMENT", "object": "BBB breakdown", "chunk": 6}
{"article": "PMC3940003.txt", "subject": "CD163 immunoreactive microglia", "relationship": "RESPONDED_TO", "object": "BBB damage", "chunk": 6}
{"article": "PMC3940003.txt", "subject": "CD163 immunoreactive microglia", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "A\u03b2 plaques", "chunk": 6}
{"article": "PMC3940003.txt", "subject": "CD163 immunoreactive microglia", "relationship": "MONITORED_DURING_TREATMENT", "object": "A\u03b2 plaque deposition", "chunk": 6}
{"article": "PMC3940003.txt", "subject": "CD163", "relationship": "INDICATES_PRESENCE_OF", "object": "brain parenchyma", "chunk": 8}
{"article": "PMC3940003.txt", "subject": "CD163", "relationship": "RELATED_TO", "object": "microglia/macrophages", "chunk": 8}
{"article": "PMC3940003.txt", "subject": "CD163", "relationship": "RELATED_TO", "object": "neuritic plaques", "chunk": 8}
{"article": "PMC3940003.txt", "subject": "CD163", "relationship": "ASSOCIATED_WITH", "object": "compromised blood vessels", "chunk": 8}
{"article": "PMC3940003.txt", "subject": "CD163", "relationship": "MONITORED_DURING_TREATMENT", "object": "treatment", "chunk": 8}
{"article": "PMC3940003.txt", "subject": "CD68", "relationship": "RELATED_TO", "object": "phagocytic function", "chunk": 8}
{"article": "PMC3940003.txt", "subject": "CD163", "relationship": "RELATED_TO", "object": "extracellular protein pathology", "chunk": 8}
{"article": "PMC3940003.txt", "subject": "A\u03b2", "relationship": "STIMULANT_FOR", "object": "microglia", "chunk": 8}
{"article": "PMC3948001.txt", "subject": "dopamine", "relationship": "INDICATES_PRESENCE_OF", "object": "hypodopaminergic symptoms", "chunk": 1}
{"article": "PMC3948001.txt", "subject": "dopamine", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "treatments for PD, especially dopamine agonists", "chunk": 1}
{"article": "PMC3948001.txt", "subject": "dopamine", "relationship": "RELATED_PROGNOSIS", "object": "hypoactivation of the dopamine reward pathway secondary to the degenerative processes observed in PD", "chunk": 1}
{"article": "PMC3948001.txt", "subject": "dopamine", "relationship": "RELATED_TREATMENT", "object": "dopamine agonists can induce impulse control disorders.", "chunk": 1}
{"article": "PMC3948001.txt", "subject": "SHAPS", "relationship": "USED_TO_DIAGNOSE", "object": "anxiety and depression.", "chunk": 1}
{"article": "PMC3948001.txt", "subject": "Snaith\u2013Hamilton Pleasure Scale (SHAPS)", "relationship": "RELATED_TREATMENT", "object": "treatments for PD", "chunk": 1}
{"article": "PMC3948001.txt", "subject": "anhedonia", "relationship": "INDICATES_PRESENCE_OF", "object": "hypodopaminergic symptoms in Parkinson\u2019s disease", "chunk": 1}
{"article": "PMC3948001.txt", "subject": "anhedonia", "relationship": "DIAGNOSITC_OF", "object": "major depression", "chunk": 1}
{"article": "PMC3948001.txt", "subject": "anhedonia", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "treatments for PD", "chunk": 1}
{"article": "PMC3948001.txt", "subject": "anhedonia", "relationship": "ASSOCIATED_WITH_POOR_OUTCOME", "object": "poor therapeutic outcome", "chunk": 1}
{"article": "PMC3948001.txt", "subject": "anhedonia", "relationship": "RELATED_PROGNOSIS", "object": "the hedonic capacity may remain intact", "chunk": 1}
{"article": "PMC3948001.txt", "subject": "physical consummatory anhedonia", "relationship": "SPECIFIC_FOR", "object": "PD subjects", "chunk": 1}
{"article": "PMC3948001.txt", "subject": "consummatory anhedonia", "relationship": "RELATED_PROGNOSIS", "object": "endogenomorphic depression", "chunk": 1}
{"article": "PMC3948001.txt", "subject": "anticipatory anhedonia", "relationship": "RELATED_PROGNOSIS", "object": "non-endogenomorphic depression ", "chunk": 1}
{"article": "PMC3948001.txt", "subject": "BDI-II total score", "relationship": "RELATED_PROGNOSIS", "object": "Depression", "chunk": 3}
{"article": "PMC3948001.txt", "subject": "BDI-II total score", "relationship": "INDICATES_PRESENCE_OF", "object": "Depression", "chunk": 3}
{"article": "PMC3948001.txt", "subject": "ENDO-BDI-II >6", "relationship": "INDICATES_PRESENCE_OF", "object": "Endogenomorphic depression", "chunk": 3}
{"article": "PMC3948001.txt", "subject": "BDI-II >11", "relationship": "INDICATES_PRESENCE_OF", "object": "Depression", "chunk": 3}
{"article": "PMC3948001.txt", "subject": "SHAPS \u22653", "relationship": "INDICATES_PRESENCE_OF", "object": "Anhedonia", "chunk": 3}
{"article": "PMC3948001.txt", "subject": "MMSE", "relationship": "RELATED_PROGNOSIS", "object": "Cognitive function", "chunk": 3}
{"article": "PMC3948001.txt", "subject": "UPDRS part III", "relationship": "RELATED_PROGNOSIS", "object": "Motor function", "chunk": 3}
{"article": "PMC3948001.txt", "subject": "Hoehn and Yahr stage", "relationship": "RELATED_PROGNOSIS", "object": "Disease severity", "chunk": 3}
{"article": "PMC3978219.txt", "subject": "Florbetapir (AV-45)", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "Clinical purposes", "chunk": 1}
{"article": "PMC3978219.txt", "subject": "Florbetapir (AV-45)", "relationship": "RELATED_TO", "object": "Diagnosis of Alzheimer\u2019s disease from the earliest stages", "chunk": 1}
{"article": "PMC3978219.txt", "subject": "Florbetapir (AV-45)", "relationship": "INDICATES_PRESENCE_OF", "object": "Amyloid burden in the brain of patients with AD compared to healthy controls", "chunk": 1}
{"article": "PMC3978219.txt", "subject": "Florbetapir (AV-45)", "relationship": "USED_TO_DIAGNOSE", "object": "Probable AD", "chunk": 1}
{"article": "PMC3978219.txt", "subject": "Florbetapir (AV-45)", "relationship": "RELATED_PROGNOSIS", "object": "Progression of Alzheimer's disease", "chunk": 1}
{"article": "PMC3978219.txt", "subject": "Florbetapir (AV-45)", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Clinical use of  AV-45 imaging", "chunk": 1}
{"article": "PMC3978219.txt", "subject": "Florbetapir (AV-45)", "relationship": "MONITORED_DURING_TREATMENT", "object": "Progression of Alzheimer's disease", "chunk": 1}
{"article": "PMC3978219.txt", "subject": "Florbetapir (AV-45)", "relationship": "BIOMARKER_DYNAMICS_UNDER_TREATMENT", "object": "Progression of Alzheimer's disease", "chunk": 1}
{"article": "PMC3978219.txt", "subject": "Abnormal cerebral spinal fluid biomarkers", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 2}
{"article": "PMC3978219.txt", "subject": "AV-45 uptake", "relationship": "INDICATES_PRESENCE_OF", "object": "Alzheimer's Disease", "chunk": 3}
{"article": "PMC3978219.txt", "subject": "AV-45 uptake", "relationship": "DIAGNOSTIC_OF", "object": "Alzheimer's Disease", "chunk": 3}
{"article": "PMC3978219.txt", "subject": "AV-45", "relationship": "INDICATES_PRESENCE_OF", "object": "Prodromal Alzheimer's Disease", "chunk": 4}
{"article": "PMC3978219.txt", "subject": "AV-45", "relationship": "RELATED_TO", "object": "Amyloid burden", "chunk": 4}
{"article": "PMC3978219.txt", "subject": "AV-45", "relationship": "GUIDES_TREATMENT_SELECTION", "object": "Cortical quantification using MRI or PET methods", "chunk": 4}
{"article": "PMC3978219.txt", "subject": "AV-45", "relationship": "IS_BASIS_FOR_THERAPY_CHOICE", "object": "PET template-based quantification", "chunk": 5}
{"article": "PMC3978219.txt", "subject": "AV-45", "relationship": "RELATED_TREATMENT", "object": "Clinical use", "chunk": 5}
{"article": "PMC3978219.txt", "subject": "AV-45", "relationship": "IS_TARGET_OF_TREATMENT", "object": "MRI-based quantification", "chunk": 5}
{"article": "PMC3978219.txt", "subject": "AV-45", "relationship": "INDICATES_PRESENCE_OF", "object": "Prodromal AD", "chunk": 5}
